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In 1975, Rodbard introduced the concept of mechanical homeostasis; that arteries have an 
inherent capacity to maintain homeostatic stress states by altering their morphology through a 
negative feedback mechanism in response to mechanical loads. More recently, this capacity has 
been leveraged to develop acellular, in situ tissue-engineered vascular grafts (iTEVGs) which 
promote host growth and remodeling (G&R) to develop new arteries (neoarteries) in the tissue's 
functional site (in situ). These grafts offer a much-needed option to address the lack of viable 
autologous conduits, difficulties in scaling traditional tissue engineered grafts, and the rising 
demand for bypass grafting in an aging population.  One such acellular, poly (glycerol sebacate) 
(PGS) iTEVG developed by Wang et al. has demonstrated in situ mature elastin and collagen 
formation in young hosts. However, the trial and error nature of graft design, coupled with the lack 
of knowledge of fundamental mechanisms guiding neoarterial G&R impedes efforts to translate 
these successes across age and species.  
In this work, we take a coupled theoretical and experimental approach to understanding 
salient mechanisms guiding neoartery formation in young and aged hosts. We developed a 
mathematical model of graft degradation based on in vitro assessment of enzymatic degradation. 
Next, we translated successful neoartery development from a rat aorta to the substantially smaller, 
rat carotid artery. We determined that after three-months of remodeling, the neoartery has similar 
mechanical properties to those of the clinical gold standard, vein graft. We then successfully 
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translated the iTEVG to an aged murine carotid model and assessed differences in mechanical, 
microstructural, and biological stages of neoarterial G&R in young versus aged hosts over the 
course of six months. Subsequently, a constrained mixture model-based G&R tool was developed, 
informed with these experimental data, and used to predict long-term neoarterial G&R response 
in both age groups. Finally, we identified a common mode of adverse remodeling in neoarteries - 
rupture and calcification. Motivated by these results, we developed new techniques to analyze 
calcification in a parallel, model system exhibiting similar modes of adverse remodeling - cerebral 
aneurysms. These results provide insights for future work developing strategies necessary to 
optimally design iTEVGs.  
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1.1 The Need for Small Diameter Vascular Grafts 
“Operating on the edge of cardiovascular disease” --- Edward Lakatta [1] 
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality, 
globally, and in the United States [2]. Atherosclerosis induced coronary heart disease alone 
accounts for 31% of global deaths and 45% of deaths in the U.S. Another 8.5 million people in the 
U.S. and 202 million worldwide suffer from atherosclerosis-derived  peripheral artery disease [3]. 
Furthermore, this situation is expected to worsen as the world population is aging. Globally, the 
population aged 60 or above is growing at a rate of about 3% year, and by 2050, a quarter of the 
population in every country will be over 60 years old [4]. In the U.S., the prevalence of CVD in 
the aged population is about 80% in people over 80 years old [2]. Although epidemiological studies 
have shown that lifestyle, lipid levels, genetics and hypertension are risk factors for CVD, age 
remains the biggest contributor to this disease [5].  
Despite advances in endovascular treatments, bypass grafting remains the only suitable 
alternative for revascularization in many patients suffering from coronary heart disease (Figure 1). 
Furthermore, there is an increased need for revascularization in the older population since studies 
have also shown that aging is associated with increased thickening and dilatation of arterial walls 
even in the absence of atherosclerosis [6]. In the U.S. alone, 400,000 coronary artery bypasses and 
460,000 peripheral artery bypasses are performed annually [2], [3].  Furthermore, another 110,000 
receive arteriovenous fistulae for hemodialysis access annually in the U.S.[7]. The clinical gold 
standard for bypassing small diameter (< 6mm) arteries like the coronaries is the vein graft. 
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However, expanded indications for the procedure, shift to elderly population and increased number 
of re-operations limits the availability of suitable autologous grafts for bypass grafting[8]. The lack 
of viable autologous conduits has led to the widely recognized need for off-the-shelf, functional, 














1.2 Cardiovascular Soft Tissue: Arteries 
“…the old who enjoy good health die through lack of sustenance, and this is brought about 
by the continuous narrowing of the passage of the mesenteric vessels by thickening of the coats of 
these vessels” --- Leonardo da Vinci, Notes on the death of a centenarian, 1508 [9] 
 
That normal functioning of arteries is crucial to the overall health of an individual is 
uncontested. In order to design alternative conduits to replace dysfunctional arteries, there is first 
a need to understand the normal structural and functional requirements of the arterial wall. 
1.2.1  Designing the Arterial Wall: Gross Morphology 
140 milliliters of nearly incompressible blood are ejected during the systolic phase of each 
cardiac cycle in the human body. In order to accommodate this volume of blood, the arterial 
network must, first and foremost, be compliant. Secondly, there is a limit on the strain that an 
arterial wall can undergo. These constraints arise since arterial cells can undergo undesirable 
phenotypic changes with increased strain. Furthermore, arteries need to be sufficiently reinforced 
to withstand periods of elevated blood pressure [10].  In order to meet these design requirements, 
a typical, normal, healthy arterial wall is comprised of three main layers – tunica intima, tunica 





Figure 2: Arterial wall structure. 
Schematic depicting the three layers – tunica intima, tunica media, and tunica externa, of the arterial wall 
[11]. (B) Second harmoic generation image of a cross-section of a young rat carotid artery (unpublished, 
created following protocol outlined in Appendix B). Elastic lamellae flouresce in green, collagen 




The healthy tunica intima consists of a fully confluent endothelial cell layer, a highly 
sensitive lining between the arterial wall and the circulating fluid that regulates wall shear stress. 
The tunica media is primarily comprised of circumferentially aligned vascular smooth muscle cells 
(VSMCs) embedded within a matrix composed of elastic lamellae and collagen fibers. The 
outermost layer, the tunica externa, is comprised of collagen fibers along with fibroblast cells. The 
sheets of elastin, called elastic lamellae, are primarily responsible for the complaint behavior of 
arteries, especially in the low-strain regime. Mechanically, collagen is the main load bearing 
protein, especially in high-strain regimes, limiting the expansion of the arterial wall through 
mechanisms of fiber re-orientation and straightening [12].   
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1.2.2  Designing the Arterial Wall: Microstructural Architecture 
Proteoglycans, extracellular matrix (ECM) proteins, and vascular cells are the main 
constituents of the arterial wall. Proteoglycans consist of a core protein to which 
glycosaminoglycans (GAGs) are attached. The highly negatively charged GAG chains enable the 
proteoglycans to function as lubricants and dampers due to their ability to sequester water [13]. 
Extracellular proteins like collagen and elastin are the main load-bearing entities in the wall. 
Collagen is composed of three polypeptide α chains that form a triple helical structure. The most 
abundant collagen types present in the arterial wall are fibrillar type collagens I and III that 
constitute approximately 60% and 30% of total arterial collagen respectively [10]. However, it 
must be noted that the relative amount of each type changes as a function of age and location in 
the arterial tree. Collagen III fibers in the wall are typically thinner with an average diameter of 
0.5-1.5µm, while type I fibers have diameters in the range of 2-10µm [14].  As can be seen in 
Figure 2B, collagen fibers in the arterial wall have a crimped wavy structure in the unloaded state 
in both the medial and adventitial layers of the wall. These fibers are straightened out during 
loading; a feature of collagen fibers that contributes to the nonlinearity observed in the typical 
mechanical stress-strain response of arteries [12]. The other main load bearing protein in the 
arterial wall is elastin. Elastin is a highly stable and extremely hydrophobic protein that stores 
elastic energy, and is the primary component that confers the arterial wall its flexibility. It is widely 
believed that a majority of the elastin is laid down during development and that the body has a 
limited capacity to produce elastin after puberty [15]. In contrast, collagen fibers are constantly 
degraded and produced with a half-life of 60-70 days [16] in order to maintain ECM integrity over 
time, in normal, diseased, and physiologically altered conditions. Cellular components of the 
arterial wall primarily include endothelial cells, VSMCs, and fibroblasts. Endothelial cells form 
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the inner lining of the arterial tree and are responsible for sensing and maintaining a constant wall 
shear stress in arteries. VSMCs constitute the “active” component of the arterial wall, in that they 
regulate arterial diameter through their contractile ability. These cells are partially contracted in 
the homeostatic state and impart a basal tone to arteries. In conjunction with endothelial cells, 
VSMCs regulate the blood vessel diameter to maintain homeostatic blood flow in the body. While 
VSMCs in arteries are primarily contractile, they can exhibit a spectrum of phenotypic changes. 
For example, VSMCs display a synthetic phenotype during remodeling and repair. Fibroblasts, 
located mostly in the adventitial (external) layer of the arteria wall are the main source of collagen 
production within the wall [17]. It has been estimated that each fibroblast can synthesize 
approximately 3.5 million procollagen molecules/cell/day [18]. Fibroblasts therefore play a major 
role in regulating collagen homeostasis by controlling the balance of collagen degradation and 
production. 
1.2.3  Mechanical Properties of the Arterial Wall  
The mechanical behavior of soft tissues like arteries greatly depends on the composition 
and organization of its ECM and cellular components.  Constitutive models provide a 
mathematical formulation that best predicts salient features of the material response of a system. 
As discussed in previous sections, the arterial wall is a composite material made of passive load 
bearing structures like collagen and elastin, and active cellular component like VSMCs.  There is 
extensive literature on constitutive modeling of arteries which can briefly be described in three 
categories – structural models, phenomenological models and structurally motivated models. 
Structural models include explicit constitutive equations for each individual component in the 
composite material. Due to this, these models can provide insights into the mechanisms of load-
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bearing in the material, albeit, at the cost of adding complexity to the governing equations. 
Furthermore, it is practically impossible to make measurements for the properties of individual 
components. Phenomenological models described the gross mechanical response of the material 
without taking individual constituents into question. Structurally motivated models present a 
compromise between the two extremes by considering the role of certain load bearing constituents 
like collagen fiber straightening, re-orientation without modeling each mechanical properties of 







Figure 3: Schematic of a typical nonlinear stress-stretch curve of arterial walls as compared to the linear 





Seminal works by Roach and Burton posited that arteries exhibit a nonlinear stress-strain 
response as seen in Figure 3 due to the elastic response of highly compliant elastin in the low strain 
regime and recruitment (straightening) of stiff, wavy collagen fibers in the high strain regime [19]. 
Hill et al. confirmed this by imaging collagen fibers under various loading conditions and 
observing that collagen recruitment initiates at finite strains [12]. The transition regime in the curve 
is the region wherein most collagen fibers are recruited for load-bearing thereby transferring load 
from elastin alone to a combination of both elastin and collagen fibers. Under certain conditions it 
is sufficient to assume that the arterial wall can be modeled as a hyperelastic material with the 









Where 𝑊𝑊𝑖𝑖𝑖𝑖𝑖𝑖 is isotropic strain energy function which describes the response of primarily, 
elastin and GAGs. 𝑊𝑊𝑎𝑎𝑎𝑎𝑖𝑖𝑖𝑖𝑖𝑖 represents the strain energy function of collagen and is often defined 
using recruitment models that describe the gradual recruitment of collagen fibers [12]. Other 
approaches also describe fiber distribution models either as a continuous probability density 
function [20], [21] or in the form of two [22], four-fiber family [23] models that model fibers in 
discrete dominant directions.  
From the strain energy function in Equation 1-1, the Cauchy stress tensor can be calculated 
as 
 










Where p is the Lagrange multiplier that arises out of the incompressibility constraint, F is 
the deformation gradient and 𝑪𝑪 = 𝑭𝑭𝑻𝑻𝑭𝑭, is the right Cauchy Green tensor.  
1.3 In Situ Tissue Engineered Vascular Grafts 
“Seducing the Body to Regenerate” --- Martin Stoddart [24] 
 
The most common prosthetic vascular grafts are made from expanded 
polytetrafluoroethylene (ePTFE, a.k.a. Gore-Tex) and woven polyethylene terephthalate (PET, 
a.k.a Dacron). While these grafts are relatively inexpensive and have long shelf-lives, they perform 
poorly in small diameter applications due to poor mechanical characteristics, thrombosis, stenosis, 
and infection [8], [25]. As an alternative, various tissue-engineered strategies have been suggested 
in recent years. These can broadly be classified into four major categories—ECM-derived cellular 
[26], ECM-derived acellular [27], [28], synthetic cellular [29], [30] and synthetic acellular grafts 
[31]. While ECM-derived strategies have shown remarkable in-host remodeling with some even 
reaching Phase II clinical trials [27], they are associated with complicated and high production 
times along with significant production costs, which serve as a barrier to clinical translation. 
Furthermore, applications have been limited to large diameter and high flow conditions. 
 In situ tissue engineered vascular grafts (iTEVGs) are a disruptive, state-of-the-art 
technology, wherein a synthetic degradable graft transforms within the host body into a functional 
new artery (neoartery). Conceptually, iTEVGs are acellular, biodegradable, polymeric conduits 
that harness host growth and remodeling (G&R) to deposit ECM proteins like elastin and collagen 




Figure 4: Schematic of iTEVG tranformation into a neoartery 
An acellular, polymeric graft is implanted. Host cells invade the graft, degrade the polymer, proliferate, and 





The goal of iTEVGs is to develop a structurally and functionally sound neoartery that 
exhibits the general characteristics of a native artery (outlined in chapters 1.2.1 1.2.2 1.2.3 ) and 
can integrate and grow within the host body. iTEVGs offer a much-needed alternative for treating 
atherosclerosis due to their ease of fabrication, reduced regulatory burden and the ability to form 
an adaptive tissue that is capable of G&R within the host. Specifically, the work in this thesis 
focuses on an iTEVG developed by Wang et al [31]. This iTEVG is a bi-layered graft made of a 
poly (glycerol sebacate) (PGS) inner core and polycaprolactone (PCL) outer sheath. The iTEVG 
has demonstrated the capacity for neoartery formation with mature elastin, collagen and nerve 
formation in the rat aorta of young animals [31]. If successful in humans, this technology would 
have the advantages of both autologous and synthetic grafts, making them attractive candidates for 
commercial use. Notwithstanding their remarkable success, the main barrier to clinical translation 
of these grafts remains the trial and error nature of graft design with emphasis on avoiding early 
graft rupture, thrombosis and compliance matching alone. While these criteria are absolutely 
necessary for successful implantation, they are not sufficient for long term biological and 
functional integration of the iTEVG with surrounding tissue. Thus, there is a need to understand 
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the fundamental mechanisms guiding neoarterial remodeling to enable translation of iTEVGs to 
the clinically relevant aged population. The rationale is that once we have mechanistic 
understanding of evolving graft and neoarterial properties, we can develop mechanism-based 
functional forms in our G&R computational tool and combine them with global optimization 
strategies to design TEVG’s for older animals. 
1.4 Arterial Adaptation: Growth and Remodeling with Age 
“Inside every old person is a young person wondering what happened.” --- Anonymous 
 
Section 1.2 described the morphology and function of normal, healthy arteries. However, 
arteries are constantly being subjected to a variety of forces and bio-chemo-mechanical cues which 
require them to remodel and grow. Pioneering works by Wolinsky and Glagov have shown that 
arteries maintain tensional homeostasis in order to sustain constant levels of transmural stress [32]. 
They showed that the average tension per lamellar unit of an aortic media was constant across 
species. Following this, Langille et al. (e.g. [33], [34]) showed that arteries in young species have 
an inherent capacity for altering their morphology in response to mechanical stimuli. This ability 
of arteries to undergo G&R enables them to maintain mechanical homeostasis - a constant, 
preferred mechanical state - despite altered mechanical loading. Young arteries respond to changes 
in flow, pressure and longitudinal tension to maintain a constant homeostatic mechanical 
environment. A decrease in blood flow leads to a reduction in diameter [35], whereas hypertension 
leads to wall thickening [36]. Furthermore, an increase in longitudinal strain is normalized by an 
increase in endothelial cell replication rates, and increased collagen and elastin deposition[37]. It 
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must, however, be noted that arteries are not adept at restoring homeostatic conditions under 
reduced longitudinal strains [38].  
While arteries are highly adept at G&R in response to mechanical stimuli, this response is  
highly dependent on age. For example, carotid arteries of aged Fischer rats were not able to 
remodel in response to reduced flow potentially due to altered eNOS activity [39]. Aging also 
reduces cell proliferation rates, leads to endothelial cell dysfunction [40], and is associated with a 
dilatation and stiffening of arteries [41]. It also widely known that aging has a significant impact 
on regeneration and healing. There has been a growing consensus that aging delays wound healing 
[42], regeneration [43] and the host response to implants [44]. iTEVGs fundamentally leverage the 
G&R capability of the host body to develop neoateries. Hence, there is a need to understand the 
role of aging on the biomechanics of iTEVGs.  
1.5 Theoretical Models of Growth and Remodeling 
“All models are wrong but some are useful” --- George Box 
 
While the fundamental form of biological tissue is encoded in the genes, its final structure 
and functionality are optimized according to its mechanobiological environment. A known 
example is the loss of bone mass and muscles atrophy due to weightlessness. G&R is a 
fundamental component of living systems. Living tissues continuously change and adapt through 
changes in mass and geometry (growth), rearrangement of the microstructure (remodeling) and 
shape (morphogenesis). These organisms grow and shrink, and become stronger or weaker at very 
small timescales. As discussed in Section 1.4, the constituents in the arterial wall can change in 
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time due to orchestrated production and removal of ECM. For example, the mass of individual 
components in the wall can increase due to the production of ECM components by the cells (e.g. 
fibroblasts and VSMCs) and also decrease due to their breakdown by matrix metalloproteases 
(MMPs). These changes require the body to adapt to a new set of mechanical conditions. The main 
component mediating mechanical homeostasis during these altered conditions is ECM turnover. 
ECM turnover refers to combined process of synthesis and degradation of ECM components. It is 
well known that increased mechanical loading leads to increased ECM synthesis [45]–[48] as well 
as ECM degradation [49]. These changes allow the body to not only change shape but also alter 
its mechanical properties.  
Theoretical frameworks that model this phenomenon can be used to gain insights into G&R 
mechanics and the mechanisms that drive them. In the context of these models, growth specifically 
refers to change in mass while remodeling refers to changes in the organization of the material (for 
example fiber orientation, recruitment etc.) leading to changes in anisotropy, stiffness and strength. 
Since the seminal works of D’Arcy Thompson describing the mathematical and physical aspects 
of growth and form [50], and Skalak’s formal description of G&R using a volumetric growth-
based continuum mechanics framework [51], various groups have extended these approaches to 
describe G&R in soft and hard tissues. Skalak et al. assumed that the original stress-free body can 
be divided fictitiously into small parts that can “grow” independently. These individual parts can 
then be assembled to obtain the final configuration. The final stress in the body is dependent on 
deformations due to this assembly and applied loads but not due to “growth”. This approach is 
based on the idea of growth as a change of form. Among others, Rodriguez et al. [52], Taber et al. 
[53], and Rachev et al.[54] have used this concept of volumetric growth to model left ventricular 
hypertrophy, the development of  arteries as well as their response to hypertension in maturity. 
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Growth is modeled through the multiplicative decomposition of the deformation gradient into a 
growth tensor (𝑭𝑭𝑔𝑔) and an elastic tensor (𝑭𝑭𝑒𝑒). Epstein et al. presented a theory of growth that 
viewed growth as a local rearrangement of material inhomogeneities [55]. Drawing from theories 
of plasticity, Eckart first introduced the concept of multiple natural configurations and provided a 
mathematical formulation for the same [56]. Rajagopal et al., along with Wineman, then extended 
this formulation to provide a unified framework to study metal plasticity [57], twinning [58], and, 
viscoelastic fluids [59]. Ambrosi et al. then applied this framework of volumetric growth with 
evolving natural configurations to model biological tumor growth [60]. More recently Kuhl et al. 
[61] have used this theory to explain the mechanism of folding  in the brain, and the 
mechanobiology [62] and expansion of skin in reconstructive surgery [63].   
While these models describe the consequences of growth and predict G&R responses with 
reasonable accuracy, they do not necessarily describe the cause of G&R. Kinematic growth is 
described by prescribing evolution equations for the expansion of fictitious stress-free elements. 
However, G&R mostly occurs in a stressed configuration and is accompanied by a production or 
removal of constituents. In order to overcome these limitations, and drawing from the continuum 
theory of mixtures [64],  Humphrey and Rajagopalan [65] introduced the constrained mixture 
theory based model of G&R. This theory is based on a few key assumptions: 
1. That soft tissues can be modeled as a mixture of different constituents 
(e.g. collagen, elastin etc.). 
2. The mixture is constrained; all constituents in a material point are 
subject to the same motion. 
3.  The mass per unit current volume is assumed to be constant along the 
G&R process. 
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This theory has been successfully used for predicting time-courses of arterial adaptations and 
disease progression in diverse cases. Initial studies by the authors focused on arterial adaptation to 
changes in mechanical stimuli in young healthy arteries. It was shown that this theory was able to 
capture key morphological changes in response to mechanical forces; dilatation in response to 
increased flow [66], hypertension induced wall thickness [67], and axial force induced G&R [68]. 
Qualitative features of disease progression due to aging [69] and unbounded growth, i.e. aneurysm 
growth could also be predicted [70]. Watton et al. employed a simpler membrane, rate-based 
formulation of this approach to predict the growth of cerebral aneurysms [71] and further refined 
it with mechanobiological equations to model the effect of various drug therapies on aneurysm 
G&R [72]. This theory has recently been extended to understand the effect of vascular 
interventional strategies like stentplasty for vasospam [73], and venous bypass grafting for treating 
atherosclerosis [74]. Since this theory is based on the knowledge that vascular tissues adapt their 
structure and function to achieve a certain homeostatic stress state, there is a need to understand 
the final homeostatic condition for the application under consideration. Thus, translating this 
theory to modeling iTEVGs for arterial circulation requires experimental data to determine their 
homeostatic state. Furthermore, since each constituent is modeled explicitly, there is an inherent 
need for biological and mechanical data to understand application-specific mass kinetics equations 
in order to use this model not only for qualitative, but quantitative predictions. Therefore, in order 
to understand the fundamental mechanisms guiding iTEVG formation across age and develop a 
G&R based approach to guide rational design of these constructs, we designed the following 
specific aims. 
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1.6 Specific Aims 
Since the first clinical use of a tissue engineered product (the epithelium) in 1981 [75], 
there has been very little change in the trial and error nature of tissue engineering product design. 
In this work we propose a new paradigm for vascular graft design which will not only accelerate 
clinical translation of grafts but can also be used for design of other mechanobiology based tissue 
engineered devices. It has long been known that mechanical stimuli influence not only gross 
morphological [76], [77] and protein remodeling [38],[39] but also stem cell lineage differentiation 
[80], [81]. While mature arteries are extremely quiescent with cell proliferation rates of 0.01- 1% 
per day, both physiological and pathological changes can elicit a significant remodeling response 
involving ECM synthesis, degradation and turnover [82]. As noted by Zilla et al. [83], there needs 
to be a focus on clinically relevant models when designing TEVG’s to improve success rates to 
translation. Since older populations are the target audience for therapy, these grafts need to be 
designed for the older demographic. Unfortunately, translating results between animal models is 
not a trivial task since not only do the graft parameters have to be optimized for a new model but 
the model itself reacts very differently to diverse mechanobiological cues. The overall goal of this 
dissertation is to understand the fundamental mechanisms guiding iTEVG formation and rationally 
design neoarteries in an aged murine model. In order to achieve these goals, we will take a 
combined in vivo, ex vivo and in silico approach.  
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1.6.1  Specific Aim 1 
Determine changes in graft material properties during degradation. Successful 
neoartery development is contingent on the effective interplay between graft degradation and ECM 
deposition. Our hypothesis is that both in vitro and in vivo degradation are governed by the same 
passive degradation mechanism. Thus, in this aim our objective is to improve the predictive 
capability of our G&R tool by developing physics-based functional forms for changes in graft 
properties during degradation by conducting in vitro degradation experiments. 
1.6.2  Specific Aim 2 
Determine structure-function and biological evolution equations for neoartery 
formation in young rats. Understanding the mechanism of G&R in young rats as a function of 
initial graft properties is a fundamental requirement for developing grafts for other models. In 
order to develop this mechanistic understanding, we will track biological and mechanical 
remodeling in young rats implanted with our successful bi-layered grafts at three time points post-
implant; using the data to assess its performance relative to clinical gold standard - vein grafts.  
 
1.6.3  Specific Aim 3 
Develop a data-driven computational G&R tool for iTEVG modeling for both young 
and aged hosts. Translating the success of iTEVGs from young to old animals, across species, or 
even across different sites in the body is not a trivial task due to the large number of graft (porosity, 
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degradation rate, wall thickness etc.) and system parameters (cellular infiltration, rate of ECM 
deposition etc.) governing the remodeling response. Hence, there is an unmet need for a 
sophisticated approach to iTEVG design that can reduce the time and cost for clinical translation. 
In this aim we will modify the theory of constrained mixtures to incorporate an iTEVG component 
in the reference configuration to develop a tool that can be used for guiding experimental design 
of iTEVGs. The rationale behind the proposed work is that it is only with a mechanistic G&R 
model, coupled with our rich experimental dataset, that it will be possible to rationally design 
optimal iTEVG properties for various animal models and ultimately human clinical trials. 
1.6.4  Specific Aim 4 
Determine effect of age on neoartery formation. We hypothesize that the rate of 
formation of ECM proteins in both young and old animals is governed by the same 
mechanobiological cues but with altered rates of productions. We will identify and quantify the 
differences in neoartery formation between young and old rats by obtaining biological and 
mechanical data. We will obtain these data by implanting grafts in both young and old animals and 
tracking biological and mechanical evolution over time. We will then use this data to tailor, 




1.6.5  Specific Aim 5 
Determine the prevalence and role of calcification in a parallel model system of 
adverse remodeling. G&R is a natural mechanism of adaptation to diverse mechanobiological 
cues developed by the body. However, not all G&R leads to the recapitulation of the native 
environment. Calcification is thought to be one of the principal manifestations of adverse 
remodeling in the arterial wall, especially in diseases like atherosclerosis. Understanding the role 
of calcification in the biology and mechanics of soft tissues is a first step toward designing 
strategies to prevent the occurrence or strategically use its presence for robust G&R. In order to 
understand the potential role of calcification in soft tissues, we will investigate its role in a parallel 
model system that exhibits similar modes of failure – cerebral aneurysms. In this aim, our goal is 
to understand the prevalence and role of calcification in cerebral aneurysms in order to guide G&R 
strategies. We will also develop tools and techniques to simultaneously image ECM components 
along with calcification. These methods will enable us to better understand pathological G&R and 
develop strategies to mitigate adverse remodeling. This in turn will guide iTEVG design, while 






2.0 Degradation and Erosion Mechanisms of Acellular Bioresorbable Porous Vascular  
The work in this chapter is largely reproduced with permission from the following 
manuscript: 
Gade, Piyusha S., Keewon Lee, Blaise N. Pfaff, Yadong Wang, and Anne M. Robertson. 
"Degradation and erosion mechanisms of bioresorbable porous acellular vascular grafts: an in 
vitro investigation." Journal of The Royal Society Interface 14, no. 132 (2017): 20170102. 
2.1 Introduction 
A fundamental mechanism of in situ tissue regeneration from biodegradable synthetic 
acellular vascular grafts is the effective interplay between graft degradation, erosion and the 
production of ECM. Degradation studies on PGS have been focused on solid PGS in vivo [84], 
[85] or base-accelerated degradation in vitro [86], with the aim of understanding rate of mass loss 
as a function of degradation.  However, no studies have investigated the effect of degradation and 
erosion on porous small diameter PGS grafts. Since the efficacy of the G&R tool depends on well-
formulated functional forms, there is a much-cited [74], [87], [88] need in the field of biomechanics 
for experimental data to develop these functional forms. Furthermore, our preliminary 
computational studies showed the time constants associated with graft erosion and degradation are 
critical for remodeling, with fusiform aneurysms forming if the degradation rate was too fast. The 
objective of this aim is to understand the degradation and erosion mechanisms of porous PGS 
grafts while also formulating mechanism-based functional forms to inform the G&R tool and 
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improve robustness of its predictions. The working hypothesis is that both in vitro and in vivo 
degradation are governed by passive degradation mechanisms. Thus, mechanistic functional forms 
can be used by adjusting rate constants and boundary conditions for the in vivo model. The 
rationale for this aim is that improved understanding of graft degradation will not only improve 
the G&R tools robustness but will also enable us to have a mechanistic understanding of the 
process. This knowledge is critical for future translational work in mature and large animal models.  
Developments in biomechanics have led to formulation of continuum mechanics based, 
mixture theory-driven G&R computational models that predict vascular G&R response to altered 
physiological conditions [68], [89], [90]. These models have been useful in predicting G&R 
response in diseased conditions like aneurysms [91]–[94] and are being extended to model the in 
vivo development of neo- tissue from a degrading TEVG in venous circulation [95]. In our prior 
work, we used this G&R model to conduct a parametric study to understand the effect of 
degradation rates on long-term neoarterial development [96]. Briefly, we postulate the following 



























where 𝑊𝑊(𝑠𝑠) is the total strain energy of the mixture, 𝜌𝜌𝛼𝛼(0) is the density of constituent at time 
𝑠𝑠 = 0, 𝑄𝑄𝛼𝛼(𝑠𝑠) is the survival function that represents remaining mass and 𝑊𝑊� 𝛼𝛼 �𝑪𝑪𝑎𝑎(0)
𝛼𝛼 (𝑠𝑠)� 
represents the evolving strain energy function of the degrading constituent. 𝑊𝑊� 𝛼𝛼 �𝑪𝑪𝑎𝑎(𝜏𝜏)
𝛼𝛼 (𝑠𝑠)� and 
𝑚𝑚𝛼𝛼(𝜏𝜏) represent the strain energy function and rate of deposition of constituents respectively, 
where �𝑪𝑪𝑎𝑎(𝜏𝜏)
𝛼𝛼 (𝑠𝑠)� is the right Cauchy–Green tensor at current time s, defined relative to the 
configuration at time t. The detailed description of this theory has been presented in chapter 4.0. 
The survival function and changing mechanical properties are phenomenological equations which 
can be tuned to refine the predictive capability of the tool. There is a much-cited need in the field 
of biomechanics for experimental data to develop these constitutive equations and obtain the 
requisite rate constants [65], [74], [87], [96]. Our prior computational work with this model 
showed that the time constants associated with graft erosion and degradation are critical for the 
remodeling process, with fusiform aneurysms forming if the degradation rate was too fast. It must 
be noted that while degradation is defined as the deleterious change in properties due to scission 
of polymer chains into monomers [97], we are primarily concerned with the manifestation of these 
changes in the context of mechanical properties. Erosion of the grafts is defined as the reduction 
in mass through surface or volumetric (bulk) erosion. 
While there is a critical need to understand the erosion and degradation process of TEVGs, 
the only data available are based on studies of solid PGS erosion in vivo [84] and base- accelerated 
degradation in vitro [86], with no data on degradation or erosion of porous small diameter PGS 
TEVGs. 
In this study, we address this need by investigating the degradation and erosion 
mechanisms of porous PGS TEVGs used for in situ neoartery formation [98]. We acquire 
experimental data by conducting an in vitro analysis of the porous grafts used in our in vivo studies 
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exposed to enzymatic degradation and provide a constitutive equation (functional form) for mass 
loss and mechanical property change as a function of degradation time. Furthermore, we use these 
data to develop a diffusion-based erosion model for predicting mass loss. This mechanistic, 
physics-based explanation allows formulation of erosion as a boundary-value problem and can be 
used for modeling the phenomena under different boundary conditions. To our knowledge, this is 
the first investigation that studies the degradation and erosion process for porous PGS TEVGs and 
provides a mechanistic framework to model erosion with validation against experimental data. 
These results provide physical insights into the mechanisms of degradation and erosion and will 
be of great value for G&R frameworks as the basis of predictive tools for rational design of 
TEVGs. 
PGS is a widely used elastomer in the field of tissue engineering due to its biocompatibility 
and fast degradability. It has been used in myocardial engineering [99]–[101], vascular graft and 
microvasculature fabrication [31], [102], bone and cartilage engineering [103], [104] and nerve 
guide development [105]–[107], to name a few. These applications require an understanding of 
the degradation and erosion process of the polymer as it guides load transfer and remodeling 
response. Hence, understanding these mechanisms will have translational benefits by providing 
the necessary information to tune properties of PGS (like curing time, temperature, porosity) to 
achieve desired degradation rates. This work also has broader applicability to other elastomers 
manufactured by salt leaching [108]–[110] as they exhibit a similar porous morphology which we 
have found to play a major role in degradation. 
This work is broadly divided into two parts—modeling erosion as pertaining to mass loss 
and modelling degradation as manifested by change in mechanical properties. Section 2 outlines 
the methods used to investigate the enzymatic degradation of grafts in vitro followed by outlining 
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the analytical solution of the erosion boundary value problem and predicting mass loss through 
this process. Section 3 provides constitutive relationships of mass loss based on in vitro enzymatic 
degradation assays and outlines the relative contribution of bulk versus surface erosion. Results 
from the mathematical modelling of erosion are presented in the context of theoretical as compared 
to the experimental mass loss. Furthermore, we investigated the changes in mechanical properties 
of the degrading grafts and introduced a scalar damage function with an explicit time-dependence 
to represent the weakening of mechanical properties over degradation time s. Finally, we analyze 
the results in the context of TEVG development and refinement of G&R tools for guiding graft 
design. 
2.2 Materials and Methods 
2.2.1  Graft Fabrication 
The PGS prepolymer was synthesized as previously described [85]. Briefly, 20 grafts were 
fabricated from a solvent casting/ salt leaching method using 25–32 mm ground salts as porogens 
[111]. Salts were packed into the mold, which consisted of a stainless-steel rod (outer diameter = 
0.8mm) as a mandrel and a Teflon outer tubing (inner diameter = 1.58mm, length = 20mm). The 
salt mold was then fused in humidified chamber at 37ºC for 90 min. Salt templates were released 
from the mold. PGS prepolymer was dissolved with tetrahydrofuran to prepare 20% (w/v) solution. 
The volume of PGS solution was adjusted as 3:1 mass ratio of salt: PGS, and added to salt 
templates. Salt templates were placed in a fume hood for 1 h to evaporate solvent, and cured in a 
vacuum oven at 150ºC for 24 h. After curing, grafts were placed in a series of two water baths 
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Figure 5 Scanning electron microscopy image of salt-leached PGS core. 
 
2.2.2  Enzymatic Degradation 
Since graft mechanics cannot directly be studied in vivo due to the growth of neotissue 
upon graft degradation, we conducted an in vitro analysis of the effect of enzymatic degradation 
on graft properties to understand the physics of degradation and erosion of these grafts. Cholesterol 
esterase was the enzyme of choice for the study as it has been reported to be the primary enzyme 
responsible for catalysis of PGS degradation by hydrolysis of ester groups in vivo [112]. Fabricated 
PGS samples (n = 4 at each of the 4 time points) were immersed in 1 ml solution of phosphate 
buffered saline with 0.2 units µg-1 PGS of cholesterol esterase (Sigma-Aldrich) kept in an incubator 
at 37ºC maintained at a pH of 7.4. Enzyme concentration was chosen through preliminary 
experiments that iteratively determined the concentration required to achieve complete in vitro 
mass loss by three weeks, a time constant found to match in vivo observed rates of mass loss [113]. 
 26 
Initial enzyme concentration for this process was obtained from Chen et al. [114]. The medium 
was replaced every 2 days to maintain enzyme activity. Mass loss, change in volume fraction, 
morphology and mechanical properties were recorded at days 1, 4, 7 and 10 after which the grafts 
lost most of their structural integrity. 
2.2.3  Dry Mass Loss 
The mass of each sample was recorded before immersion in degradation media and at every 
time point post-degradation. Wet samples at every time-point were thoroughly dried by 














where 𝑚𝑚(𝑠𝑠) is the dry mass after degradation time 𝑠𝑠 and 𝑚𝑚(0)is the initial dry mass. 
 
2.2.4  Change in Volume Fraction 
Porosity and pore size of grafts were measured using a sub micrometer resolution (0.35 
mm) Skyscan 1272 (Bruker Corporation) 11 Mp micro-computed tomography (microCT) 
instrument. Samples were scanned before immersion in degradation media for baseline 
measurements. Following enzymatic degradation, samples were lyophilized at predetermined time 
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points and dry samples were scanned to measure change in porosity and pore size over time. 
Briefly, samples were mounted on a brass stub with a Styrofoam holder (Figure 6a) and scanned 
using the following settings: camera pixel size of 7.4 mm, image pixel size of 2.8 mm, frame 
averaging of 10, rotation step size of 0.18 and scanned 180 degrees around the vertical axis. In 















where 𝜙𝜙𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) is the in vitro volume fraction (also called porosity) of PGS, 𝑉𝑉𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) is the 
volume of PGS and 𝑉𝑉𝑔𝑔𝑔𝑔𝑎𝑎𝑔𝑔𝑔𝑔(𝑠𝑠) is the total graft volume as calculated using microCT at time 𝑠𝑠. To 
obtain volume fraction, a three-dimensional image was reconstructed as a stack of 2 mm average 
thick sections in the axial plane using NRecon (Bruker Corporation). Volume fraction was 
calculated by using CT-Analyser (Bruker Corporation). Briefly, a region of interest (ROI) was 
defined along the length of the graft followed by identifying a threshold value to obtain a binary 
image with air as the background (Figure 6c). These binary images were then used to obtain overall 
dimensions and a three-dimensional morphometric analysis was conducted to obtain metrics of 
volume fractions and to create a surface mesh using the marching cubes algorithm (Figure 6d). We 



















Figure 6 Methodology of obtaining PGS volume fraction. 
(a) Image of PGS graft mounted on brass stub in styrofoam holder, (b) scanned CT image, (c) reconstructed 
surface mesh with (d) PGS in red and pores in green. 
 
 
2.2.5  Apparent Density 
The balance of mass equation in mixture theory allows formulation of mass exchange 
between different constituents. This exchange leads to mass deposition/removal which can occur 
as a surface or volume erosion process. Surface erosion constitutes evolution of the entire boundary 
of the species and volume erosion is surface erosion at a microscopic level (at pore surface) 
throughout the bulk of the body [115]. Looked at another way, pure surface erosion requires that 
the apparent density of the body remains constant, whereas volume erosion leads to a change in 
apparent density, where the apparent density of PGS (𝜌𝜌𝑎𝑎𝑃𝑃𝑃𝑃𝑃𝑃) is defined as the mass of PGS per unit 
total TEVG volume. The apparent density can also be defined in terms of graft porosity as follows: 
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 𝜌𝜌𝑎𝑎𝑃𝑃𝑃𝑃𝑃𝑃 = 𝜌𝜌𝑇𝑇
𝑃𝑃𝑃𝑃𝑃𝑃 × 𝜙𝜙𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) Equation 2-5 
 
where 𝜌𝜌𝑇𝑇𝑃𝑃𝑃𝑃𝑃𝑃 is the true material density of PGS.  
 
2.2.6  Change in Bulk Morphology 
Three-dimensional images obtained from microCT reconstruction were used to calculate 
the changes in inner and outer diameter as functions of time exposed to enzymatic degradation. 
These were measured at every 0.2 mm and averaged across the length of the sample followed by 















where 𝑑𝑑(0) and 𝑑𝑑(𝑠𝑠) are the diameters of the scaffolds at time 𝑠𝑠 = 0 and current time, 
respectively.  
 
2.2.7  Mechanical Testing 
PGS grafts were assumed to be isotropic as they were fabricated using the method of salt-
leaching. Uniaxial tensile testing was performed on each sample to calculate the change in 
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mechanical properties as a function of time exposed to enzymatic degradation. The wet length, 
diameter and thickness of each sample was recorded before mounting the sample. Each sample 
was tested uniaxially to failure on a custom-designed biaxial inflation testing machine. For this 
purpose, only axial tension was applied since grafts were porous and could not be pressurized. 
Briefly, the device consists of mounting points for various gauge cannulae (Zephyrtronics Inc.) 
which are used to mount specimens. A bath is provided for submerging samples in desired solution 
at 37ºC (Figure 7). Samples can be stretched axially at a controlled strain rate via a computer-
controlled actuator (Aero- tech Inc., Model ANT-25LA) under a video camera (Edmund Optics, 
model EO-5012C) capturing images which are analyzed using custom written MATLAB 











The load is recorded by a load cell (Transducer Techniques, model MDB-5) affixed to one of the 
mounts of the device. In this case, samples were stretched uniaxially to failure to obtain their 
mechanical properties. Samples were mounted on gauge 27 cannulae followed by lightly gluing 
250 mm silica microspheres (Whitehouse Scientific Ltd) on the surface for local strain 
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measurements. Four preconditioning cycles were performed by stretching the samples to 10% of 
their initial length at a strain rate of 0.005mm/s. This was followed by stretching the samples to 





𝜎𝜎𝑧𝑧 =  
𝑓𝑓
𝜋𝜋(𝑟𝑟𝑖𝑖(𝑡𝑡)2 − 𝑟𝑟𝑖𝑖(𝑡𝑡)2)









where 𝑓𝑓 is the force recorded by the load cell, 𝑟𝑟𝑖𝑖(𝑡𝑡) and 𝑟𝑟𝑖𝑖(𝑡𝑡) are the outer and inner radii, 
respectively, at current time (t), calculated assuming isovolumetric deformations. 𝑙𝑙(0) and 𝑙𝑙(𝑡𝑡) are 
the initial and current lengths, respectively. This data was fit to a standard neo-Hookean model 





𝑊𝑊� 𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) =  
𝛽𝛽(𝑠𝑠)
2






where 𝑠𝑠 represents the G&R time and 𝑝𝑝1 is the first invariant of the right Cauchy–Green tensor, 
namely the trace of 𝑪𝑪𝑎𝑎(𝜏𝜏)
𝛼𝛼 (𝑠𝑠). 
2.2.8  Mathematical Modeling of Surface Erosion 
In this section, we discuss the analytical solution for the mass loss from a graft subjected 
to enzymatic degradation. We hypothesized that the mechanism of TEVG mass loss is through a 
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time evolving concentration gradient set up by diffusion of the eroded PGS from the exposed graft 
surface. This diffusion-driven mass loss can occur in the volume occupied by the solvent 
(degradation media) which serves as the transport medium for the eroded solute. We model the 
graft as a thick walled, circular cylinder and define a cylindrical coordinate system (𝑟𝑟,𝜃𝜃, 𝑧𝑧) with 
the z-axis coincident with the centerline of the graft. We consider an initial value problem, where 
at time 𝑠𝑠 = 0, the graft is placed in an impermeable cylinder of radius 𝑅𝑅3 that represents the beaker 
in the experiment.  Ω1 and Ω2 denote the inner solvent region (0 ≤ 𝑟𝑟 ≤ 𝑅𝑅1(𝑠𝑠), 0 ≤ 𝜃𝜃 ≤ 2𝜋𝜋, 0 ≤
𝑧𝑧 ≤ 𝐿𝐿) and outer solvent region 𝑅𝑅2(𝑠𝑠) ≤ 𝑟𝑟 ≤ 𝑅𝑅3, 0 ≤ 𝜃𝜃 ≤ 2𝜋𝜋, 0 ≤ 𝑧𝑧 ≤ 𝐿𝐿, respectively (figure 3). 
In this work, we approximate these moving boundaries Г1 and Г2 as independent of time, based 
on our perturbation analysis of the moving boundary problem [116]. It follows from the 
perturbation analysis that this approximation is valid when the ratio 𝑐𝑐𝑠𝑠
𝜌𝜌𝑎𝑎𝛼𝛼 
≪ 1. In this study, 𝑐𝑐𝑠𝑠
𝜌𝜌𝑎𝑎𝑃𝑃𝑃𝑃𝑃𝑃 
=




Figure 8 Schematic of cross section of TEVG submerged in degradation media.  
Diffusion of eroded PGS occurs in the domains 𝛀𝛀𝟏𝟏 and 𝛀𝛀𝟐𝟐. Г𝟏𝟏 and Г𝟐𝟐 represent the inner and outer surfaces 





The eroded PGS (solute) sets up a concentration gradient in both these domains and Fick’s law in 
conjunction with conservation of mass can be used to model the rate of change of concentration 
gradient. Figure 3 shows a representative two-dimensional cross section of the hollow cylinder 










Where 𝑭𝑭 is the mass flux and 𝐷𝐷 is the coefficient of diffusion, a scalar material constant. For 
convenience, it is assumed that all materials we consider are isotropic with respect to diffusion and 












The diffusion is modelled as axisymmetric and independent of axial position, so that Equation 














� ,          𝛺𝛺1,Ω2 
Equation 2-11 
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We impose the standard Noyes–Whitney equation [117] to describe the rate of dissolution of the 

















Where ℎ is a material coefficient, c is the molar concentration and 𝜕𝜕𝑖𝑖 is the saturation limit for the 
solute (eroded PGS) in the solvent (enzymatic media). We assume the concentration is initially 




 𝜕𝜕(𝑟𝑟, 0) = 0      𝑖𝑖𝑎𝑎         𝛺𝛺1,Ω2 Equation 2-13 
   
2.2.8.1 Solution in the Inner Domain, 𝛀𝛀𝟏𝟏 










(𝜕𝜕𝑖𝑖 − 𝜕𝜕)     𝑟𝑟 = 𝑅𝑅1,      𝑠𝑠 > 0  
Equation 2-14 
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The classical method of separation of variables can be used to obtain the solution 𝜕𝜕(𝑟𝑟, 𝑠𝑠) to 
Equation 2-11 subject to the boundary condition Equation 2-14 and initial condition Equation 2-13 
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𝜕𝜕𝑖𝑖
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     ?̂?𝑠 = 𝑠𝑠
𝐷𝐷
𝑅𝑅12









Using the definitions in Equation 2-15, the equation for radial diffusion (Equation 2-11), the 





















�            ?̂?𝑟 𝜖𝜖 �0, ?̂?𝛽�                  ?̂?𝑠 > 0,
𝜕𝜕𝑢𝑢�
𝜕𝜕?̂?𝑟
=  − 𝑢𝑢�                                  𝑎𝑎𝑡𝑡 ?̂?𝑟 =   ?̂?𝛽,                ?̂?𝑠 > 0,












Using standard methods of separation of variables (see, for example, Carslaw and Jaeger [118]), 
we look for a factorized solution 𝑢𝑢� =  𝑇𝑇�(?̂?𝑠)𝑅𝑅(?̂?𝑟) for (Equation 2-16), from which it follows, that 




𝑇𝑇′� + 𝛼𝛼2?̂?𝛽2𝑇𝑇� = 0,      𝑅𝑅�′′ +  
1
𝑟𝑟 �
𝑅𝑅�′ + 𝛼𝛼2𝑅𝑅� = 0, 
Equation 2-17 
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For ?̂?𝑠 > 0 and 𝑟𝑟 �𝜖𝜖 �0, ?̂?𝛽�, where 𝛼𝛼2 is a positive, real constant and we have used the “′” notation to 
denote differentiation with respect to the independent variable. The well-known solutions to 









where we have imposed the boundedness of the solution at ?̂?𝑟 = 0. The equation for 𝑅𝑅�(?̂?𝑟) in 




 𝐿𝐿�𝑅𝑅�� ≡ �?̂?𝑟𝑅𝑅�′�
′











𝐿𝐿�𝑅𝑅�� = −𝛼𝛼2?̂?𝑟𝑅𝑅�     𝑟𝑟 �𝜖𝜖 �0, ?̂?𝛽�








The Lagrange identity holds for this singular problem (Equation 2-20) (e.g. page 659 Boyce and 
DiPrima) [119], and we therefore have the completeness of the set of eigenfunctions 𝑅𝑅�(?̂?𝑟) in the 
appropriate function space, so the solution 𝑢𝑢�  can be represented as the following series 
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𝛼𝛼𝑎𝑎?̂?𝑟)𝐽𝐽0(𝛼𝛼𝑚𝑚?̂?𝑟)?̂?𝑟𝑑𝑑?̂?𝑟 =  �
0                                               𝑚𝑚 ≠ 𝑎𝑎
?̂?𝛽2(1 + 𝛼𝛼𝑎𝑎2)
2𝛼𝛼𝑎𝑎2














































Using this last result with (Equation 2-26) in (Equation 2-27), we obtain the solution for 𝑢𝑢�  in Ω1 
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Substituting 𝑢𝑢� = 1 −  𝑐𝑐
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2.2.8.2 Solution in the Outer Domain, 𝛀𝛀𝟐𝟐 








(𝜕𝜕𝑖𝑖 − 𝜕𝜕)     𝑟𝑟 = 𝑅𝑅2,      𝑠𝑠 > 0  
Equation 2-32 











The classical method of separation of variables can be used to obtain the solution 𝜕𝜕(𝑟𝑟, 𝑠𝑠) to 
Equation 2-11 subject to the boundary conditions (Equation 2-32) and (Equation 2-33), with the 
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�            ?̂?𝑟 𝜖𝜖 �?̂?𝛽,
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ϒ
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As for the solution in the inner domain, the classical method of separation of variables is used and 













𝑢𝑢� =  �[𝐴𝐴𝑎𝑎𝐽𝐽0(𝛼𝛼𝑎𝑎?̂?𝑟) + 𝐵𝐵𝑎𝑎𝑌𝑌0(𝛼𝛼𝑎𝑎?̂?𝑟)] 𝑒𝑒−𝛼𝛼𝑛𝑛
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𝑢𝑢� =  �[𝐶𝐶𝑎𝑎𝜙𝜙0(𝛼𝛼𝑎𝑎?̂?𝑟)] 𝑒𝑒−𝛼𝛼𝑛𝑛






















𝜙𝜙0′ − 𝜙𝜙0 = 0                           ?̂?𝑟 =  ?̂?𝛽











Applying the boundary condition at Г2(?̂?𝑟 =  ?̂?𝛽) given in Equation 2-41 with Equation 2-39, we 
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The eigenfunctions 𝜙𝜙0(𝛼𝛼𝑎𝑎?̂?𝑟) are linear combinations of Bessel functions 𝐽𝐽0(𝛼𝛼𝑎𝑎?̂?𝑟) and 𝑌𝑌0(𝛼𝛼𝑎𝑎?̂?𝑟) and 



















































And, after multiplying Equation 2-41 by the quantity 2𝑟𝑟𝜙𝜙′, rearranging terms and integrating over 








































































where it should be recalled that 𝛼𝛼𝑎𝑎 can be determined through Equation 2-42 and 𝜙𝜙𝑎𝑎(𝛼𝛼𝑎𝑎?̂?𝑟) is 
defined in Equation 2-39  
Using this result, the mass loss in the outer domain can be obtained by using equations 



























2.2.9  Determination of Degradation Constants 
Mass loss was theoretically calculated through the above boundary value problem using 
two degradation constants. The experimental condition required change of degradation media 
every two days which changed the solute concentration. This process was modelled by repeatedly 
solving the dimensional form of equation Equation 2-51 at each two-day time point, after which 
the solute concentration in the solution was returned to zero. For this analysis, we let 𝜕𝜕𝑖𝑖 =
0.25𝑔𝑔𝑙𝑙−1 [120] as the degradation products of PGS are sebacic acid and glycerol, with glycerol 
being miscible in the media. 𝐷𝐷 and ℎ are obtained by fitting dimensional form of equation Equation 
2-51 to only the first experimental mass loss time point. These values of h and D are then used to 
predict mass loss at all other subsequent times. These predicted values were validated against the 
experimentally observed mass loss at each time point. 
2.3 Results 
2.3.1  Baseline Graft Evaluation 
The fabricated grafts (n = 20) had an average outer diameter of 1.51±0.02 mm, inner 
diameter of 0.85±0.13mm and length of 9.62±0.36 mm. Porosity of 72.76±1.89% and pore size 
of 25–32 mm with 99.99% interconnectivity of pores were observed. MicroCT analysis was 
conducted to assess heterogeneity within samples before exposing them to enzymatic degradation.  
Equation 2-7a shows the variation in porosity along the length and Equation 2-7b shows the pore 
size of a representative sample. All samples showed consistent porosity of 71.84±1.76 across their 
 47 








Figure 9: Baseline graft porosity and pore size. 
Variation in (a) porosity and (b) pore size of PGS sample at time s = 0. No significant axial variation in 
porosity was observed. 
2.3.2  Erosion of Tissue Engineered Vascular Grafts 
Changes in mass, volume fraction and bulk morphology were assessed as a function of 
time exposed to enzymatic degradation. These are important parameters that indicate the extent of 
erosion of these grafts. They are also valuable in understanding and modelling the mechanism of 
erosion in these porous TEVGs. 
2.3.2.1 Survival Function: Best-fit to Experimental Mass Loss 
Rate of mass loss is of fundamental importance for understanding and modelling 
degradation of these grafts. Equation 2-8 shows the in vitro rate of mass loss of these porous grafts 
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when exposed to enzymatic degradation. In the constrained mixture model, mass loss of the 














where ∆𝑚𝑚(𝑠𝑠) is defined in Equation 2-2. In order to obtain the functional form of the survival 
function for these porous grafts, we performed nonlinear regression on mass loss as a function of 
time exposed to enzymatic degradation in vitro. Figure 10 shows the experimental mass loss with 
the best-fit exponential form of the survival function. Rate constant 𝑄𝑄2 specifies the rate of 
degradation. The form of this survival function is generally assumed to be sigmoidal [96] due to 
lack of experimental data in the literature.   However, it is clear from our experimental data that 
an exponential function is better suited to model mass loss (𝑅𝑅2 value of 0.99), than the sigmoidal 





Figure 10: Mass remaining (survival function) as a function of time exposed to enzymatic degradation.  
Data are presented as mean±standard deviation (n=4, each time point) 
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Table 1: Functional forms for survival function with best-fit values and goodness of fit 
 
 
Functional Form Equation Parameter Values 𝑅𝑅2 
Exponential 𝑄𝑄𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) = 𝑄𝑄1𝑒𝑒−𝑄𝑄2𝑖𝑖 𝑄𝑄1 = 97.74,𝑄𝑄2 = 0.07𝑑𝑑−1 0.99 
Linear 𝑄𝑄𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) =  ?̇?𝑚𝑠𝑠 + 𝑚𝑚(0) ?̇?𝑚 = −5.02𝑑𝑑−1,𝑚𝑚(0) = 93.8 0.88 
Sigmoidal 𝑄𝑄𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) = �1 + 𝑒𝑒𝑘𝑘𝑝𝑝(𝑖𝑖−𝑖𝑖𝑔𝑔𝑔𝑔𝑖𝑖𝑒𝑒𝑔𝑔)�
−1
 𝑘𝑘𝑝𝑝 = 1.42𝑑𝑑
−1, 𝑜𝑜𝑓𝑓𝑓𝑓𝑠𝑠𝑒𝑒𝑡𝑡 = 27𝑑𝑑 0.03 
2.3.2.2 Mass Loss is Surface Erosion Driven 
The mass loss of TEVGs can be due to a range of mechanisms, from pure surface erosion 
to pure volume erosion. There was a 20% reduction in outer diameter at day 10 with a negligible 
change in the inner diameter, Figure 11. The small change in inner radius can be attributed to 
saturation of the inner domain and will be explained in detail in later sections. Also, the apparent 
density of the grafts (as normalized with the original apparent density to account for between 
sample variations) also remains fairly constant as seen in Figure 12 over the duration of 
degradation. Therefore, mass loss is nearly completely due to erosion of the outer diameter, thus 
showing that these TEVGs primarily undergo surface erosion, rather than a combination of bulk 








Figure 11: Loss of inner and outer diameter as a function of  time exposed to enzymatic degradation 
Surface erosion is characterized by reduction in diameter of sample. This plot shows the reduction in inner 
and outer diameters as a function of time exposed to enzymatic degradation. Data are presented as mean±s.d. 





Figure 12: Time course of apparent density normalized to initial density of each sample exposed to enzymatic 
degradation.  
A value of 1 represents no change in apparent density of the sample, consistent with minimal volume erosion. 




2.3.3  Mathematical Modeling of Tissue-Engineered Vascular Graft Erosion 
A simple mass balance shows that saturation of the inner domain causes at most a 0.044% 































This is consistent with the result that no discernible change in inner radius is observed. As the 
inner core saturates, the observed surface erosion can be attributed to reduction in outer diameter. 
Based on the observation that TEVG erosion was primarily driven by a concentration gradient as 
seen by the negligible loss in inner diameter, we developed a concentration gradient-driven mass 
diffusion equation to model this mass loss process. Using Equation 2-51 and the approach 
elucidated earlier for the outer domain, we determined that the best-fit values of h and D are 
1.053 × 10−6 𝑚𝑚𝑚𝑚/𝑠𝑠 and 2.123 × 10−6 𝑚𝑚𝑚𝑚
2
𝑖𝑖
 respectively. Using these values obtained by fitting 
to the first experimental time point, and the roots of Equation 2-42 outlined in Table 2, we can 







Table 2: Roots of equation 2.25 
 
 
n 1 2 3 4 5 6 7 




Figure 13 shows the experimental and predicted mass loss from the mechanistic model in the outer 
domain. The first experimental time point was used to fit ℎ,𝐷𝐷 required in Equation 2-51. As can 
be seen, the predictions at later time points closely follow the experimentally observed mass loss 







Figure 13: Mathematical modeling of graft erosion. 
(a) Graph of experimental and theoretically predicted mass loss. Predicted mass loss is obtained by fitting 
dimensional form of equation (2.28) to day 1 experimental data. (b) The analytical solution is an infinite 





 Observing the spatial distribution of concentration at the experimental time points of 1 and 
2 days show that saturation is observed at day 1 and the saturation front increases over time (Figure 
14). As noted in section Material and methods, after 2 days, the degradation medium was replaced 
in the beaker to maintain enzyme activity and prevent complete saturation. Through the use of 
three terms in the series Equation 2-51, this analytical approach models the experimental 
phenomena and re-establishes the concentration gradient which can be seen by the increase in rate 
of mass loss after 2 days following a period of reduction in rate of mass loss, Figure 13.This method 







Figure 14: Predicted evolution of concentration with time. 
Graph of (a) non-dimensional concentration 𝒖𝒖�(𝒓𝒓, 𝒔𝒔) and (b) concentration c normalized to 𝒄𝒄𝒔𝒔 as a function of 
radius 𝑹𝑹𝟐𝟐 ≤ 𝒓𝒓 ≤ 𝑹𝑹𝟑𝟑 at 1 day (orange) and 2 days (black). Almost 50% radial saturation was observed at day 




2.3.4  Degradation of Tissue-Engineered Vascular Grafts 
2.3.4.1 Change in Mechanical Properties 
Change in mechanical properties due to degradation is a crucial component of in situ host-
remodeling. Degradation of polymer alters mechanical properties of the grafts, which causes a 
transfer of load from the degrading graft to the surrounding cells under in vivo conditions. In order 
to capture this phenomenon accurately in our G&R tool, we need to obtain the functional form and 
rate constants associated with the evolving material properties. Figure 15 shows the stress–stretch 
data fitted to a neo-Hookean model (Equation 2-8) at each degradation time point with an 𝑅𝑅2 >




Figure 15: Cauchy stress–stretch curves (circles) as a function of time exposed to enzymatic degradation. 




Section 2.3.2.2 shows that the TEVG mass loss is primarily surface driven; however, the 
mechanical properties are not. Specifically, the mechanical properties of the grafts do not scale 
with density. We introduce an explicit time dependence of mechanical properties to the existing 
G&R models by introducing a scalar damage function ζ(𝑠𝑠)such that 0 ≤ ζ(s) ≤ 1. This damage 
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function ‘softens’ the material over degradation time s. A value of one for the damage function 
signifies zero damage and a value of zero represents complete loss of mechanical properties. 





𝑊𝑊𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) =  
𝛽𝛽(𝑠𝑠)
2
[𝑝𝑝1 − 3] = 𝜁𝜁(𝑠𝑠) �
𝛽𝛽0𝑃𝑃𝑃𝑃𝑃𝑃
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where 𝛽𝛽0𝑃𝑃𝑃𝑃𝑃𝑃 = 34.43 𝑘𝑘𝑘𝑘𝑎𝑎 
The damage function is obtained by a nonlinear regression fit of 𝜁𝜁(𝑠𝑠) normalized to the 
shear modulus at 𝑠𝑠 = 0 (Figure 16). It can be seen from Table 3 that an exponential fit to the 
normalized 𝜁𝜁(𝑠𝑠) values yielded an 𝑅𝑅2 value of 0.96. In summary, the experimental data provided 
by the in vitro enzymatic degradation study conducted on these porous TEVGs enable the 











Figure 16: Mechanical parameters. 
(a) Neo-Hookean parameter fit as a function of time. (b) 𝜻𝜻(𝒔𝒔) fit as a function of time, to model damage-like 
phenomena in changing mech- anical properties of grafts exposed to enzymatic degradation. Data are shown 





































































(𝑝𝑝1 − 3)�  
 
where values of 𝑄𝑄1 and 𝑄𝑄2 are given in Table 1. 
 
 
Table 3: Functional forms for time-evolving neo-Hookean parameter with best fit values and goodness of fit. 
 
 
Functional Form Equation Parameter Values 𝑹𝑹𝟐𝟐 
Exponential 𝜁𝜁(𝑠𝑠) = 𝜁𝜁1𝑒𝑒−𝜁𝜁2𝑖𝑖 𝜁𝜁1 = 1, 𝜁𝜁2 = 0.164 0.96 
Linear 𝜁𝜁(𝑠𝑠) =  𝜁𝜁𝑠𝑠 + 𝜁𝜁0̇  𝜁𝜁 = −0.086, 𝜁𝜁0 = 1̇  0.89 
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2.4 Discussion 
Successful G&R elicited by porous acellular TEVGs rests on the effective interplay 
between PGS degradation, erosion and ECM deposition. Computational G&R tools have proven 
to be sources of predictive capabilities that guide rational design of TEVGs. However, this 
predictive capability depends on the knowledge of certain properties that can be prescribed through 
experimental data or mechanistic models. Two such material properties that are the focus of this 
study are degradation and erosion rates of grafts. It has been postulated that the main mechanism 
of ECM deposition is through the stress driven mechanobiological response of ECM-producing 
cells which requires accurate modeling of load transfer from the graft. Since graft mechanics 
cannot directly be studied in vivo due to the growth of neotissue upon graft degradation, we 
conducted an in vitro analysis of the effect of enzymatic degradation on graft properties.  
We took two approaches to modeling the mass loss due to erosion of these TEVGs based 
on experimental data. Firstly, we obtained functional forms and rate constants of the survival 
function by providing a best-fit to mass loss over time. While most previous models assume a 
sigmoidal mass loss [95], we observe that an exponential model provides a better fit in this context. 
Another significant finding was that despite the porous nature of these grafts, most mass loss 
occurs at the surface of these TEVGs. This was evidenced by the little change in density, pore size 
and inner diameter of the grafts over degradation time. Based on these results, we formulated a 
mathematical model of graft erosion and validated the proposed theoretical model with 
experimental data. The boundary value problem formulated herein, enables the prediction of mass 
loss through two degradation constants ℎ and 𝐷𝐷. Furthermore, differences between the in vivo and 
in vitro setting can be included in this framework by changing the rate constants and boundary 
conditions while using the same functional forms of the equations. For example, the inner 
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boundary condition can be changed to a convection boundary condition to account for blood flow 
in the lumen in vivo. Cell infiltration in vivo is expected to alter the rate constants for degradation 
and erosion and not the functional forms themselves. These rate constants can be tuned for in vivo 
applications based on measurements of neoartery formation. For example, the parameters ℎ and 𝐷𝐷 
can be tuned for in vivo mass loss through a parametric evaluation guided by observations from 
experiments. The rate of degradation could additionally be affected in vivo by strains experienced 
by the graft. However, due to the nature of graft implantation, there is no axial strain at 
implantation and the presence of the PCL sheath restricts circumferential strain to be less than 4%. 
The influence of larger strains on degradation rates can be evaluated, if needed, in future studies. 
Another important aspect of the in-host remodeling process is the changing load bearing 
contribution of the degrading TEVG which guides cellular response over time. We observed that 
while mass loss is largely surface driven, mechanical properties are not. Herein, we provided a 
constitutive relationship for the `weakening' of material properties due to degradation over time 
by introducing a damage function. This key finding ensures that mechanical properties are 
extracted from the dependence on mass loss alone and are explicitly modeled as functions of 








Figure 17: Per cent change in porosity as a function of time exposed to enzymatic degradation.  
Very small increase in porosity suggests little volumetric degradation. Data are shown as mean±s.d. (n = 4 




It must be noted that while erosion was primarily observed on the outer surface of the 
grafts, we did observe some minor volume degradation at the pores. Figure 17 shows that there 
was an 8% increase in porosity at day 10 which corresponds to only a 3% mass loss. We also 
modeled mechanical properties of the graft using an assumption of isochoric deformation for an 
incompressible material. This assumption is often made in models of the artery wall and vascular 
grafts [68], [121], and future studies can explore the importance of modeling the graft using a two-
parameter coupled compressible Neo-Hooken model [122]. 
These findings not only provide an understanding of the fundamental process of PGS 
degradation and erosion, but also provide broader insights into the in vivo remodeling process. The 
finding that graft surface erosion is dominated by an evolving concentration gradient implies that 
the pores in these grafts saturate which is consistent with data found here on mass loss. This has 
implications in the inflammatory response of cells; a crucial first response that guides further 
remodeling [123]. Furthermore, since pore size is one of the major determinants of macrophage 
polarization [124] it can be conjectured that these cells sense the fabricated pore size and that their 
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behavior can be modulated as desired through this particular graft parameter. It must also be 
mentioned that while this study enabled us to understand the underlying mechanism of graft 
degradation, the effect of volume degradation can be enhanced in vivo by the presence of cells, 
especially macrophages. This phenomenon is currently under investigation in our group and is 
being included in the G&R framework to improve its predictive capability for use in rational design 
of TEVGs. 
2.5 Conclusion 
In summary, this work provides much-needed experimental data required to guide 
computational G&R modelling in the field. It is the first study that takes a physics-based approach 
to informing G&R computational tools with physical mechanisms of degradation and erosion of 
these grafts using a controlled environment. It also serves as an essential complement to our 
ongoing in vivo study of neoartery formation using the PGS core studied here as replacement 
vessels in the carotid artery of rats [52]. These results are of value not only for the use of G&R 
frameworks as predictive tools but also for understanding the fundamental mechanisms 
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analysis of the enzyme concentration required to achieve an appropriate rate of graft degradation. 








3.0 Determine the Evolution of Cellular Content, ECM, and Mechanical Properties during 
Neoartery Formation in Young Rats 
The work in this chapter was largely reproduced from the following manuscript: 
Lee, Kee-Won, Piyusha S. Gade, Liwei Dong, Zhaoxiang Zhang, Ali Mubin Aral, Jin 
Gao, Xiaochu Ding et al. "A biodegradable synthetic graft for small arteries matches the 
performance of autologous vein in rat carotid arteries." Biomaterials 181 (2018): 67-80. 
3.1 Introduction 
In our prior work, we successfully elicited G&R in a young healthy rat abdominal aorta 
model through the implantation of a porous, synthetic, bilayered graft [31], [98]. In order to 
translate this success to small diameter and mature animal models, there is a need to understand 
the mechanobiology of the remodeling process in these young rats. There is also a critical need to 
understand the remodeling process in the context of initial graft properties. Correlation of 
quantifiable mechanics and biological parameters to initial graft properties like degradation rate 
and mechanical properties can aid iTEVG design. The objective of this aim to a) develop a 
mechanistic understanding of the remodeling process in young rats and, b) compare the effects of 
remodeling to the surgical gold standard – vein graft. 
We set out to design an iTEVG that could withstand arterial pressure immediately upon 
implantation and leverage the natural regenerative capabilities of the host to transform the structure 
into an arterial conduit in vivo, bypassing cell harvesting and culture completely. We use a 
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relatively fast-degrading and highly porous tube as the major component [31] to enable rapid cell 
infiltration and host remodeling. The polymer, poly(glycerol sebacate) (PGS), is elastomeric and 
promotes elastin synthesis [102]. The tubular core is surrounded by a slow-degrading and thin 
sheath made of poly(caprolactone) (PCL) to increase suturability and avoid graft dilation. Multi-
layered and bi-layered designs have been previously reported in tissue engineered vascular 
structures made of collagen gels [125], poly(ester urethane)urea [126], and PCL micro and 
nanofibers [127], [128]. The composition of our bi-layered graft is different in that > 90% of the 
graft is made of PGS. This design induces the host to replace the acellular scaffold with a 
structurally sound vascular conduit in a rat abdominal aorta at 3 months [31] and further matched 
the elastin content while maintaining good patency in a 1-year follow-up [98]. Recent studies using 
the fast-degrading material support our approach, demonstrating cell infiltration and vascular 
remodeling and inhibited calcification in mouse and rat aorta [129], [130]. However, the aorta is a 
large-diameter artery with a high blood flow and its hemodynamics and mechanical properties are 
quite different from small-diameter arteries. The small diameter increases the risk of early graft 
stenosis and thrombosis [131], [132] and the low blood flow affects long-term patency of the grafts 
[133]. Thus, we examined whether our design would meet the more stringent requirement of 
grafting rat carotid arteries. Furthermore, we compared the performance with the autologous graft 
from external jugular veins because the vein is the largest source for small artery grafting clinically. 
Previous studies of degradable synthetic grafts in small arteries have used the common 
carotid artery because it is easily accessible and long enough to implant and monitor the graft 
[134]. Compared to the aorta, the common carotid has a smaller diameter, lower blood flow and is 
more muscular and stiffer. Acellular grafts made of PCL and chitosan enhances cell infiltration 
and arterial remodeling in carotid arteries and supports the feasibility of using iTEVGs in the 
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peripheral arterial circulation [135]. However, the presence of significant graft materials at the 
terminal time point makes it difficult to predict outcome upon complete degradation of the graft 
material. We chose 3 months as a terminal time point for this study because very little graft material 
is left and the remodeled conduit consists mostly of host tissues. The key data are patency, 
morphological change, inflammatory responses, cellular organizations, ECM production, and 
mechanical properties. 
3.2 Materials and Methods 
3.2.1  Graft Fabrication and Characterization 
3.2.1.1 Graft Fabrication 
The PGS inner core was fabricated as described previously in Section 2.2.1 . To fabricate 
the outer sheath, PCL (Mn = 80,000 Da) (Sigma-Aldrich, St. Louis, MO) was dissolved in 2,2,2- 
trifluoroethanol (ThermoFisher Scientific, Waltham, MA) at 14% w/vol and electrospun onto the 
rotating cured PGS-salt tubes size = 22 gauge, distance between the needle and aluminum col- 
using the following conditions: applied voltage = ± 12 kV, needle lector = 30 cm, distance between 
the mandrel and aluminium collector = 10 cm, infusion rate = 29 ml/min, and mandrel rotating 
speed = 80 rpm. The thickness of PCL outer sheath was controlled in a targeted range of 20 - 25 
µm by varying time and monitored using a high- speed laser micrometer (LS-7070M, Keyence 
Corp., Itasca, IL). After electrospinning, PGS-PCL-salt tubes were dried in a vacuum chamber for 
24 h and residual salt was dissolved in a series of two 10mLwater baths (first bath for 24 h and 
 66 
second bath for 48 h). Final grafts were lyophilized, sterilized with a gamma irradiation (dose = 
25 kGy), and soaked into the heparin solution (100 U/mg) for 5 min before implantation. 
3.2.1.2 Graft Characterization: Gel Permeation Chromatography (GPC) 
The molecular weights of the electrospun PCL sheets before and after gamma irradiation 
were examined using Waters Ambient Temperature GPC equipped with Gramm column and 
tetrahydro- furan (THF) as stationary and mobile phases (Waters Corporation, Milford, MA). 
Three different locations of the PCL sheets and the gamma-irradiated PCL sheets were taken for 
GPC analysis. The samples were prepared in THF at 1.5 mg/mL and filtrated through 0.2 mm 
syringe filter before the test (n = 3). Polystyrene was used as the standard polymer to calibrate the 
molecular weight. 
3.2.1.3 Differential Scanning Calorimetry (DSC) 
The crystallinity of electrospun PCL was measured before and after gamma sterilization. 
Five-milligram portions (n = 3) were scanned in a Q1000 MDSC (TA Instruments, New Castle, 
DE) operating in unmodulated mode. Samples were heated at 10ºC/min from 25 ºC to100 ºC. 














where, ∆𝑯𝑯𝒇𝒇 is the measured heat of fusion and ∆𝑯𝑯𝒇𝒇𝒐𝒐 is the heat of fusion of purely crystalline PCL, 
taken as 136 J/g. 
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3.2.1.4 Uniaxial Tensile Test  
Electrospun PCL sheets before and after gamma sterilization were cut using the dog-bone 
cutting die (TestResources Inc., Shakopee, MN). The mechanical properties were measured 
according to the standard method (ASTM D412) using an electromechanical testing machine 
(Insight, MTS Systems, Eden Prairie, MN) equipped with a 5N load cell. Uniaxial tensile force 
was applied to dog-bone specimens (gauge length = 7 mm, and width of narrow section = 1 mm) 
for three samples with an average length of 28 mm, average width of  5 mm which were extended 
until failure at a rate of 5 mm/min while recording the force. Ultimate tensile stress, linear elastic 
modulus, and strain at complete failure were calculated from the stress-strain curves. 
3.2.1.5 Scanning Electron Microscopy (SEM)  
The morphology of the iTEVGs was examined using SEM. Grafts were cut into 2 mm 
segments transversely, mounted onto aluminum stubs, sputter-coated with gold, and observed with 
a field emission SEM (6330F, JEOL, Tokyo, Japan). Inner diameter, wall thickness and PCL 
sheath thicknesses of the graft were measured from cross-sectional SEM images using ImageJ 
software (National Institutes of Health (NIH), Bethesda, MD). 
3.2.1.6 X-ray Micro-Computed Tomography  
Porosity and pore size distribution of grafts were measured using X-ray micro-computed 
tomography (micro-CT) as described in Section 2.2.4 . 
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3.2.2  Graft Implantation 
All procedures involving animals were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh following NIH guidelines for the care and use of 
laboratory animals. Male Sprague Dawley rats (8 to 9 weeks old; 225-250 g, n = 50, Charles River 
Laboratories, Wilmington, MA) were used in this study. Eight rats were used to characterize 
carotids and external jugular veins (n = 4 each) for cell and ECM content and dimensions. For 
graft implantation, 42 rats were randomly divided into two groups for implantation of iTEVGs and 
autologous vein grafts. The 21 rats in each group were randomly divided into three groups of 7 
rats for each time point (day 14, 30, and 90). The time points were selected based on our previous 
study demonstrating near complete graft material degradation within 90 days. Rats were 
anesthetized with isoflurane inhalation (5% for induction, then 1-3% for maintenance), and their 
limbs were fixed in the supine position.  
Experimental group: The midline of the neck was cut longitudinally. Blunt dissection created 
the operating space, exposing left sternocleidomastoid and sternohyoid. The left 
sternocleidomastoid was retracted to the lateral side, then the left common carotid artery was 
exposed, clamped, and transected it at 2 mm proximal to the bifurcation of internal and external 
carotid artery; a segment of 5 mm common carotid artery was removed as well. The graft (10-mm 
long) was interpositioned by end-to-end anastomosis using interrupted 10-0 polyamide 
monofilament sutures (AROSurgical, Newport Beach, CA).  
Control group: To compare with iTEVGs, the autologous external jugular vein was used as a 
control. The skin incision was made in the same way as described above. The left external jugular 
vein was exposed, ligated all branches, and harvested as 10-mm long segment. The left common 
carotid artery of the same rat was exposed, clamped, and transected as mentioned above. The 
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external jugular vein was interpositioned by end-to-end anastomosis using running 10-0 polyamide 
monofilament sutures. No anticoagulation and antiplatelet treatments were administrated during 
and after implantation. The contralateral right common carotid artery was used as an age-matched 
healthy control. Both antibiotic (Baytril, 10 mg/kg) and analgesic (Buprenorphine, 0.1 mg/kg) 
medications were given until 72 h after implantation. To measure dimensions of native vessels, 
native common carotid arteries and external jugular veins (n = 4 each) were explanted, cut as 2-
mm thickness, and viewed with a stereomicroscope (SMZ745T, Nikon Instruments Inc., Melville, 
NY). Both inner diameter and wall thickness were measured from cross-sectional images using 
the NIS-Elements software (Nikon).       
3.2.3  Patency Monitoring 
The blood flow was checked with a flow coupler monitor (GEM1020M, Synovis Micro, 
Birmingham, AL) at 5, 10, 15, and 30 min after removing clamps. A high-frequency ultrasound 
imaging system (Vevo2100, FUJIFILM Visualsonics, Toronto, Canada) was used to monitor the 
inner diameter and flow velocity of mid-grafts and contralateral native carotids at day 14, 30, 60 
and 90 after implantation. Animals were anesthetized with 1-2% isoflurane via precision vaporizer 
and 1 L per minute gas flow and placed on a custom-built platform with a warming pad in a 
position. The hair on the neck area was removed with hair removal cream and ultrasound gel 
(AccuGel, Lynn Medical, Wixom, MI) was then applied to the skin. Transcutaneous ultrasound 
imaging was performed on the neck using a linear array transducer MS 550 centered at 40 MHz. 
B-mode, color Doppler mode, and PW mode images along the long axis and middle region of the 
graft and native carotids were measured through the cardiac cycle recorded from ECG leads and 
stored for offline analysis. Cine loop images were later analyzed using a high-frequency ultrasound 
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imaging system (Vevo2100) software for overall patency, inner diameter changes, and flow 
velocity at and around the graft. Both the inner diameter and flow velocity were obtained by 
averaging end-diastolic and end-systolic inner diameter and flow velocity measured from B-mode 
and PW mode images, respectively.   
3.2.4  Histology and Immunofluorescence Staining 
All explanted grafts and native carotids were rinsed with PBS, fixed in 10% formalin for 1 h 
at 4°C, and dehydrated in 30% sucrose solution at 4°C for 24 h. Tissue sections were embedded 
in optimal cutting temperature compound (Sakura Finetek, Torrance, CA), frozen at -80°C for 2 
h, and cryosectioned to 8-µm thickness. Tissue slides were stained with H&E, Masson’s trichrome, 
Verhoeff-van Gieson, and Alizarin red to examine cell presence and infiltration, collagen, elastin, 
calcium, respectively. All histological images were representative of three independent sections 
per group (n = 4) and captured with an inverted microscope (Eclipse Ti-E, Nikon). The luminal 
area and wall thickness of both grafts and native carotids were measured from H&E staining 
images with a high-power magnification (60×) using the NIS-Elements software (Nikon). Tissue 
sections (8-µm thick) were fixed with 4% paraformaldehyde for 1 h at 4°C and permeabilized with 
0.2% Triton X-100 for 5 min at room temperature. Tissue sites on slides were blocked with 5% 
normal goat serum (NGS) (Sigma-Aldrich) for 24 h at 4°C, incubated with primary antibodies in 
1% NGS for 45 min at 37°C, were rinsed twice with PBS, followed with the corresponding 
secondary antibodies in 1% NGS for 45 min at 37°C. Antibodies used are described in Table 4. 
Nuclei were counterstained with 4',6-diamidino-2-phenylindole (DAPI) (Life Technologies, 
Carlsbad, CA) at room temperature for 20 min. Tissue slides without primary antibodies were used 
as negative controls.  
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Table 4: Antibodies used.  
Primary and secondary antibodies used for immunofluorescence staining and Western blotting. 
 
 
Primary Dilution Company Secondary Dilution Company 
Immunofluorescence staining 
CD11b 1:100 Abcam Alexa 647 α-mouse 1:400 
Invitrogen 
CCR2 1:50 ThermoScientific Alexa 594 α-rabbit 1:400 
CD68 1:100 EMD Millipore Alexa 488 α-mouse 1:400 
iNOS 1:100 Abcam Alexa 594 α-rabbit 1:400 
CD206 1:100 Abcam Alexa 594 α-rabbit 1:400 
vWF 1:200 Abcam Alexa 594 α-rabbit 1:400 
αSMA 1:500 Sigma FITC- conjugated 
calponin 1:100 Abcam Alexa 647 α-mouse 1:400 
Invitrogen 
MHC11 1:100 Abcam Alexa 594 α-rabbit 1:400 
Ki67 1:100 Abcam Alexa 594 α-rabbit 1:400 
collagen I 1:100 Abcam Alexa 594 α-rabbit 1:200 
collagen III 1:100 Abcam Alexa 594 α-rabbit 1:200 
elastin 1:100 Santa Cruz Biotechnology Alexa 488 α-mouse 1:400 
fibrillin-1 1:500 Dr. Dieter P. Reinhardt (from McGill University) Alexa 594 α-rabbit 1:200 
Western blotting 






TM 1:1500 Abcam 1:100000 
VCAM-1 1:200 Santa Cruz Biotechnology 1:1000 
p-Akt 
(Ser473) 1:2000 Cell Signaling Technology 1:20000 




p-ERK1/2 1:1000 Santa Cruz Biotechnology 1:20000 
β-actin 1:50000 Sigma 1:2000 
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3.2.5  Endothelial Cell Examination 
The grafts and native carotids were explanted at day 90, cut longitudinally by using 
microscissors, and fixed with minute pins. For SEM, samples were fixed with 2.5% glutaraldehyde 
for 2 h at room temperature, washed with PBS, and dehydrated in graded series of ethanol. After 
the critical-point drying, samples were mounted onto aluminum stubs, sputter-coated with gold, 
and observed with a field emission SEM. For en face immunofluorescence staining, samples were 
fixed with 4% paraformaldehyde at 1 h and permeabilized with 0.2% Triton X-100 for 5 min at 
room temperature. Samples were blocked with 5% NGS for 24 h at 4°C, incubated with the mouse 
anti-CD31 (1:200, Abcam, Cambridge, MA) primary antibody, and then incubated with Alexa 
Fluor 594 goat anti-mouse IgG (1:400) secondary antibody. Immunofluorescence images were 
captured with the inverted microscope. 
3.2.6  Western Blot Analysis 
The grafts and native carotids were homogenized in cold RIPA buffer (Cell Signaling 
Technology, Danvers, MA) containing protease inhibitor cocktail. The homogenized tissues were 
centrifuged at 14,000×g for 10 min at 4°C and protein contents of the supernatants were measured 
by Pierce 660nm Protein Assay (ThermoFisher Scientific). Equal amounts (20 µg) of proteins were 
separated on 8% SDS/PAGE gels and transferred onto polyvinylidene fluoride membranes 
(ThermoFisher Scientific). Membranes were blocked with 5% bovine serum albumin (EMD 
Millipore, Burlington, MA) and incubated with primary antibodies at 4°C with shaking at 90 rpm 
overnight. After washing with Tris-buffered saline, membranes were probed with secondary 
antibodies at room temperature for 2 h. Antibodies used are described in Table 4. HRP-based 
 73 
detection was performed using Pierce ECL Western Blotting Substrate (ThermoFisher Scientific, 
Waltham, MA). Membranes were stripped and reprobed, and blots were visualized by X-ray film 
exposure with the use of a quality X-ray processor (AX700LE, Alphatek, Salem, WI). The 
intensity of blots was quantified using ImageJ software (NIH) and normalized to that of β-actin. 
3.2.7  Biochemical Assays 
Collagen quantification. Collagen contents of grafts and native carotids were measured using 
the Sircol Insoluble Collagen Assay kit (Accurate Chemical & Scientific Corp., Westbury, NY). 
Tissue segments (3-mm long) were minced finely, weighed to obtain wet weight, and then digested 
with the Fragmentation Reagent at 65 °C for 2 h 30 min to convert the insoluble collagen to 
denatured soluble collagen. Collagen content in pooled supernatants was measured following the 
manufacturer’s instructions and normalized to tissue wet weight (µg/mg). 
Elastin quantification. Elastin contents of grafts and native carotids were measured using a 
Fastin Elastin Assay kit (Accurate Chemical & Scientific Corp.). Tissue segments (3-mm long) 
were minced finely, weighed to obtain wet weight, and then digested with 0.25M oxalic acid at 
100 °C for 1 h three times to extract the mature insoluble elastin into the solution supernatant. 
Elastin content in pooled supernatants was measured following the manufacturer’s instructions 
and normalized to tissue wet weight (µg/mg). A sample size of  n = 4 was used for graft explants 
as well as native carotids. All samples were tested in triplicate during the same assay run. Bare 
iTEVGs were used as a negative control. 
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3.2.8  Mechanical Evaluation 
Suture retention strength measurement. Suture retention strength of grafts and native vessels 
was measured using a uniaxial testing machine (Insight, MTS Systems, Eden Prairie, MN) 
equipped with a 5 N load cell according to ISO 7198. Both bare grafts and explanted external 
jugular veins and native carotids were cut longitudinally by microscissors to obtain rectangular 
samples (length = 10 mm, width = 4 mm). A single 9-0 Nylon suture (AROSurgical) was inserted 
through the 2 mm of the edge of each sample and tied to form a loop. The non-sutured end of each 
sample and the suture loop were secured to separate clamps in the testing machine and the suture 
was pulled at the rate of 50 mm/min with recording the force. Grafts were tested in the dry state, 
but native vessels were tested in the wet state using saline at room temperature. Suture retention 
strength was defined as the maximum force recorded before the suture was pulled through each 
sample. A sample size of n = 5 was chosen for grafts and native vessels.   
Biaxial inflation test. Circumferential mechanical properties of the explanted grafts were 








Figure 18: Schematic of biaxial – inflation mechanical testing device mounted under a multiphoton 
microscope.  
The biaxial load is applied to the cannulated vessel using the actuator for applying axial stretch and pressure 
controller to pressurize the vessel. The multiphoton microscope objective lens is used to image the vessel from 




Entire segments of grafts were mounted on the device by suturing them on cannulae and immersed 
in a water bath maintained at 37˚C. For local strain measurement, 350-400 μm microspheres 
(Zephyrtronics Inc., Pomona, CA) were lightly glued on the surface of grafts and tracked using a 
video camera (EO-5012C, Edmund Optics, Barrington, NJ) which captures images at 5 megapixels 
and 6 frames per second giving a final pixel size of 2.2 × 2.2 µm to obtain local axial strain 
measurement. Both axial and circumferential strains were calculated by analyzing these images 
using a custom code in MATLAB (R2014b, Mathworks, Natick, MA). The load was measured 
using a high precision load cell (MDB-5, Transducer Techniques, Temecula, CA) mounted on one 
end of the device and axial strain controlled using a computer-controlled actuator (ANT-25LA, 
Aerotech Inc., Pittsburgh, PA). Testing consisted of four preconditioning cycles during which the 
grafts were stretched to the in vivo axial strain level and cycled from 0-120 mmHg. Following 
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preconditioning, the grafts were tested at the following axial strain levels: 0, 10, 20%, in vivo strain 
and 40% axial strains by performing three inflation cycles from 0-120 mmHg at each strain level. 
High-strain modulus was calculated by fitting a line to the high strain region of the stress-stretch 












where ∆𝐷𝐷 is the change in the inner diameter of the sample. The outer diameter is measured and 
thickness calculated using the isovolumetric deformation assumption. 𝐷𝐷0 is the inner diameter at 
70 mmHg and ∆𝑘𝑘 is 40 mmHg.  
Burst pressure measurement. Explanted grafts and native carotids (10-mm long,  n = 3 each) 
were cannulated and pressurized with PBS using 20 mL syringe at an infusion rate of 5 mL/min 
until failure. The luminal pressure was measured using a pressure transducer (PX309-100G5V, 
Omega Engineering Inc., Stamford, CT) with a range of 0-5000 mmHg. The data were recorded 
using a data acquisition system (PowerLab 8/30, ADInstruments, Colorado Springs, CO). 
Collagen fiber imaging under biaxial loads. Explanted grafts and native carotids (10 mm long, 
n = 3 each) were cannulated and mounted on the biaxial inflating testing device (Figure 18). The 
device was then mounted directly under a multiphoton microscope (FV1000 MPE, Olympus, 
Center Valley, PA) objective lens to image the vessel under specified inflated pressures and axial 
load. In particular, specimens were axially stretched to their respective measured in vivo strains 
and imaged at two pressures; 0 mmHg (no load) and 120 mmHg (maximum physiologic load). An 
excitation wavelength of 800 nm and 1.12 NA 25× MPE water immersion objective was used for 
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all samples. SHG signal was collected using a 400 nm emission filter with ± 50 spectral bin. Planar 
images were taken starting from the outer wall, moving toward the lumen at 2 µ𝑚𝑚 intervals. 
Collagen fiber recruitment was quantified through fiber tortuosity using the manual filament 
tracing function in Imaris (Bitplane, Switzerland). Fibers were manually traced on 2D images 
generated from projections of stacks of 2D imaging data taken across the thickness of the sample 
within a central region (200 × 100 𝜇𝜇𝑚𝑚). This region was chosen such that it was possible to image 
through the entire wall thickness of the sample. Straightness is defined as such that a straightness 
value of one represents fully straightened collagen fiber and less than one represents fibers with 
some curvature/undulation. Similarly, collagen fiber orientation was quantified using the manually 
traced fibers mentioned above. Angles of θ = 0° and 90° represent fibers aligned in the 
circumferential and longitudinal direction, respectively. 
3.2.9  Statistical Analysis 
All measured data were reported as a mean ± SD. A log-rank test (for survival curve) and an 
unpaired, two-tailed Student’s t-test were performed to compare two groups. A one-way analysis 
of variance (ANOVA) with Tukey’s multiple comparisons was performed to compare three 
groups. Statistical analysis was performed using Prism version 7 (GraphPad Software, La Jolla, 
CA) to assess the statistical significance at P < 0.05. 
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3.3 Results 
3.3.1  Graft Characterization 
The porous PGS core and the electrospun PCL sheath can be seen in the SEM image of a 
representative iTEVG, (Figure 19A) with an inner diameter of 768 ± 24 µm matching that of the 
vein graft, and significantly larger than that of the native common carotid artery (referred to as a 














Figure 19: Morphology of the iTEVG and native vessels.  
(A) Cross-sectional SEM images of the PGS-PCL bi-layered iTEVG. The bottom row represents the 
partial magnification of the box shown in the top row (left). Scale bars, 500 µm (top, left), 10 µm (top, 
right, and bottom, right), 100 µm (bottom, left). (B) Representative images for H&E staining in the 
middle region of the explanted native common carotid artery and external jugular vein (top row), 
and the magnification of the box region shown in the top row (bottom row). Carotid, common carotid 
artery. EJV, external jugular vein. IMT, intima-media thickness. A, adventitia. Scale bars, 200 µm 




The wall thickness was 391 ± 23 µm, significantly larger than that of the carotid (P < 0.0001) and 
vein (P = 0.0074). The PCL sheath thickness was 23.6 ± 14 µm. MicroCT revealed a total porosity 
of 72.8 ± 1.9 % and the average pore size of 26.6 ± 3.2 µm, corresponding well to a calculated 
porosity of 75% and salt particles with diameters of 25-32 µm. Pore interconnectivity was greater 
than 99 %.     
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3.3.2  Neoarteries Showed Comparable Patency to Vein Grafts 
We interpositioned both the synthetic and vein grafts (n = 21 each) in the left common 
carotid artery of Sprague Dawley rats and kept the right carotid as a control (Figure 20A).Newly 
formed microvessels in the outer wall of both grafts suggested graft integration into the host. 
Ultrasonography at days 14, 30, 60, and 90 demonstrated open lumen and blood flow of the 
remodeled neoarteries similar to those of vein grafts and the native common carotid artery (referred 
to as a “carotid” in all figures) at day 90 (Figure 20B). The overall patency was 90.5% (19/21) for 
the neoarteries and 100% (21/21) for vein grafts, and there was no statistical difference (Figure 
20C). One neoartery developed distal thrombosis at day 6 and one ruptured at day 9. The inner 
diameter of neoarteries and vein grafts was similar but significantly larger than that of native 
carotids at all time points (P < 0.05) (Figure 20D). At day 90, the inner diameter tended to be 
smaller in the vein graft (0.98 mm) than in the neoarteries (1.13 mm), although this difference is 
statistically insignificant. The flow velocity of both grafts was similar to that of native carotids 
(contralateral) except that the vein graft displayed a significantly lower flow at day 14 (P = 0.013) 






Figure 20 Graft implantation and patency. 
 (A) Gross appearance of the grafts at day 0 and 90 post-implantation. Arrows indicate suture lines. Day zero 
is the graft (row 1) and native vein (row 2) immediately after implantaion. (B) Representative ultrasound 
images of both grafts and native artery at 90 days of remodelin. B-mode (top row), color Doppler and pulse 
wave (PW) modes (bottom row). Arrows indicate suture lines.. (C) Survival plot showing the overall patency 
of the grafts. There is no statistical difference between the two remodeled grafts (P = 0.15). (D) The inner 
diameter measured by B-mode images. (E) Flow velocity measured in the middle region of the remodeled 
grafts and native carotids by PW mode images. Data in (D) and (E) are means ± standard deviation (SD) (n = 




3.3.3  Neoarteries Exhibit Outward Remodeling  
We examined mid-sections of the remodeled grafts using histology and morphometry to 
assess cell infiltration, organization, and morphological changes. H&E staining showed a 
substantial and early cell infiltration in iTEVGs followed by cell and ECM organization (Figure 
21A). A dense luminal cell layer and little remaining synthetic materials were visible in the wall 
at day 14. Cells distributed throughout the wall and were denser in the outer wall at day 30. 
Circumferentially-organized cells and ECM were observed in the wall with a distinct medial-like 
layer at day 90. The distribution of cells and ECM was asymmetric near the lumen but resembled 
native carotids. Conversely, vein grafts showed disrupted endothelium at the luminal surface, and 
cell infiltration from the outer wall at day 14, followed by increased cell density in the lumen at 
day 30. At day 90, dense and disorganized cells and ECM were observed within the inner wall.  
Morphometrical analysis indicated that the luminal area increased gradually in neoarteries, 
but decreased in vein grafts with time (Figure 21B). At days 14 and 30, there was no significant 
difference in the luminal area between the neoarteries and vein grafts. However, the vein displayed 
a trend of decreasing luminal area and became significantly smaller than that of the neoarteries at 
day 90 (P = 0.036). Both grafts had significantly larger luminal area and wall thickness than native 
carotids at all time points (P < 0.001). However, the wall thickness increased in vein grafts but 
decreased in neoarteries so the latter approached the thickness of native carotids over time while 








Figure 21 Histological and morphological assessments at middle regions.  
(A) Representative images for H&E staining in the middle region of grafts and native carotids at each time 
point. The bottom row represents the magnification of the box region shown in the top row. Scale bars, 200 
µm (top row) and 50 µm (bottom row). (B) Luminal area. (C) Wall thickness. Both (B) and (C) were 
measured by using H&E stained images from three independent sections per sample. Data in (B) and (C) are 




Furthermore, while the remodeled PGL-PCL grafts showed consistent luminal area and 
wall thickness throughout the graft at all time points, the remodeled vein graft showed distinct 
change in both the luminal area and wall thickness along the vessel at the early time point (Figure 
22A). At day 14, the luminal area of the remodeled vein graft was minimal at the proximal region 
and became significantly larger toward the distal region (P = 0.008, middle and 0.0003, distal) 
than that of the remodeled PGS-PCL graft (P = 0.007, distal) (Figure 22B). In contrast, the wall 
thickness of the vein graft was maximal at the proximal region and became significantly smaller 
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toward the distal region (P < 0.0001, middle and distal) than that of the neoarteries (P < 0.0001, 
middle and distal) (Figure 22C). At day 90, remodeled vein grafts had a significantly smaller 







Figure 22 Histological and morphological assessments of grafts at anastomotic regions.  
(A) Representative images for H&E staining in both proximal and distal regions of remodeled grafts at each 
time point. Scale bars, 200 µm. (B) Luminal area. (C) Wall thickness. P, proximal. M, middle. D, distal. Both 
(B) and (C) were measured by using H&E stained images from three independent sections per sample. Data 
in (B) and (C) are means ± SD (n = 4). * represents P < 0.05. 
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3.3.4  Remodeled Neoarteries Exhibit Heightened Monocyte Recruitment Markers at 90 
Days 
We evaluated monocyte infiltration into the grafts to assess the initial host response. We 
stained mid-section of grafts with C-C chemokine receptor type 2 (CCR2) and CD11b, markers 
for monocyte recruitment, adhesion, and migration. The expression of CCR2 and CD11b were 
highest at day 14 and decreased thereafter in both grafts (Figure 23A and Figure 23C). Many 
CCR2+ cells infiltrated remodeled PGS-PCL grafts at day 14, but were almost absent at day 30, 
and disappeared at day 90. CD11b+ cells were dispersed through the wall at day 14 and limited to 
the abluminal area thereafter. Conversely, in remodeled vein grafts, CCR2+ cells dispersed 
throughout the wall at day 14 and persisted at the lumen and the abluminal areas at day 90. 
Quantification of the fluorescent-positive cells revealed that the neoarteries had more CCR2+ cells 
at day 14 (P = 0.015) but less at days 30 (P = 0.0003) and 90 (P = 0.002) than vein grafts (Figure 
23B).On the other hand, more CD11b+ cells were detected in neoarteries than the vein grafts at 





Figure 23: Infiltration of inflammatory monocytes. 
(A) Representative images for immunofluorescence staining with the monocyte recruitment marker CCR2. 
Arrows denote CCR2+ cells. L, lumen. (B) Quantification of the results shown in (A). (C) Representative 
images for immunofluorescence staining with the monocyte adhesion, migration marker CD11b. (D) 
Quantification of the results shown in (C). Scale bars, 100 µm (A and C). Data in (B) and (D) are means ± SD 
(n = 4). * represents P < 0.05. 
3.3.5  Remodeled Neoarteries Exhibit Similar Macrophage Distribution to Vein Grafts at 
90 Days 
We stained mid-sections of remodeled grafts with CD68, inducible nitric oxide synthase 
(iNOS), and CD206, markers of the newly recruited, pro-inflammatory (M1), and alternatively 
activated (M2) macrophages, respectively. Consistent with CD11b expression, both CD68 and 
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iNOS expression were highest in the lumen at day 14, decreased markedly thereafter, and were 
limited to the abluminal area in both grafts (Figure 24A and Figure 24C). Remodeled neoarteries 
showed significantly more CD68+ cells than vein grafts at day 14 (P = 0.034) (Figure 24B). There 
was no significant difference in the iNOS+ cells between remodeled neoarteries and vein grafts at 
all time points (Figure 24D). Conversely, CD206 expression was minimal at day 14 and increased 
gradually with time (Figure 24E). At day 14, CD206+ cells in remodeled neoarteries were 
significantly less than that in vein grafts (P < 0.0001); however, no difference was observed at 
later time points (Figure 24F). The ratio of iNOS+ to CD206+ cells was significantly higher in 
remodeled neoarteries than in vein grafts at day 14 (P < 0.0001) but showed no significant 
difference thereafter (Figure 24G). These results show that neoarteries enabled early infiltration of 






Figure 24: Macrophage infiltration and polarization. 
(A) Representative images for immunofluorescence staining with the pan-macrophage marker CD68. L, 
lumen. (B) Quantification of the results shown in (A). (C) Representative images for immunofluorescence 
staining with the M1 macrophage marker iNOS. (D) Quantification of the results shown in (C). (E) 
Representative images for immunofluorescence staining with the M2 macrophage marker CD206. (F) 
Quantification of the results shown in (E). (G) The area ratio of iNOS+ to CD206+ cells representing the 
M1/M2 macrophage ratio. Scale bars, 100 µm (A, C, and E). Data in (B), (D), (F) and (G) are means ± SD (n = 




3.3.6  Endothelial Cells Cover Neoarterial Luminal Surface by 1 Month 
We examined the luminal surface of the remodeled grafts using SEM and 
immunofluorescence staining with EC markers CD31 and vWF to assess EC coverage. At day 14, 
no ECs appeared for the remodeled neoarteries. Remodeled vein grafts showed disrupted 
endothelium in the luminal surface. At day 30, ECs covered the luminal surface of both grafts as 
demonstrated by vWF expression (Figure 25A). SEM images showed that ECs completely covered 
the lumen of both grafts at day 90 and were aligned in the flow direction, resembling that of native 













Figure 25: Endothelial cell coverage in vein graft and neoarteries.  
(A) Representative images for immunofluorescence staining with the endothelial cell (EC) marker vWF. 
The external jugular vein (EJV) image (bottom, left) represents ECs of the vein graft before 
interposition to the carotid artery. L, lumen. Scale bars, 100 µm. (B) Longitudinal SEM images 
showing the lumen of the neoartery (top row) and vein graft (bottom row) at day 90. Arrows 




Tightly-bound ECs with cobblestone-like morphology were clearly observed in 
neoarteries. CD31+ and vWF+ cells in the luminal surface confirmed EC coverage in both grafts 
(Figure 26A). Western blot analysis indicated that both the remodeled neoarteries and vein grafts 
expressed endothelial nitric oxide synthase (eNOS) and thrombomodulin (TM), but did not express 
vascular cell adhesion protein-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), 
indicating quiescence (Figure 26B). There were no significant differences in eNOS and TM 
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expressions between the remodeled neoarteries and vein grafts (P = 0.98 and 0.50) (Figure 26C). 
However, eNOS and TM expressions in both grafts were significantly lower than in native carotids 
(P < 0.05).   
We stained mid-section of grafts with smooth muscle contractile phenotypic and cell 
proliferating markers. Alpha-smooth muscle actin (SMA)+ cells were observed in the middle of 
the wall at day 14 and dispersed at day 30 in both grafts. More αSMA+ cells were organized near 
the outer layer in the remodeled neoarteries. In contrast, more αSMA+ cells were present near the 
lumen in the remodeled vein grafts. At day 90, the neoarteries showed a dense, concentric cell 
layer expressing calponin and myosin heavy chain, markers of contractile VSMCs (Figure 26D). 
There was no evidence of proliferating VSMCs, indicated by a negative expression of Ki67. On 
the contrary, remodeled vein grafts contained numerous proliferating αSMA+ and Ki67+ cells near 
the lumen. Alpha-SMA+ cells were disorganized in the wall and the expression of calponin and 
myosin heavy chain was weaker than neoarteries. We further investigated the activation of Akt 
and extracellular signal-regulated kinases 1 and 2 (ERK1/2) (Figure 26E). These are protein 
kinases of phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) and 
Ras-mitogen-activated protein kinase (MAPK) cascades, both of which are major signaling 
pathways of VSMC proliferation. Western blot analysis indicated that the expression of 
phosphorylated-Akt and ERK1/2 was significantly higher in the remodeled vein graft than in the 
neoarteries (P = 0.0036 and 0.0072) and native carotids (P = 0.0008 and 0.016) at day 90 (Figure 
26F). These results correlated with more proliferative VSMCs in the vein graft at day 90. Taken 
together, the neoarteries were closer to native carotids than remodeled autologous vein grafts in 






Figure 26: Arterial-like tissue remodeling at day 90. 
 (A) Representative images for en face (left) and cross-sectional (right) immunofluorescence staining with EC 
markers, CD31 and vWF. Arrows indicate the flow direction. L, lumen. Scale bars, 100 µm. (B) Immunoblots 
of grafts and native carotids for eNOS, TM, VCAM-1, and ICAM-1. (C) Quantification of the relative 
intensity of each blot normalized to β-actin expression. Data are means ± SD (n = 3). * represents P < 0.05. (D) 
Representative images for immunofluorescence staining with VSMC phenotype markers, αSMA, calponin, 
and smooth muscle-myosin heavy chain (SM-MHC), and proliferation marker Ki67. L, lumen. Scale bars, 
100 µm. (E) Immunoblots of p-Akt (Ser473) and p-ERK1/2. p-ERK1, 44 kDa (top). p-ERK2, 42 kDa 
(bottom). (F) Quantification of the relative intensity of each blot normalized to β-actin expression. Data are 
means ± SD (n = 3). * represents P < 0.05. 
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3.3.7  Remodeled Neoarteries show Comparable ECM Levels to Remodeled Vein Grafts 
ECM proteins provide mechanical support for the vessel and guide cellular differentiation 
and functions. We examined collagen and elastin using histology, immunofluorescence staining, 
and multiphoton microscopy. Masson’s trichrome and Verhoeff-van Gieson staining showed 
collagen fibers spanning the wall and some elastic fibers near the lumen in both grafts. Remodeled 
neoarteries had similar organization and distribution of ECM protein assemblies to native carotids 
with circumferentially organized collagen and elastin near the outer wall and the lumen, 
respectively. However, remodeled vein grafts had thick collagen fibers in the entire wall and 
aggregated elastin near the lumen. Alizarin red staining revealed that there is no calcification in 
either graft (Figure 27A). Immunofluorescence staining revealed the expression of collagen I and 
III across the entire wall of both grafts, in contrast to native carotid where collagen I and III were 
segregated to the adventitia and medial layers respectively.   Furthermore, the remodeled 
neoarteries expressed elastin and fibrillin-1. Vein grafts displayed weaker expression of fibrillin-
1 in the lumen than the remodeled neoarteries. Biochemical assays indicated that both grafts 
contained comparable densities of collagen (Figure 27B), but significantly less elastin than native 
carotids (P < 0.0003) (Figure 27C). As implanted, the iTEVGs contain no ECM but have similar 
collagen and elastin contents to the vein graft at 3 months: these were 88% and 23% of those in 






Figure 27: ECM protein deposition and quantification at day 90.  
(A) Representative images for histology and immunofluorescence staining with collagen and elastin markers. 
Masson’s trichrome, Verhoeff-van Gieson, Alizarin red staining show collagen (blue), elastin (black), but no 
calcium (red) deposition, respectively. L, lumen. Scale bars, 100 µm. (B) Quantification of total collagen using 
Sircol Insoluble Collagen assay. (C) Quantification of elastin using Fastin assay. Data in (B) and (C) are 




3.3.8  Neoarteries Exhibit Similar Compliance to Vein Grafts due to Collagen Fiber Re-
orientation 
We evaluated mechanical properties of grafts and native carotids using suture retention, 
biaxial inflation – extension, compliance, and burst pressure tests. Suture retention strength of both 
bare grafts and explanted external jugular veins was similar (P = 0.058), but significantly lower 
than that of native carotids (P < 0.0001 and 0.0024) (Figure 28A). There was no significant 
difference in the mechanical performance of the two types of grafts; both lacked a toe-region 
leading to a lower range of stretch in the loading curves compared with native carotids and veins.  
At physiological values of pressure, the intramural stress within both grafts was in the range of 40-
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50 kPa (Figure 28B). Both grafts were significantly stiffer compared with native carotids as shown 
by the high strain modulus (P = 0.031) (Figure 28C). There was no significant difference in the 
burst pressure, a marker of bulk strength, between all three groups (Figure 28D), demonstrating 
that both types of grafts were capable of withstanding the arterial pressure by 3 months post-
implantation. However, compliance of both grafts was significantly lower than that of native 
carotids and veins (P < 0.05) (Figure 28E).     
We assessed the microstructural response to loading of each of the groups using second 
harmonic generation (SHG) imaging for collagen fibers and two-photon excitation for elastin 
fibers (Figure 28F). The first main difference between the groups was the lack of visible elastin 
fibers in both grafts as compared to native carotids. Secondly, there was a difference in collagen 
fiber load bearing mechanism between the two grafts. In native carotids, collagen fibers bear 
biaxial load by two mechanisms – (a) recruitment (straightening) and (b) change in orientation 
(Figure 28G). However, vein grafts did not exhibit collagen fiber recruitment or fiber re-alignment 
upon loading. Rather, most collagen fibers remained aligned in the axial (±60 - ±90˚) direction 
and very few in the circumferential (-30 to +30˚: 14% 0 mmHg vs. 16% 120 mmHg) direction 
upon pressurization. In contrast, 13% of collagen fibers in the remodeled neoarteries were crimped 
under zero pressure and were recruited upon pressurization. Furthermore, fiber re-alignment 
measurements showed that neoarteries behaved similarly to native carotids with a significant (P < 
0.001) change in fiber re-alignment upon pressurization. Fibers re-aligned from the longitudinal 
to the circumferential direction (-30 to +30˚: 15% 0 mmHg vs 57% 120 mmHg) upon 
pressurization. These findings suggest that the remodeled neoarteries enabled the remodeling of 






Figure 28: Assessment of mechanical response. 
 (A) Suture retention strength of bare grafts and native vessels before implantation. (B) Circumferential 
stress-stretch curves. (C) High strain moduli. (D) Burst pressure. (E) Compliance. (F) Schematic of biaxial 
inflation device used with a multiphoton microscope to image collagen fibers (left). Planar images were 
obtained starting from the outer wall, moving down to the inner wall with images stacked to obtain projection 
images of collagen fibers across the thickness of the sample. Scale bars, 100 µm. Note the difference in 
collagen fiber density, morphology and orientation between samples (right). (G) Collagen fiber straightness 
and orientation quantified in each slice across sample thickness and normalized to a total number of traced 
fibers. A value of 1 represents completely straightened (recruited) fibers. Orientation was measured from θ = 
0° to 90° with θ = 0° being the circumferential direction. Data in (A) - (E) are means ± SD (n = 5 for A and n = 






To date, all tissue-engineered grafts in clinical trials are cell-based, needing human cells for 
seeding polymeric scaffolds or creating cell sheets. Using banked allogeneic cells greatly reduces 
waiting time for grafts; however, isolation, expansion, and seeding of recipient endothelial or 
endothelial progenitor cells are still necessary. In a 1-month pig study, decellularized tissue-
engineered matrix showed better patency rate than autologous internal jugular vein grafts, resisting 
luminal occlusion and intimal hyperplasia. The dense collagenous matrix appears to inhibit host 
cell infiltration and ECM content was not reported. Decellularized porcine small intestine 
submucosa showed patency and arterial-like tissues similar to saphenous vein in a canine carotid 
model for 6 months. However, this xenogeneic graft was prone to acute thrombosis, despite 
systemic administration of heparin. No ECM contents or mechanical data were reported.    
The iTEVG reported here relies on the host cells to infiltrate and remodel the iTEVG after 
implantation as it is a degradable. Compared with autologous veins and current tissue-engineered 
grafts, these iTEVGs avoid donor-site morbidity and immunogenicity, reduce fabrication cost and 
time, and ease storage and transport requirement. This approach poses its own challenges but offers 
the potential to combine the advantages of tissue-engineered grafts and conventional synthetic 
grafts.  
Ultrasonography data indicated that the 90-day patency was similar for the remodeled 
PGS-PCL and the autologous vein grafts studied here. One implanted PGS-PCL graft developed 
a distal thrombosis at day 6 and one ruptured at day 9. Since the rupture was mainly due to a defect 
of the PGS core, we believe that defect-related failure will decrease significantly for larger and 
thicker grafts used in clinical applications and by the quality control steps in manufacturing. 
Compared with previous studies using acellular micro-fibrous grafts in the rat carotid artery 
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interposition model, our PGS-PCL grafts displayed slight better patency at 90 days (90.5% of 
cases) without anti-thrombogenic surface modifications. In particular, hirudin-polyethylene glycol 
(PEG) conjugated grafts had only 83% patency at 1 month and 86% patency at 6 months.   Stromal 
cell-derived factor (SDF)-1α decorated grafts showed 89% patency at 3 months [136]. Despite the 
anti-thrombogenic surface modification, these grafts with an inner diameter of 1 mm were prone 
to thrombosis. PCL grafts with an inner diameter of 0.7 mm also showed an overall 73% patency 
for 72 weeks, dropping to 57% patency for 12 weeks.  
At 3 months, the autologous vein grafts showed certain signs of neointimal hyperplasia: 
reduced luminal area, thickened wall, and many proliferative VSMCs in the wall. None of these 
were present in the remodeled neoartery. Histological data indicated that early geometrical changes 
were crucial determinants to long-term patency of vein grafts in bypass. Increased lumen and wall 
thickness in the vein graft in the first 1 month were usually followed by relative stability. However, 
decreased lumen and increased wall thickness after 1 month indicated neointimal hyperplasia. 
Initial lumen dilation of vein grafts was evidenced by maximal luminal area and minimal wall 
thickness at day 14. Additionally, vein grafts had lower flow velocity than carotids at day 14, but 
similar thereafter (Figure 20E). After day 14, the narrowing lumen and thickening wall reflected 
further adaptation processes with corresponding VSMC migration and proliferation (Figure 26D), 
and ECM deposition in the inner wall (Figure 27 A).  
The divergence between the vein and the PGS-PCL grafts might be related to the different 
inflammatory responses. The PGS-PCL grafts induce more extensive early inflammatory response 
than vein grafts at day 14. There is no difference of M1 macrophages (iNOS+) in both grafts. After 
14 days, the population of pro-inflammatory cells subsides in the neoarteries, whereas M2 
macrophages (CD206+) increase. This finding suggests a resolution of inflammation and 
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macrophage polarization towards a healing outcome. On the contrary, CCR2+ cells persist to day 
90 in vein grafts (Figure 24A and Figure 24B). CCR2, a monocyte chemoattractant protein (MCP)-
1 receptor, mediates monocyte migration from bone marrow to peripheral blood. CCR2+ cells, 
classified as inflammatory monocytes, extravasate to inflamed tissues in the early inflammatory 
phase. CCR2+ cells enhance angiogenesis and tissue repair, however, excessive expression of 
MCP-1/CCR2 induces VSMC proliferation, leading to intimal hyperplasia in vein grafts. This is 
consistent with our observation of VSMC proliferation and a narrower lumen in the vein graft at 
90 days (Figure 22B and Figure 26D).  
Short-term recruitment of bone marrow-derived circulating monocytes has been achieved 
in acellular grafts by a burst release of exogenous MCP-1. Here, the graft design induces an initial 
influx of bone marrow-derived circulating monocytes, initiating inflammation-mediated vascular 
remodeling. CD11b+ and CD68+ cells remain near the abluminal surface of the neoarteries after 
day 14 (Figure 23C and Figure 24A). This could be caused by the continued presence of the small 
amount of PCL in the outer layer. Conversely, vein graft shows densely packed CD11b+ and 
CD68+ cells near both the luminal and abluminal surfaces at day 14, suggesting that living cells 
and ECM inhibit infiltration of these cells into the vessel wall. After day 14, CD11b+ cells almost 
disappeared. It is likely that the slow degrading PCL sheath contributes to the extended presence 
of resident monocytes (CCR2-, CD11b+) and their differentiation to tissue macrophages (CD11b+, 
CD68+). Tissue-resident macrophages have similar functions to M2 phenotypes that play a 
fundamental role in the resolution of inflammation and tissue homeostasis [137]. We found that 
both CD68+ and CD206+ but few iNOS+ cells were observed in the same abluminal area in the 
neoarteries at day 90 (Figure 24A, C, and E). In the remodeled grafts, the distribution and 
organization of VSMCs correlate directly with the morphology and organization of ECM proteins. 
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Thick, disorganized collagen fibers and aggregated elastin are present in vein grafts alongside 
randomly orientated VSMCs. On the other hand, the remodeled neoarteries have collagen and 
elastin aligned circumferentially alongside VSMCs at 3 months, resembling the organization in 
native carotids (Figure 27A). The newly synthesized elastin in the remodeled neoarteries co-exists 
with fibrillin-1 and is equivalent to 23% of that found in native carotids. Several studies have 
reported elastin production in small artery grafting using pre-clinical animal models. 
Decellularized engineered allografts contained elastin corresponded to 8.8% of an ovine femoral 
artery at 6 months. Porcine small intestine submucosa grafts loaded with heparin and VEGF 
showed a varied range of elastin contents in an ovine carotid artery model at 3 months, but no 
fibrillar elastin was observed.  However, elastin fibers were not visible under MPM for either graft. 
The functional requirements of replacement vascular grafts have changed from just sufficient 
suture retention strength and burst pressure to requiring functional adaptability and sound 
microstructure-function relationship. There is also a pressing need to understand the mechanical 
cues that govern ECM deposition and the manifestation of these cues into a structural response to 
gain a mechanistic understanding of the long-term graft remodeling. As the first step toward this, 
we used nondestructive SHG testing to understand the microstructural behavior of collagen 
loading. An important mechanism for compliance in the native arteries is the gradual recruitment 
and re-orientation of collagen fibers which leads to their nonlinear stress-strain relationship. At 
sub-physiological loads, elastin fibers and the surrounding matrix are the main load-bearing 
components while collagen fibers are engaged at physiological levels. While the origin of a crimp 
(waviness) in collagen fibers is unknown, native arteries synthesize collagen at various levels of 
crimp. These undulations are one mechanism for enabling high compliance followed by stiffening 
at higher loads. In our neoarteries, some collagens exhibit crimp; however, most fibers are already 
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straightened at low pressures (Figure 28G), which is one of the main causes of a higher graft 
stiffness. This diminished crimp might be attributed to the fact that collagen fibers are being rapidly 
synthesized to bear load to compensate for the degradation of the graft material. Furthermore, as 
collagen fibers are continually turning over, it is possible that over a longer time frame, the level 
of crimp will increase.  
We recognize that our neoarteries exhibited a significantly lower compliance at lower 
strains than that of native carotids and veins (Figure 28E), likely because of the low elastin content 
at 90 days. However, this does not inevitably preclude elastin synthesis at later timepoints as 
evidenced by comparable elastin production by neoarteries to the native aorta seen at 1 year in our 
previous work [98]. Thus, the lower compliance in our grafts than in native carotids and veins is 
not necessarily a sign of maladaptive remodeling. Furthermore, collagen fibers in our grafts exhibit 
native-like functional behavior and are capable of recruitment and re-orientation during 
pressurization, suggesting that collagen is exhibiting adaptive remodeling. In contrast, vein grafts 
lack recruitment and re-orientation of collagen fibers upon loading which is more typical of scar-
like collagen. Furthermore, vein grafts also show extensive remodeling with stiffening in both the 
low and high strain regions as compared to the native vein prior to implant. Consistent with the 
functional characteristics, histological and SHG imaging reveal thicker walls and dense collagen, 
which, coupled with high levels of proliferating VSMCs, indicate a fibrotic remodeling response 
in the vein grafts. This work represents the first step towards a detailed mechanical and biological 
evaluation of remodeling grafts that requires a long-term study. 
 The observations in this study are limited to the rat model and the 3-month follow-up window. 
Rats enable a high-throughput, cost-effective study to assess cell infiltration. However, rats have 
different regenerative potentials, hemodynamics, and physiology than humans. This study uses 
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young rats; thus, the effect of aging on host remodeling remains unknown. Additionally, 
methodological limitations include performing multiphoton microscopy only under in vivo 
measured strains and two pressure levels. Future studies should include analysis of multiple 
loading configurations to completely characterize the biaxial properties of the evolving grafts.  To 
our knowledge, this is the first report of a neoarteries that performs comparably to an autologous 
vein in small artery grafting. We are currently performing a long-term study in a sheep carotid 
model before the clinical translation of these grafts.  
3.5 Conclusion 
In summary, we developed biodegradable iTEVGs that do not require cell seeding before 
implantation and compared their performance with autologous vein grafts in a rat carotid artery 
model for 3 months. Compared with autologous vein grafts, our iTEVGs have: (1) similar patency 
without anti-thrombogenic surface modifications; (2) consistent morphological changes without 
any signs of stenosis; (3) extensive but transient infiltration of circulating inflammatory 
monocytes, leading to quickly-resolved inflammation and arterial-like tissue remodeling; (4) 
remodeled wall with circumferentially organized, contractile, non-proliferating VSMCs; and (5) 
recruitment and re-orientation of newly synthesized collagen fibers upon mechanical loading. The 
critical next step of this study is to test our design in large animals and aged animals; both are 
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4.0 Data-Driven Growth and Remodeling Computational Tool for iTEVG Modeling 
4.1 Introduction 
The scope of this chapter is to develop a G&R theoretical model to predict the evolution 
of an iTEVG to a neoartery in the host. As outlined in chapter 1.5, constrained mixture theory-
based G&R tools have been employed to understand salient features of arterial remodeling, 
aneurysm formation and neotissue formation in the venous circulation. These tools are based on 
the knowledge that vascular tissues adapt their structure and function to achieve a certain 
homeostatic stress state. In chapters 2.0 and 3.0, we obtained biological and mechanical data to 
understand the final homeostatic condition for iTEVGs. In this chapter, we utilize these data to 
translate this tool to neoartery formation in the arterial circulation. This chapter will outline the 
G&R framework in which the evolving neoartery is idealized as a thick-walled cylindrical tube. 
The chapter begins with a discussion of the relevant kinematics, followed by outlining the 
constitutive formulation for mass production and degradation, and describing the mechanical 






4.2 Constitutive Framework 
4.2.1  G&R Formulation 
Three fundamental assumptions govern G&R mechanics – (i) that the evolving iTEVG is 
modeled as a mixture comprising of PGS, PCL, collagen, elastin, and VSMCs. (ii) This mixture is 
constrained, i.e. all constituents at a material point are subject to the same motions, and (iii) mass 
per unit current volume (?̅?𝜌) is assumed to be constant throughout the G&R process. 
G&R occurs across time 𝜏𝜏 ∈ [0, 𝑠𝑠]. We denote the reference configuration at time s = 0 as 
𝜅𝜅0 and the changing configuration of the body at arbitrary time τ by κ(τ). The current configuration 
is then κ(s). Infinitesimal material segments are mapped from κ0 to κ(τ) through the deformation 









Figure 29: Schematic of configurations describing the G&R kinematics. 
The cohort-specific, stress-free natural configuration is denoted as 𝒌𝒌𝒏𝒏(𝝉𝝉)





In general, the constituents deposited at time τ will not be deposited in a stress-free 
configuration. In defining the constitutive response of this material, it is therefore useful to 
introduce an additional reference configuration 𝜅𝜅𝑎𝑎(𝜏𝜏)
𝛼𝛼  that is related to κ(τ) through a deposition 
pre-stretch tensor denoted as 𝑮𝑮𝛼𝛼(𝜏𝜏), Figure 29. The pre-stretch tensor is defined such that the 
stress-free configuration is shifted by the deposition pre-stretch relative to the current 
configuration. Note that each constituent can be deposited at its own pre-stretch and hence the rep-
stretch tensor has the additional superscript 𝛼𝛼. Our approach thereby captures pre-stretches 
imposed by cells on the constituents they synthesize during the incorporation of newly secreted 
material into the ECM. The deformation gradient used to map material elements of individual 
constituent α from its natural, stress-free configuration 𝜅𝜅𝑎𝑎(𝜏𝜏)
𝛼𝛼  to the current G&R configuration at 
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time s (see Figure 1) is denoted by 𝑭𝑭𝑎𝑎(𝜏𝜏)
𝛼𝛼 (𝑠𝑠). The right Cauchy Green tensor for each cohort of 



















𝛼𝛼 (𝑠𝑠) = 𝑭𝑭(𝑠𝑠)𝑭𝑭−1(𝜏𝜏)𝑮𝑮𝛼𝛼(𝜏𝜏) Equation 4-2 
4.2.2  Governing Equations 
In this framework, growth is fundamentally described by tracking the evolution of mass 
density of the N individual constituents. For a constituent 𝛼𝛼, the mass density per unit reference 
and current volume is denoted by 𝜌𝜌𝛼𝛼 and 𝜌𝜌𝛼𝛼���� respectively. The total mass density can then be 
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It then follows that  





It thus follows from equation Equation 4-6, that  𝜌𝜌(0) =  ?̅?𝜌. Although ?̅?𝜌 is constant, equation 
Equation 4-6 also shows that mass per unit reference volume (𝜌𝜌) is a function of time 𝜏𝜏. 
It must be emphasized that while ?̅?𝜌 is constant, 𝜌𝜌𝛼𝛼���� is not. The mass density per unit reference 















where 𝑄𝑄𝛼𝛼(𝑠𝑠) is the survival function and represents the survival fraction of material present in the 
original reference configuration (i.e. PGS, PCL). 𝑚𝑚𝛼𝛼(𝜏𝜏) and 𝑞𝑞𝛼𝛼(𝑠𝑠 − 𝜏𝜏) are, respectively, mass 
density production rates per unit reference volume and survival fraction at time s of material 
deposited at time τ. 
Furthermore, we assume that for every constituent 𝛼𝛼, there exists a strain energy function 


























𝝈𝝈(𝑠𝑠) = −𝑝𝑝(𝑠𝑠)𝑰𝑰 + 2𝑭𝑭(𝑠𝑠)
𝜕𝜕𝑊𝑊(𝑠𝑠)
𝜕𝜕𝑪𝑪(𝑠𝑠)





Where, 𝑝𝑝(𝑠𝑠) is the Lagrange multiplier enforcing the incompressibility constraint and 𝝈𝝈𝑎𝑎𝑐𝑐𝑔𝑔(𝑠𝑠) is 
outlined in section 4.2.6 . 
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4.2.3  Kinematics of Cylindrical Deformation 
We model the iTEVG as an axisymmetric thick-walled cylinder undergoing finite 
extension and inflation. We introduce cylindrical polar co-ordinates (𝑟𝑟, 𝜃𝜃, 𝑧𝑧) and (𝑟𝑟, 𝑡𝑡, 𝑧𝑧) 
representing the graft pre/post-implantation, and the experimentally loaded configuration 
respectively. Throughout the remainder of this work, we will consider motions for which the radial 
displacement depends at most upon radial position and time, and axial displacement depends, at 
most, upon time. For such motions, the deformation gradient tensor with respect to cylindrical 
polar coordinates is diagonal. In particular, the deformation gradient for motions from the un-
implanted state κ0 to the in vivo, loaded configuration immediately after surgery κ(s = 0) (i.e., the 



















where, 𝑟𝑟0 and 𝑟𝑟(0) are radial positions in configurations 𝜅𝜅0 and 𝜅𝜅(𝑠𝑠 = 0), respectively, and 𝑙𝑙(0) 
and 𝑙𝑙0 are the implanted and un-implanted axial lengths respectively. The deformation gradient 




















The axial stretch 𝜆𝜆(𝑠𝑠) = 𝑙𝑙(𝑠𝑠)/𝑙𝑙(0) is prescribed in the in vivo configuration at all G&R times 𝑠𝑠, 
where 𝑙𝑙(𝑠𝑠) is the current in vivo axial length. Since the density of the newly deposited material is 
constant, namely ?̅?𝜌(𝑠𝑠) = ?̅?𝜌(0) = 𝜌𝜌(0), the mass of an infinitesimal material particle can be 
expressed in the following equivalent forms, 
 
 




It follows that the current radial position 𝑟𝑟(𝑠𝑠) can be expressed as a function of an original (before 
















where, 𝑟𝑟𝑖𝑖(𝑠𝑠) and 𝑟𝑟𝑖𝑖(0) are the current and original radii respectively. 
At any intermediate time 𝑠𝑠 = 𝜏𝜏 during our simulation, we may pause the G&R process and 
enter an experimental mode whereby we numerically simulate a set of experimental protocols 
against which to compare the predictions of the model to laboratory results. Accordingly, we 


















which describes the motion from the loaded, in vivo configuration at time τ to the unloaded, excised 





 𝑅𝑅(𝜏𝜏) = {𝛬𝛬(𝜏𝜏)[𝑟𝑟2(𝜏𝜏) − 𝑟𝑟𝑖𝑖2(𝜏𝜏)] + 𝑅𝑅𝑖𝑖2(𝜏𝜏)}1/2 Equation 4-15 
4.2.4  Constituent Production and Degradation 
4.2.4.1 PGS and PCL Degradation 
The mechanical properties of PGS and PCL are the primary drivers of early G&R response. 
Motivated by the in vitro studies performed in Section 2.3.4.1, we prescribed the following 





𝑊𝑊𝑃𝑃𝑃𝑃𝑃𝑃(𝑠𝑠) =  
𝛽𝛽(𝑠𝑠)
2
[𝑝𝑝1 − 3] = 𝜁𝜁(𝑠𝑠) �
𝛽𝛽0𝑃𝑃𝑃𝑃𝑃𝑃
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Where 𝛽𝛽0𝑃𝑃𝑃𝑃𝑃𝑃 =  34.43 𝑘𝑘𝑘𝑘𝑎𝑎, and 𝛽𝛽0𝑃𝑃𝑃𝑃𝑃𝑃 =  350 𝑘𝑘𝑘𝑘𝑎𝑎 based on the works of Eshraghi and Das who 
determined the modulus based on uniaxial tensile testing of dog-bone shaped specimens at a 
displacement rate of 50 mm/min[138]. 
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4.2.4.2 Production of Load Bearing Constituents in Phase I 
Data obtained from iTEVG neoarterial development in young and aged hosts was used to 
develop the functional form of mass production. Notwithstanding the complex phenomenon 
governing ECM deposition, we assumed that αSMA+ synthetic cells (VSMCs and fibroblasts) were 
the primary producers of collagen and hence prescribed the following form for mass of collagen 




 𝑚𝑚1𝛼𝛼(𝑠𝑠) =  𝑚𝑚∞𝛼𝛼 �exp �ksyn(𝑠𝑠 − 𝑜𝑜𝑓𝑓𝑓𝑓𝑠𝑠𝑒𝑒𝑡𝑡)�� 
Equation 4-17 
   
4.2.4.3 Production of Load Bearing Constituents in Phase II 
Following initial rapid deposition of collagen through synthetic VSMCs under the 
influence of PGS degradation, the production of fibrillar constituents are assumed to depend upon 
several mechanical factors. Since neoarterial G&R is guided by homeostatic stresses, we propose 















Where 𝑚𝑚∞𝛼𝛼 is the homeostatic mass density production rate, 𝜉𝜉𝑚𝑚(𝑠𝑠) is the synthetic ability of 
VSMCs, and ϒ(.) are mechanobiological scaling functions that depend on deviations of transmural 
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Intramural Stress Dependence 
The mechanobiological scaling functions must capture some of the salient qualitative 
features of remodeling.  Mass production should be negligible for low deviations of intramural 
stress from homeostatic levels and saturate at higher deviations. The function should reach a  
maximum sensitivity of 𝐾𝐾𝜎𝜎𝛼𝛼 at some intermediate levels of stress deviation. One possible function 
that captures this behavior is the piecewise sinusoidal function that is dependent on deviations of 
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∗ �1 + sin�𝜔𝜔𝑎𝑎𝑒𝑒𝑔𝑔�∆𝜎𝜎𝛼𝛼 + 𝑏𝑏𝑎𝑎𝑒𝑒𝑔𝑔���                                           ∀ ∆𝜎𝜎 ∈ �𝑙𝑙𝑎𝑎𝑒𝑒𝑔𝑔, 0�,
1
2
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Where 𝜔𝜔𝑎𝑎𝑒𝑒𝑔𝑔 = 2𝐾𝐾𝛼𝛼 and 𝜔𝜔𝑝𝑝𝑖𝑖𝑖𝑖 = 1.5 + 2𝐾𝐾𝛼𝛼/(Υ𝑚𝑚𝑎𝑎𝑚𝑚 − 1) 
Saturation limits 𝑙𝑙𝑎𝑎𝑒𝑒𝑔𝑔 = −𝜋𝜋/𝜔𝜔𝑎𝑎𝑒𝑒𝑔𝑔 and 𝑙𝑙𝑝𝑝𝑖𝑖𝑖𝑖 = 𝜋𝜋/𝜔𝜔𝑝𝑝𝑖𝑖𝑖𝑖. Υ𝑚𝑚𝑎𝑎𝑚𝑚𝛼𝛼  is the maximum scaling value 
and offsets 𝑏𝑏𝑎𝑎𝑒𝑒𝑔𝑔 =
𝜋𝜋
2𝜔𝜔𝑛𝑛𝑛𝑛𝑛𝑛











Figure 30: Mechanobiological scaling function modulating mass deposition in response to deviations in 
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And 𝒎𝒎𝛼𝛼(𝑠𝑠) is unit vector describing fiber orientation. The Cauchy stress distribution resulting 













Where 𝑪𝑪(𝑠𝑠)������ = 𝐽𝐽−
2
3(𝑠𝑠)𝑪𝑪(𝑠𝑠) is the modified right Cauchy-Green tensor.  
 
Shear Stress Dependence 
The shear-stress dependent function Υ𝜏𝜏𝑤𝑤 (∆𝜏𝜏𝑤𝑤) captures the emerging behavior of 
signaling pathways involving various endothelium-derived factors (e.g., growth factors, mitogens, 
inhibitors, etc.) which affect the synthesis of ECM and the proliferation of myocytes (Figure 31). 
We assume that these factors, and by consequence the function Υ𝜏𝜏𝑤𝑤, are spatially uniform in the 
neoartery. Similar to the case for intramural-stress driven G&R, we postulate the form 
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Figure 31: Mechanobiological scaling function modulating mass deposition in response to deviations in wall 




This relation thereby couples the local chemical concentrations to the active response which may 
be a function of radial position and captures the aggregate mitogenic and synthetic effects of a host 
of chemical agonists released by the endothelium in response to changing wall shear stress. No 
deviation from homeostatic values of shear and transmural stress maintains the mass production 






Figure 32: Fold rate of mass production as a function of deviation from homeostatic wall shear stress and 
transmural stress.  
 
4.2.5  Degradation of Deposited Constituents 
As outlined in section 1.5, continuous collagen degradation and deposition (turnover) is 
one of the fundamental mechanisms of maintaining arterial homeostasis. In order to model this 
phenomenon, we introduce a survival function that models how much of the constituents deposited 











where, 𝐾𝐾𝑞𝑞𝛼𝛼 = 𝐾𝐾𝑞𝑞ℎ𝛼𝛼 �1 + Δ𝜁𝜁𝛼𝛼(𝑠𝑠)�
2
 are the evolving cohort specific rate parameters for mass 
removal, and 𝐾𝐾𝑞𝑞ℎ𝛼𝛼  is the homeostatic rate parameter. This enables us to model mass degradation as 
























being the normalized difference between fiber tensions at times 𝑠𝑠 and deposition time 𝜏𝜏 within an 
individual cohort of constituent 𝛼𝛼. 𝑃𝑃ℎ𝛼𝛼 is the homeostatic deposition stretch and 𝜆𝜆𝑎𝑎(𝜏𝜏)
𝛼𝛼  is the fiber 
stretch. 
4.2.6  Mechanical Properties of Load Bearing Constituents 
Collagen Fibers and Passive Smooth Muscle Cells 
Collagen and the passive response of VSMCs are modeled using the four-fiber family 
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� − 1]  
Equation 4-24 
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where 𝜕𝜕2𝛼𝛼  and 𝜕𝜕3𝛼𝛼 are mechanical constants, 𝑝𝑝4𝑎𝑎(𝜏𝜏)
𝛼𝛼 (𝜏𝜏) = 𝜼𝜼𝛼𝛼(𝜏𝜏).𝑪𝑪(𝑠𝑠).𝜼𝜼𝛼𝛼(𝜏𝜏), and 𝜼𝜼𝛼𝛼(𝜏𝜏) =
𝑭𝑭−1(𝜏𝜏)𝑮𝑮𝛼𝛼(𝜏𝜏)𝑴𝑴𝑎𝑎(𝜏𝜏)
𝛼𝛼 .  The deposition stretch tensor for the fibrillar constituents is the structural 
tensor 𝑮𝑮𝛼𝛼(𝜏𝜏) = 𝑃𝑃ℎ𝛼𝛼(𝜏𝜏)𝒎𝒎𝛼𝛼(𝜏𝜏) ⊗𝒎𝒎𝛼𝛼(𝜏𝜏), where 𝑃𝑃ℎ𝛼𝛼 > 1 is the scalar homeostatic stretch imposed 
upon the fiber oriented in the direction 𝒎𝒎𝛼𝛼 at time 𝜏𝜏.  
 
Elastin 















where 𝜕𝜕𝑒𝑒 is a shear modulus and 𝑝𝑝1𝑛𝑛(𝜏𝜏)
𝑒𝑒 (𝜏𝜏) captures the effects of deposition stretches and motions 
subsequent to the incorporation of elastin. 𝑝𝑝1𝑛𝑛(𝜏𝜏)






𝑒𝑒 (𝑠𝑠) = 𝑭𝑭(𝑠𝑠)𝑭𝑭−1(𝜏𝜏)𝑮𝑮𝑒𝑒(𝜏𝜏). 𝑮𝑮𝑒𝑒(𝜏𝜏) = 𝑰𝑰 is the deposition stretch tensor at time 𝜏𝜏. 
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where 𝜌𝜌𝑚𝑚(𝜏𝜏) is the evolving VSMC mass density, 𝑇𝑇𝑚𝑚𝑎𝑎𝑚𝑚 is the maximum contractile force 
generated by VSMCs and 1 − 𝜉𝜉𝑚𝑚(𝜏𝜏) captures the complementary relationship between contractile 
and synthetic VSMCs. Here we assume a binary representation of VSMC phenotype, recognizing 
that when more data is available, this representation can be generalized. 𝐶𝐶(𝜏𝜏) is the ratio of 




 𝐶𝐶(𝜏𝜏) = 𝐶𝐶𝑏𝑏 − 𝐶𝐶𝑖𝑖∆𝜏𝜏𝑤𝑤(𝜏𝜏) Equation 4-28 









Figure 33: Active force as a function of  deviation from homeostatic wall shear stress at different levels of 
synthetic ability.  




𝑓𝑓𝑎𝑎𝑐𝑐𝑔𝑔 enables VSMCs to maintain a basal tone at homeostasis and increases vasoactivity with 
changes in the ratio of vasoconstriction and dilation factors (Figure 33).  
Table 5 summarizes the main parameters in the G&R model along with the dimensions. 
These parameters will be tailored using experimental data in future chapters to model neoarterial 







Table 5: Dimensions of parameters in G&R model 
 
 
Variable Definition General Units [MLT] 
𝝆𝝆 Mass density per unit reference volume 𝑀𝑀1𝐿𝐿−3𝑇𝑇0 
𝝆𝝆𝜶𝜶 Mass density per unit reference volume of individual 
constituent 
𝑀𝑀1𝐿𝐿−3𝑇𝑇0 
𝝆𝝆� Mass density per unit current volume 𝑀𝑀1𝐿𝐿−3𝑇𝑇0 
𝝆𝝆𝜶𝜶���� Mass density per unit current volume of individual 
constituent 
𝑀𝑀1𝐿𝐿−3𝑇𝑇0 
𝑸𝑸𝜶𝜶 Survival fraction of originally existing material 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝒎𝒎𝜶𝜶 mass density production rate per unit reference volume 𝑀𝑀1𝐿𝐿−3𝑇𝑇−1 
𝒒𝒒𝒔𝒔−𝝉𝝉 Survival fraction at time 𝑠𝑠 of material deposited at time τ 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝜷𝜷𝟎𝟎𝑷𝑷𝑮𝑮𝑷𝑷 PGS shear modulus at time 𝑠𝑠 = 0 𝑀𝑀
1𝐿𝐿−1𝑇𝑇−2 
𝜻𝜻 Damage function 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝒌𝒌𝒔𝒔𝒔𝒔𝒏𝒏 ECM synthesis rate parameter 𝑀𝑀0𝐿𝐿0𝑇𝑇−1 
𝝃𝝃𝒎𝒎 Synthetic VSMC ability 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝝉𝝉𝒘𝒘𝒉𝒉  Homeostatic wall shear stress 𝑀𝑀1𝐿𝐿−1𝑇𝑇−2 
𝒄𝒄𝟐𝟐𝜶𝜶 Fung constant 𝑀𝑀1𝐿𝐿−1𝑇𝑇−2 
𝒄𝒄𝟑𝟑𝜶𝜶 Fung constant 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝑮𝑮𝒉𝒉𝜶𝜶 Homeostatic stretch imposed on fibers 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
𝒄𝒄𝒆𝒆 Elastin shear modulus 𝑀𝑀1𝐿𝐿−1𝑇𝑇−2 
𝒇𝒇𝒂𝒂𝒄𝒄𝒂𝒂 Force generated by VSMCs 𝑀𝑀1𝐿𝐿−1𝑇𝑇−2 
𝑻𝑻𝒎𝒎𝒂𝒂𝒎𝒎 Maximum stress generated by VSMCs 𝑀𝑀1𝐿𝐿−1𝑇𝑇−2 
𝑪𝑪𝒃𝒃,𝑪𝑪𝒔𝒔 Vasoconstrictor, vasodilator constants 𝑀𝑀0𝐿𝐿0𝑇𝑇0 
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4.3 Solution Procedure 










According to the kinematic assumptions and the material symmetries outlined in Section 4.2.3 , 


















where 𝑘𝑘(𝑠𝑠) is the transmural pressure, 𝑟𝑟𝑖𝑖(𝑠𝑠) and 𝑟𝑟𝑖𝑖(𝑠𝑠) are the current inner and adventitial radii, 
respectively, and 𝜎𝜎𝜃𝜃𝜃𝜃(𝑠𝑠) and 𝜎𝜎𝑔𝑔𝑔𝑔(𝑠𝑠) are the circumferential and radial components of the Cauchy 
stress, respectively. The Lagrange multipliers vanish in the integrand, and the solution depends 
only upon the motions and transmural pressure. We therefore calculate the time-varying inner 
radius which satisfies the global radial equilibrium equation via the secant method. 
Spatial integration is performed using the Gauss-Legendre quadrature method, and 
temporal integrations of strain-energy functions and kinetics are performed using the trapezoidal 
rule. Evolving mechanical properties and geometry drive mass kinetics, and G&R advances via 
finite differences in time. 
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4.4 Conclusions 
This chapter describes the mathematical formulation of the G&R theory as applied to 
iTEVG formation. We provide the forms of constitutive equations for mass kinetics and mechanics 
of each of the constituents in the mixture. Furthermore, we provide the solution procedure to solve 
for the evolving morphology and mass density of each constituent. In the next chapter, we will 
inform this computational model with experimental data specific to young and old neoarterial (YN 




Dr. Arturo Valentin (AV), a previous postdoctoral researcher in our group, Dr. Anne M. 
Robertson, and Dr. Paolo Zunino developed the general G&R theoretical framework. AV also 
developed the first version of the kinematic computational formulation and solution procedure.  
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5.0 Role of Age in the Biological and Mechanical Evolution of Neoarteries: In Vivo, Ex Vivo 
and In Silico Study 
5.1 Introduction 
Synthetic vascular grafts have been an integral tool of vascular surgery as a treatment for 
atherosclerosis for half a century [139]. However, there remains an urgent need to develop small 
caliber (<6mm) vascular graft substitutes, especially for the older (>75 years) population where 
atherosclerosis prevalence rates are as high as 80% [140]. iTEVGs have previously shown 
successful remodeling in the rat aorta [31]; Chapter 3.0 shows that these grafts can also elicit 
neoartery formation in the rat carotid artery. Nevertheless, these studies were conducted in young, 
healthy animals. Translating this success of iTEVGs from young to old animals, across species, or 
even across different sites in the body is not a trivial task due to the large number of graft (porosity, 
degradation rate, wall thickness etc.) and system parameters (cellular infiltration, rate of ECM 
deposition etc.) governing the remodeling response. Hence, there is an unmet need for a 
sophisticated approach to iTEVG design that can reduce the time and cost for clinical translation. 
It is well known that aging elicits changes in vascular biology, ECM, and mechanical 
response of arteries. For example, older arteries exhibit increased stiffness [141], dilatation [41] 
and intimal thickening due to VSMC, macrophage and mast cell proliferation [142], [143]. 
Furthermore, there is reduction in mature elastin formation with age due to an age-associated 
reduction in lysyl oxidase [144] and increase in Ca2+ content [145].  On the other hand, there is an 
increased production of immature collagen with increased cross-linking in aged arteries which in 
turn leads to increased tensile strength as the fibers are more susceptible to nonenzymatic glycation 
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and oxidation [146]. Additionally, as outlined in Section 1.4, there is a change in the remodeling 
response of old arteries to mechanical cues. While these studies show that arterial structure, 
function and remodeling are highly age-dependent, very little is known about the effect of aging 
and diseased conditions on tissue engineered vascular graft development. While some studies have 
looked at the effects of diabetes and hypercholesteromelia on PCL [147] and PG10 grafts [148], 
the impact of aging on iTEVG development has not been evaluated. 
The G&R model outlined in Chapter 4.0 can be used to aid iTEVG design in old hosts by 
determining salient mechanisms guiding remodeling. However, in order to improve the fidelity of 
predictions, there is first a need to acquire age-specific experimental data. Thus, the overall goal 
of this chapter is twofold – (a) To translate neoartery formation to the clinically relevant aged 
animal model,  and (b) To use a combined theoretical and experimental approach to understand 
the fundamental differences in remodeling with age and develop a tailored G&R model that can 
be used for rational design of iTEVGs in older animals. The rationale behind the proposed work 
is that it is only with a mechanistic G&R tool of this kind, coupled with our rich experimental 
dataset, that it will be possible to rationally design optimal iTEVG properties for various animal 




5.2.1  Graft Fabrication, Implantation and Harvesting 
iTEVGs were fabricated using methods described previously [149], [150]. Briefly, the PGS 
core was formed using a  solvent casting and salt leaching method, followed by electrospinning a 
PCL sheath around the PGS core. The final dimensions of the graft were: inner diameter = 800µm, 
PGS wall thickness = 330µm, PCL thickness = 20 µm, length = 1cm. Grafts were finally 
lyophilized, sterilized with gamma irradiation, and soaked in a heparin solution (100 U/mg) for 5 
min before implantation. 
All procedures involving animals were approved by the Institutional Animal Care and Use 
Committee at the University of Pittsburgh following NIH guidelines for the care and use of 
laboratory animals. Male and female Sprague Dawley rats (young = 8 to 9 weeks old; n = 38, old 
= 18 months old; n = 38, Charles River Laboratories, Wilmington, MA) were used in this study. 
TEVGs were implanted in both, young and aged groups using interposition, end-to-end 
anastomosis grafting, using interrupted 10-0 polyamide monofilament sutures (AROSurgical, 
Newport Beach, CA) [149]. A high-frequency ultrasound imaging system (Vevo2100, FUJIFILM 
Visualsonics, Toronto, Canada) was used to monitor the inner diameter and flow velocity mid-
graft at days 14, 30, 60, 90 and 180 days after implantation. Remodeled neoarteries were harvested 




5.2.2  Mechanical Testing with Simultaneous Multiphoton Imaging 
Explanted young and old neoarteries (YNs, ONs) were tested using our custom-designed 
biaxial-inflation system that is compatible with the multiphoton microscope (MPM) as previously 
described [151]. Briefly, in vivo axial strain was calculated using the distance between anastomosis 
pre and post-explant. The inner and outer diameters were measured using a thin excised segment 
of the neoartery under a dissection scope prior to testing. Entire neoartery segments were mounted 
on cannulae and 350-400 µm beads were glued along their length.  The vessel was then immersed 
in a saline bath within the biaxial testing device which was placed under the multiphoton 
microscope (Olympus FV 1000 Multiphoton) for collecting second harmonic excitation from 
collagen fibers and two photon emission signals from elastin fibers. A 1.12-NA 25× multiphoton 
excitation (MPE) water-immersion objective was placed on top of the mid-neoartery segment for 
imaging. Preconditioning was performed by first pressurizing the neoarteries to 80mHg and 
stretching them from the unloaded to the in vivo axial strain level four times.  This was followed 
by stretching neoarteries to the in vivo axial strain and cyclically pressurizing them from 0-120 
mmHg four times. Following preconditioning, the grafts were tested at the following axial strain 
levels: 0, 10, 20%, in vivo strain and 40% axial strains by performing three inflation cycles from 
0-120 mmHg at each strain level. The deformation of the vessels was recorded during testing using 
a video camera (EO-5012C, Edmund Optics, Barrington, NJ) which captures images at 5 
megapixels and 6 frames per second. Force was measured using a high precision load cell (MDB-
5, Transducer Techniques, Temecula, CA) mounted on one end of the device and axial strain 
controlled using a computer-controlled actuator (ANT-25LA, Aerotech Inc., Pittsburgh, PA). 
Outer diameter and axial length were calculated from the raw images using a custom MATLAB 
(R2014b, Mathworks, Natick, MA) script. MPM imaging was performed by capturing sequential 
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scans at 2um thickness intervals at two pressure levels – 7mmHg and 120 mmHg, at each of the 
four axial strain levels used during mechanical testing. SHG signal from collagen was collected 
using backscatter epifluorescence detectors and 350- to 450-nm Chroma emission filters with a 50 
spectral bin.  
5.2.3  Data Processing and Image Analysis 
5.2.3.1 Stress-Strain Analysis 
The inner diameter of the deformed neoarteries was estimated assuming incompressibility 
of the vessel using the measured unloaded inner and outer diameter, and the deformed outer 
diameter and length. Together with the assumption of an isochoric deformation, the inner diameter 
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Where, 𝑑𝑑𝑖𝑖 is the loaded outer diameter, 𝐷𝐷𝑖𝑖 and  𝐷𝐷𝑖𝑖 are the unloaded outer and inner diameters and 
𝐿𝐿, 𝑙𝑙 are the unloaded and loaded lengths respectively. 















where, 𝑘𝑘 is the transmural pressure, 𝑟𝑟𝑖𝑖 and 𝑟𝑟𝑖𝑖 are the loaded outer and inner radii, ℎ = 𝑟𝑟𝑖𝑖 − 𝑟𝑟𝑖𝑖 is 
the wall thickness and 𝑓𝑓 = 𝑓𝑓𝑔𝑔 + 𝑘𝑘𝜋𝜋𝑟𝑟𝑖𝑖2 is the total axial force  supported by the vessel wall with 𝑓𝑓𝑔𝑔 
being the force measured by the load cell.  


















where, 𝑅𝑅0 and 𝑅𝑅𝑖𝑖 are the unloaded outer and inner radii and other variables were previously 
defined.  The stretch is calculated mid-surface, appropriate for the thin walled vessels.   
5.2.3.2 Collagen Fiber Orientation and Recruitment  
Collagen fiber orientation was quantified using CT-FIRE [152] to trace and extract 
collagen fiber metrics. The first step of this method is to apply a threshold to form a binary image. 
Next, a distance transform is performed to yield the distance from each foreground pixel to the 
nearest background pixel. Then, the maximal ridges formed by the distance transform are searched 
to create a list of nucleation points. Branches are formed by extending the fiber from each 
nucleation point based on fiber trajectory. Short fiber branches are then pruned, and closely 
associated fibers are connected based on adjustable parameters such as the minimum fiber length, 
fiber direction, and the distance between adjacent fibers. Each of the planar images, obtained at 
2um intervals, was analyzed using the following settings: fiber minimum length = 30, image 
resolution = 300 dpi and maximum fiber width = 0.5. A central region of interest was chosen such 
that it was possible to go through the entire wall thickness and avoid edge artifacts (Figure 34).  
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Fiber angles and straightness values were obtained for each image and heat maps were used to 
display the values across the wall thickness. Angle θ = 0° and 90° represent fibers aligned in the 
circumferential and longitudinal direction, respectively. A straightness value of one represents a 





Figure 34: Methodology for selecting image regions for quantifying collagen fiber orientation. 
3D reconstruction of collagen fibers imaged using multiphoton microscopy, (B) cross section image with 




5.2.3.3 Collagen Fiber Density 
Collagen fiber density was calculated using 2µm stacks of MPM images. Four non-
overlapping regions of interest were randomly selected from different regions of the image for 
each slice such that each region of interest was completely covered with collagen fibers. Following 
this, a custom-written MATLAB (Natick, MA, USA) code was used to segment the collagen fibers 
from the background followed by calculating the area of the segmented region. Collagen areal 
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density was then calculated as the ratio between the segmented area and total ROI area and 
summed across all the slices. 
5.2.4  Histology, Immunofluorescence and Biochemical Analysis 
Neoarteries were fixed in 10% formalin for 1 h at 4°C, and dehydrated in 30% sucrose 
solution at 4°C for 24 h. Tissue sections were embedded in optimal cutting temperature compound 
(Sakura Finetek, Torrance, CA), frozen at -80°C for 2 h, and cryosectioned to 8-µm thickness. 
Tissue slides were stained with H&E and images captured with a high-power magnification (60×) 
using the NIS-Elements software (Nikon). 
As previously described [153], tissue sections (8-µm thick) were fixed with 4% 
paraformaldehyde for 1 h at 4°C and permeabilized with 0.2% Triton X-100 for 5 min at room 
temperature. Tissue sites were blocked with 5% normal goat serum (NGS) (Sigma-Aldrich) for 24 
h at 4°C, incubated with primary antibodies in 1% NGS for 45 min at 37°C, rinsed twice with PBS, 
followed with the corresponding secondary antibodies in 1% NGS for 45 min at 37°C. Antibodies 
used are described in Table S1. Nuclei were counterstained with 4',6-diamidino-2-phenylindole 
(DAPI) (Life Technologies, Carlsbad, CA) at room temperature for 20 min. Tissue slides without 
primary antibodies were used as negative controls. The total number of immunofluorescent-
positive cells in each sample was calculated as (the area size of the positive staining for each 
marker / the area size of DAPI positive staining) × 100 and expressed as a percentage of the area. 
Collagen and elastin content were measured using the Sircol Insoluble Collagen Assay kit 
(Accurate Chemical & Scientific Corp., Westbury, NY) and the Fastin Elastin Assay kit (Accurate 
Chemical & Scientific Corp.) respectively. 
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5.2.5  Endothelial Cell Examination 
Endothelial cell coverage and morphology was assessed using SEM and en face 
immunofluorescence staining as outlined in section 3.2.1.5. 
5.2.6  Tailoring G&R Tool with Experimental Data 
The final mechanical homeostatic states of YN and ONs were defined as the mechanical 
properties of the arteries at the final time point.  In particular, data obtained from the biaxial 
inflation experiments for the neoarteries were used to determine best-fit parameters for a two-fiber 























where, 𝑝𝑝1 is the first invariant of the right Cauchy-Green tensor, 𝜕𝜕 is a material parameter with 
units of kPa and 𝑘𝑘 = 1,2 denotes the dominant two fiber directions which were calculated from 
multiphoton microscopy imaging of collagen fibers (refer to section 5.2.3.2).  
Mechanical homeostatic parameters and final time points, along with data from histological 
assessment up to six months were then used to determine rate constants for our G&R tool. 
Predictions from the model were validated against experimental measurements of mass deposition, 
changes in morphology and mechanical response over the course of six-months. This validated 
tool was then used for parametric studies to assess the impact of various parameters on neoartery 
 135 
formation over the course of a year.  For example, we used the tool to understand the role of two 
main rate parameters – graft degradation rate and ECM deposition rate on ON formation making 
it possible to develop strategies for attaining stable long-term remodeling in aged hosts. 
5.3 Results 
5.3.1  Successful Remodeling Six-Months Post-Implant for both Young and Aged hosts 
Pre-implantation, our graft comprised of a solvent cast, salt leached PGS core (inner 
diameter = 768 ± 24µm, wall thickness = 391 ± 23µm, porosity = 72.8 ± 1.9%) and an electrospun 
PCL sheath (23 ± 14µm) (Figure 35A). By six-months post implant, the iTEVGs had visibly 
remodeled into neoarteries in both young and aged hosts, without any visible signs of adverse 
remodeling (Figure 35B). We can see a translucent arterial structure with vasa vasorum on the 
adventitial surface of the neoarteries in both young and aged hosts.  Successful remodeling of these 
grafts was observed, with primary patency rates of 90.6% and 81.25% in young and aged hosts 






Figure 35: Neoartery development in young and aged hosts 
Scanning electron microscope image of bilayered graft comprised of a solvent cast salt leached PGS core and 
electrospun PCL sheath. (B) Gross images of interposition grafts immediately after, and 180 days post-





Six old rats in the study died due to natural causes. For both the young and old hosts, the 
primary modes of graft failure in the iTEVGS were rupture and dilation. Rupture (n = 1, 4 for YN, 
ON respectively) for both the groups was observed at early time-points, between days 4 – 7, while 
dilatation (n = 2, 1 for YN, ON respectively) occurred anywhere between 35 – 105 days post-
implant. The PGS grafts were implanted at no axial strain. As remodeling commences, there was 
an increase in vivo axial strain increased over one-month followed by a decrease until six months 
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post implant in young hosts. There was no significant difference in in vivo axial strain at three and 
six months with age Figure 35D.  
Histological H&E evaluation showed heightened cell infiltration in YNs starting at day 7 
post-implantation.  Starting one-month post-implantation, there was an associated collagen 
deposition and formation of a bi-layered YN (Figure 36A).  This response is delayed in old hosts 
wherein a bi-layered neoartery is seen only at six months post-implantation along with heightened 
cellular infiltration. Morphological evaluation based on the histology images shows that young 
hosts maintained their wall thickness over time while old hosts showed significantly increased wall 







Figure 36: Histological and morphological assessment of neoarteries in young and aged hosts. 
(A) Representative H&E images of neoarteries at each time point. Scale bar = 200 µm, 100µm in the 
main and zoomed in images respectively. (B) Luminal area and (C) Wall thickness quantified using 
H&E images for young and aged hosts. 
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5.3.2  Phases of Neoarterial Remodeling  
5.3.2.1 Two Phases of Cellular Remodeling in Young and Aged Hosts 
The neoarteries exhibited two phases of cellular remodeling. Phase I lasted for 14 days 
post-implant and was marked by a peak in the inflammation (M1 macrophage) response.  This was 
followed by phase II wherein the M1 response is virtually resolved in young hosts. In this section 
we outline the cellular and mechanical evolution of neoarteries in both phases along with the 
differences in remodeling response with age. 
Phase I (Day 0 – 14) 
 Phase I cellular remodeling response for both young and aged hosts was dominated by a 
heightened inflammatory cell infiltration comprising primarily of neutrophils and M1 
macrophages (Figure 38). ONs exhibited significantly higher M1 infiltration than YNs (Figure 
38B). Importantly, the M1 response for YNs was almost completely resolved by the end of phase 
I, whereas M1 macrophages continued to proliferate in ONs. M2 macrophages were virtually 
absent in this phase across both age groups. The YNs also show increased vascularization starting 
at day 7 based on the gross appearance of the neoarteries, while ONs demonstrated delayed 
vascularization (Figure 37).   VSMCs are the other dominant cell type seen in neoarterial 
remodeling. Both YNs and ONs displayed increased VSMC infiltration over time. ONs had 









Phase II (post Day 14)  
For YNs, phase II remodeling response was comprised of a significant reduction of the M1 
response accompanied by a switch in macrophage phenotype to M2 macrophages (Figure 38) 
along with increased vascularization (Figure 37). While there was a reduction in the M1 response 
in ONs, they still exhibited statistically higher number of M1 macrophages than YNs in phase II. 
Furthermore, ONs also showed statistically lower levels of M2 macrophages from days 90 through 
180 than YNs. Continuing on the same trend as phase I, there was increasing VSMC proliferation 
in both age groups with ONs exhibiting significantly higher number of αSMA+ cells in comparison 
to YNs (Figure 39B). This led to an intimal hyperplasia like accumulation of αSMA+ cells in the 
intimal region of ONs causing them to have increased wall thickness (Figure 39). In contrast, YNs 
did not have increased wall thickness at six months and presented αSMA+ cells in the luminal as 





Figure 38: Macrophage staining and quantification. 
Representative images of (A) macrophages (CD68 positive cells), M1 macrophages (iNOS positive cells), and 
M2 macrophages (CD206 positive cells). Scale bar = 50µm and L indicates lumen. Quantification of area 








Figure 39: Smooth muscle cell staining and quantification 
Representative images for smooth muscle cells (αSMA positive). Scale bar = 50µm and L represents the 





5.3.2.2 Two Phases of Mechanical Remodeling in Young Hosts 
The two phases of cellular remodeling in neoarterial formation were accompanied by a 
concurrent two-stage mechanical remodeling response for both the circumferential and axial 
mechanical response of YNs. 
Phase I (Day 0 – 14)  
Phase I is dominated by fast degradation of the PGS core which leads to a drastic reduction 
in stiffness of the iTEVG (Figure 40). We also observed collagen deposition as early as 6 days 
presumably due to the presence of αSMA+ cells (VSMCs and myofibroblasts). This rapid loss of 
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load bearing ability by the graft was compensated by the rapid deposition of sparse, disorganized, 
scar-like collagen (Figure 41, row 1) leading to a stiffening of the YN response. YNs in phase I 
lack of distinct collagen fiber layers that are typical of native arteries and exhibit a uniformly 





Figure 40: Mechanical stages of remodeling in young hosts. 
(A) Circumferential and (B) Axial stress-stretch response as a function of G&R time. Note the two stages of 
remodeling observed. Stage 1 corresponds to rapid softening due to graft degradation followed by rapid ECM 
deposition at Day 14 that compensates for the loss of load bearing ability by the graft. Stage 2 is dominated by 





Phase II (post Day 14)  
Phase II response is dominated by change in collagen microstructure and ECM deposition 
in response to local microenvironment (bio-chemo-mechanical stimuli). This phase exhibits a non-
monotonic change in the circumferential and axial stress-strain mechanical response in which there 
is an initial softening (day 14 – 90) followed by stiffening at day 180. The deviations in mechanical 
response tend towards a particular set point indicating that the neoarteries are potentially 
remodeling to achieve a constant homeostatic stress state (Figure 40A, B insets). The YN 
parameters of the four-fiber family model also demonstrate the non-monotonic mechanical 








Days c (kPa) c11 (kPa) c21  c12 (kPa) c22 c13 (kPa) c23 
14 867.33 1939.27 3.897 76700 7.253 25772 0.0007 
30 369 130000 19.6 52500 10.8 17900 0.316 
90 0.298 212539 11.453 234152 20.36 4873 20.63 
180 0.034 76411 330.37 363323 41.83 5831 86.91 
Old 
90 157.69 1743.37 8.742 56588 15.43 1652 14.96 
180 108.72 10308 5.704 878933 169.77 20909 15.52 
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Remarkably, as early as one month, the YN microstructural remodeling leads to the 
formation of a bi-layered wall structure. In particular, these walls display an adventitia-like layer 
with thin fibers on the abluminal side (Figure 41, row 2). Below this, is a media-like layer which 
is comprised of crimped collagen fibers that are recruited upon loading, behavior that is typical of 
native arteries[12]. Furthermore, these collagen fibers also exhibit fiber re-orientation upon 
loading, especially fibers in the adventitial layer (Figure 42, row 2). These adventitia and media-
like layers persist up to three months (Figure 42, row 3). YNs at three months also exhibit a very 
high degree of fiber re-orientation in all layers of the wall from the axial to circumferential 
direction (Figure 42, row 3). At six months, the YN s exhibit a different response from those at 
one and three months. Remodeling in YNs leads to the loss of two layers seen at earlier time-points 
and leads to the formation of a dense, thin, isotropic collagen fiber structure across the entire wall 
thickness (Figure 41, row 4). These neoarteries do not exhibit crimped collagen fibers or fiber re-





Figure 41: Second harmonic generation images of collagen fibers imaged at in vivo axial stretch in young 
hosts as a function of time.  
Collagen fibers imaged at the unloaded (0mmHg) and loaded (120mHg) states across the wall thickness. Note 






Figure 42: Collagen fiber orientation in young hosts as a function of time.  
Collagen fiber orientation quantified using CT-Fire across wall thickness and normalized as a fraction of 
total traced fibers. 0µm represents the luminal side and 0º represents the circumferential collagen fiber 
orientation.  
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ONs exhibit dense, fused collagen fibers that do not have any preferential direction at three 
months (Figure 43, Figure 44). Furthermore, these fibers do not undergo reorientation or 
straightening upon loading. At six months, ONs exhibit a highly heterogeneous response with 
some exhibiting a similar microstructural response as that seen at three months while others 
forming a bi-layered neoartery.  Figure 43 shows one such bi-layered neoartery at six months 
which displays an outer adventitial layer with thin fibers orientated in two preferential directions 
followed by an inner medial layer which had circumferentially aligned crimped collagen fibers 
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Figure 43: Second harmonic generation images of collagen fibers imaged at in vivo axial stretch in old hosts as 
a function of time.  
Collagen fibers imaged across the wall thickness in a neoartery under in vivo axial stretch at two inflation 
levels- the unloaded (0mmHg) and loaded (120mHg) states. Note the differences in collagen fiber structure, 







Figure 44: Collagen fiber orientation in old hosts as a function of G&R time. 
Neoarteries are extended to in vivo axial stretch at two pressure levels.   Collagen fiber orientation quantified 
using CT-Fire across wall thickness and normalized as a fraction of total traced fibers. 0µm represents the 




The change in collagen architecture over time includes an increase in collagen fiber density 
in both YN and ONs and (Figure 45 ) could potentially be one of the mechanisms causing the 





Figure 45: Collagen areal density in young and aged hosts over time.  
Collagen fiber density quantified by segmenting area occupied by collagen fibers in multiphoton images 




5.3.3  Differences in End-Stage Remodeling with Age 
One of the main differences in end-stage remodeling with age is the VSMC response. The 
presence the of Ki67 positive, proliferative VSMCs in the intimal region of neoarteries in ONs 
confirm the presence of hyperplasia-like remodeling at six months post-implant (Figure 46). In 
contrast, YNs demonstrated a significantly lower number of proliferating cells that did not lead 
increased wall thickness in the luminal region. . While proliferative VSMCs are observed only in 





Figure 46: Difference in end-stage cellular response with age. 
Representative images of smooth muscle cells (αSMA positive cells), proliferative VSMCs (Ki67 positive 





SEM and CD31 staining confirm the presence of a fully endothelial covered lumen in both 
YN and ONs at six months. This endothelial lining is oriented in the direction of blood flow as is 





Figure 47: End stage (180 days) endothelial cell response in young and aged hosts. 
Representative images of endothelial cell coverage, stained en-face, on the lumen of young and old neoarteries 




Gross ECM evaluation in serial sections using histological methods revealed that collagen 
I was present in the inner third of the neoarterial walls in both YN and ONs. Interestingly, collagen 
III was present throughout the wall thickness of YNs while it occurred only in the outer layer of 






Figure 48: Difference in end stage (180 days) ECM deposition. 
Representative images of collagen, including collagen I and III, and elastin architecture as stained using 








While both the YNs and ONs stiffened over time, YNs exhibited a 27% higher compliance 
and 47% lower high strain modulus as compared to ONs (Figure 49). As mentioned earlier, this 
trend can partially be attributed to the higher collagen fiber density and loss of crimped collagen 
fibers that are capable of straightening and re-orienting upon loading across both age groups. 
Furthermore, the significantly increased VSMC proliferation and the presence of calcification in 







Figure 49: End stage mechanical response with age. 
Circumferential stress-stretch curve and (B) compliance of young and old neoarteries at 180 days post-
implantation 
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5.3.4  Validation of G&R Tool 
Using data obtained from Chapters 2.0, 3.0, and 5.0, we informed our G&R tool with 
experimental rate parameters specific to YN and ON remodeling. Table 8 outlines a summary of 




Table 8: Summary of important G&R parameters in young and old neoarterial remodeling. 
 
 
Class Role Value(s) 
Measured Initial conditions  P = 93 mmHg, 𝜏𝜏𝑤𝑤ℎ = 0.5 𝑘𝑘𝑎𝑎, 𝜆𝜆(0) = 1, 









𝑎𝑎ℎ = 800 µ𝑚𝑚, ℎ𝑐𝑐𝑖𝑖𝑔𝑔𝑒𝑒 = 330 µ𝑚𝑚, ℎ𝑖𝑖ℎ𝑒𝑒𝑎𝑎𝑔𝑔ℎ = 16µ𝑚𝑚 
 Young Old 
Degradation Kinetics 𝑠𝑠0.5𝑃𝑃𝑃𝑃𝑃𝑃 = 14 𝑑𝑑𝑎𝑎𝑦𝑦𝑠𝑠, 𝑠𝑠0.5𝑐𝑐
= 70 𝑑𝑑𝑎𝑎𝑦𝑦𝑠𝑠 
21 𝑑𝑑𝑎𝑎𝑦𝑦𝑠𝑠, 𝑠𝑠0.5𝑐𝑐 = 50 𝑑𝑑𝑎𝑎𝑦𝑦𝑠𝑠 
Production kinetics 𝑘𝑘𝑖𝑖𝑠𝑠𝑎𝑎 =  0.117 𝑑𝑑−1 𝑘𝑘𝑖𝑖𝑠𝑠𝑎𝑎 =  0.162 𝑑𝑑−1 





𝜕𝜕22 =  41.83,
𝜕𝜕13 = 5831,





𝜕𝜕12 = 878933 ,
𝜕𝜕22 =  169.77,
𝜕𝜕13 =  20909,
𝜕𝜕23 = 15.52 
Assumed  Vasoactivity 𝑇𝑇𝑚𝑚𝑎𝑎𝑚𝑚 = 500 𝑘𝑘𝑘𝑘𝑎𝑎, 𝐶𝐶𝑖𝑖 = 0.68,𝐶𝐶𝑏𝑏 = 0.68 






Deposition Stretches 𝑃𝑃ℎ𝑐𝑐 = 1.08,𝑃𝑃ℎ𝑚𝑚 = 1.2,𝑃𝑃𝑒𝑒 = 1 
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Predictions from the tailored computational G&R tool were compared with the experimentally 
observed values for collagen mass deposition and wall thickness over time in both YN and ONs 
(Figure 50A, B). The tool correctly predicts the reduced collagen deposition observed in phase I 
followed by increase in collagen deposition over the course of six months. The model also 
accurately predicts the increase in collagen deposition in ONs versus YNs. The trends in 
morphological remodeling, i.e. evolution in neoarterial wall thickness is also captured by the 
model. It correctly predicts that YNs maintain a relatively constant wall thickness over time, 









Figure 50: Validation of G&R tool: ECM deposition and morphology 
Experimentally observed and computationally predicted (A) collagen mass fraction, (B) wall thickness over 




The pre-implant response of iTEVGs is governed by the stiff PCL sheath which renders 
the entire graft to be stiffer than native arteries. Following remodeling, the neoartery starts 
exhibiting the typical nonlinearity associated with native arteries. This phenomenon of 
transitioning from a stiff, linear graft to a nonlinear stress-strain response, was observed in our 
G&R simulations (Figure 51). While our G&R model accurately predicts salient governing 
features of neoarterial remodeling across both age groups, it does not capture the non-monotonic 
stress-strain response observed in phase II of remodeling. Collagen deposited in both phase I and 
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II is modeled with the same material parameters. We also do not include a recruitment stretch for 
collagen fibers in the constitutive equations. Future work will address these limitations and 







Figure 51: Predicting evolving stress-strech response in neoarteries over time. 
The G&R predicts the nonlinear stress-stretch response observed in neoarteries at later time-points. 
 
 
5.3.5  Primary Drivers of Neoarterial Remodeling: Parametric Study 
An in situ design strategy relies on the graft-host interaction to develop functional 
neoarteries. Therefore, the role of graft, as well as host response parameters on remodeling must 
be understood in order rationally tailor the grafts to specific host targets. In this section, we use 
the informed G&R computational tool to identify and investigate some of the salient mechanisms 
driving neoarterial formation in young and aged hosts.  
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5.3.5.1 Graft Degradation 
Appropriate degradation properties of biodegradable grafts are critical for the success of 
their clinical applications. The degradation rate of PGS grafts can be tuned by adjusting the cross-
linking density of PGS and PCL fibers during the curing process [154]. This enables fine-tuning 
the degradation rate to achieve the desired long-term remodeling response.  In this section we 







Figure 52: Role of graft degradation half-life on remodeling of neoarteries over time. 
Predicted time-course of fold-changes in total mass deposition for PGS half-lives of (A) 7 days, (B) 14 days, 
and, (C) 21 days. Note the unbounded (aneurysmal) growth for short degradation half-life of 7 days. 
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5.3.5.2 Varying the Degradation Half-Life of the PGS Core can Significantly Alter the 
Remodeling Morphology, and Mass Density of Neoarteries.  
Very fast degradation rates (S0.5 = 7 days) lead to unstable remodeling and dilatation of the 
graft starting as early 30 days (Figure 52A) whereas slightly slower degrading grafts with half-
lives of 14 and 21 days show stable remodeling up to a year post-implant (Figure 52B, C). This is 
presumably because the rate of collagen deposition cannot compensate for the rapid loss of load 
bearing ability of the degrading graft at very high degradation rates.  However, slower degrading 
grafts can lead to chronic inflammation and osteogenesis[155][130], which are both undesirable 
outcomes of remodeling. Thus, we determine that there exists an “optimal” degradation rate of 14 
days wherein iTEVGs undergo stable remodeling to develop neoarteries. Collagen Turnover Rate 
Collagen turnover rate is another major player in wound healing in regeneration. Rapid 
healing is associated with increased collagen turnover rates [156] and collagen half-lives are organ-
specific [157]. In our study, we find that increased collagen turnover rate of 50 days leads to 
inward, stenotic type remodeling whereas a collagen turnover rate of 70 days leads to stable 
remodeling at one-year post-implant with PGS degradation half-life of 14 days. Additionally, 
increased collagen turnover is a hallmark of regeneration and wound healing and leads to increased 
collagen content. This increased collagen in turn leads to increased to thickening of the neoarterial 






Figure 53: Time-course of fold-changes in mass deposition (J(s)) for collagen turnover rates of (A) 50, (B) 70 





Increased wall thickness is the biomechanical manifestation of hypertension. Our 
simulations suggest that the G&R tool can capture this increased wall thickness observed during 
hypertension (sustained blood pressure = 180mmHg) (Figure 54). This sustained increased in 
blood pressure leads to an inward, stenotic remodeling as opposed a to fairly constant wall 





Figure 54: Effect of hypertension on young neoarterial remodeling. 
Time course of fold-changes in mass deposition at normal (93mmHg) mean arterial pressure and (B) 




5.3.6  Combined Role of Graft Degradation and ECM Deposition for Old Neoarterial 
Remodeling 
We used our informed G&R tool to understand the interplay of graft degradation and ECM 
deposition for improved TEVG design in old hosts. We observe that ONs can fail through stenosis 
(inward remodeling) with a high graft degradation half-life (S0.5) of 7 and 14 days and a high 
deposition rate (Figure 55A, B). This stenosis can be mitigated by reducing the ECM deposition 
rate at high PGS degradation rates (Figure 55A, B)). However, simulations demonstrate a 
practically feasible method to avoid stenosis is to increase the degradation half-life to 21 days, 
which leads to non-stenotic remodeling at most ECM deposition rates (Figure 55C). ECM 
deposition can be controlled not only by varying graft degradation but also changing graft porosity 
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or chemically modifying the graft material to induce higher cell infiltration[130]. Thus, our results 
indicate that a balance of medium degradation half-life combined with lower ECM deposition rate 









Figure 55: Combined role of ECM deposition and graft degradation on remodeling of old neoarteries over 
time. 
Predicted current radius over time for polymer degradation half-lives of (A) 7 days, (B) 14 days, and, (C) 21 
days and different levels of ECM deposition. 
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5.3.7  Adverse Remodeling in iTEVGs 
Aneurysmal type remodeling leading to rupture, and calcification, were the two main 
modes of adverse remodeling seen in neoartery formation (Figure 56). As discussed in section 
5.3.5.1, one of the primary reasons for aneurysmal remodeling is the PGS degradation rate. 
Regional variations in degradataion rate can arise from variations in degradation rate between 
grafts. Another cause could be heterogeneity in the host response. Even though the hosts were 
chosen to have the same genotypic, alterations in their phenotypic response can lead to altered 







Figure 56: Modes of adverse neoarterial remodeling. 
Dilatation (A, B) and calcification (C, D) are the primary modes of adverse remodeling at early and late time-
points respectively. (E) Shadow projection of the micro-CT scan of neoartery in (D) and (F) 3D 
reconstruction of the micro-CT scan. Yellow represents calcification and grey represents tissue. 
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Since calcification is one of the major modes of adverse remodeling, there is a pressing 
need to understand the role, cause, and effect of calcification on iTEVG remodeling. 83% of old 
and 16% of young microCT scanned neoarteries exhibited calcification formation in later 
timepoints. As a first step toward determining the role of calcification in remodeling,  we 
developed tools and methodologies for analyzing the distribution and size of calcification in a 
parallel model system with similar modes of failure – human cerebral aneurysms  [158]. We further 
developed protocols for simultaneous imaging of calcification and collagen fibers in intact 
specimens (details in Appendix B)[159]. In the next chapter we employ these tools to study the 
prevalence and role of calcification in human cerebral aneurysms (CA). CAs are focal dilatations 
of the arterial wall caused due to loss of arterial elastin. CAs also have to undergo rapid remodeling 
in order to compensate for the loss of elastin. There is remarkable diversity in the remodeling 
response of CAs with some walls remodeling to be stronger than others [160]. Thus, they represent 
a model system in which the role of calcification in remodeling can be assessed. Understanding 
the role of calcification in this system can provide us guidance for future studies as well as for 






To our knowledge, this is the first study that translates neoartery formation to old animals, 
determines factors responsible for in situ recapitulation of ECM structure and function, and 
systematically investigates the role of iTEVG and host parameters in long-term remodeling.  
5.4.1  Two Phases of Remodeling  
We observe that G&R in is a nonlinear process with an initial graft degradation and 
inflammation dominated phase followed by a phase of microenvironment driven mechanical 
remodeling toward a homeostatic state (Figure 57).  Both young and old hosts exhibit these two 
phases, albeit with different rates. Porous PGS grafts lose about 50% of their mass in vitro under 
enzymatic degradation by 8 days [150]. In vivo, this passive degradation is combined with 
inflammation-driven active degradation which leads to a very rapid loss of load bearing by the 
PGS core. This loss of load bearing ability is compensated by rapid, scar-like, disorganized 
collagen fiber deposition starting at day 6. These collagen fibers are highly sparse and crimped at 
6 and remodel to develop straightened collagen fibers as the PGS continues to degrade until day 
14. The key cellular players that guide this response in phase I are M1 macrophages and some 
VSMCs and myofibroblasts that deposit collagen. Normal wound healing occurs in three stages – 
inflammation, proliferation, and tissue remodeling [161]. Macrophages seem to be key regulators 
in the wound healing response and have many functions including host defense, the promotion and 
resolution of inflammation, the removal of apoptotic cells, and the support of cell proliferation and 
tissue restoration [162]. In our study, we observed that ONs exhibited statistically higher levels of 
M1 macrophages as compared with YNs in phase I. While reports on the nature of wound healing 
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suggest that rates of wound healing are slower in aged hosts and are accompanied by delayed cell 
infiltration [42], [163], the role of macrophages in old hosts is still unclear. Some studies suggest 
that macrophages in old hosts have impaired remodeling [164], while others report reduced M1 
and M2 expression with age [165]. Yet other studies find increased macrophage expression in aged 
hosts [166], [167]. Further studies are needed to address the role of macrophages in iTEVG 












Figure 57: Schematic of phases of neoarterial growth and remodeling in young hosts. 
Phase I (Day 0 – 14) remodeling is dominated by graft degradation and heightened inflammatory cell 
infiltration (particularly, neutrophils and M1 macrophages). Phase II (post Day 14) is dominated by ECM 
deposition and remodeling in response to mechanobiological cues. Phase II also exhibits increased M2 
macrophage, myofibroblast, and contractile smooth muscle cells organization along with change in collagen 
fiber architecture over time. Neoarteries at day 30 exhibit two distinct layers of collagen fibers – thin, 
isotropic, adventitial fibers, and crimped, circumferentially oriented medial fibers. Day 180 displays an 







The transition between the phase I and phase II at day 14 was marked by a dramatic 
reduction of M1 macrophages and a switch in phenotype to M2 macrophages.  While the M1 
response was practically resolved in YNs, ONs exhibited a heightened and chronic M1 
macrophage infiltration   that is reduced, but still not resolved even at six months. Furthermore, 
ONs also exhibited statistically lower M2 macrophage infiltration.  YNs exhibit a non-monotonic 
mechanical response over time, presumably due to microstructural collagen remodeling. We 
observed that the collagen microstructure evolves from a scar-like disorganized, sparse structure 
to a bi-layered YN that has an outer adventitial layer with thin fibers and an inner layer comprised 
of crimped collagen fibers that are circumferentially aligned, typical of native arteries (Figure 57).  
One of the main mechanisms eliciting collagen fibers to bear load is the gradual recruitment of 
crimped collagen fibers upon loading [12], a behavior that is exhibited by one month YNs. This 
contributes to reduction in stiffness and development of a toe-region in the mechanical response 
of YNs at one month. This bi-layered YN continues up to three months at which point collagen 
fibers not only display recruitment, but also reorientation in the circumferential direction upon 
loading. While these changes tend toward native artery-like remodeling, these YNs demonstrate a 
very stiff response A major limitation of this study is the lack of mechanical and microstructural 
data about ONs in phase I. At three months, ONs exhibited a dense collagen network, and a lack 
of both fiber recruitment and reorientation, making them significantly stiffer than YNs. At six 
months, the ONs have a highly heterogeneous response with some neoarteries displaying a bi-
layered structure with thin adventitial fibers and crimped medial fibers that are recruited upon 
loading.  Aged native arteries exhibit a compromised homeostatic state as evidenced by increased 
stiffness,  increased collagen content, and increased GAG content  [141]. It is therefore, reasonable 
to expect an altered homeostatic state in ONs. However, since the end-point of this study was six 
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months post-implantation, future studies need to determine the trajectory of remodeling in ONs 
over longer times.  
5.4.2  Altered States of End Stage Remodeling  
While both the YN and ONs exhibited altered states of remodeling they maintained the 
general trends typical of their respective native arteries. For example, while neoarteries across age 
had significantly increased stiffness at six months, ONs had a higher stiffness than YNs. This is 
typical of native arteries, wherein old native carotids have higher stiffness as compared to young 
native carotids[141]. Furthermore, the heightened inflammatory as well as intimal hyperplasia-like 
remodeling seen in ONs at six months is typical of aged blood vessels. It is interesting to note that 
while inflammation (M1 macrophage infiltration) is resolved by six months in YNs, they also were 
associated with significantly stiffer YNs. This could potentially be due to the presence of 
proliferating VSMCs that deposit collagen. Future studies will determine if these YNs continue to 
remodel and form a bi-layered structure with increased compliance at later time points or if this 
constitutes a stable but altered state of homeostasis. 
5.4.3  G&R Models for Rational Design of iTEVGs 
In order to guide future studies, we developed a G&R computational model that can 
elucidate the salient mechanisms guiding remodeling. Parametric studies indicated that graft 
degradation, ECM deposition, collagen turnover rate, and collagen deposition pre-stretches are 
important factors controlling long-term G&R responses. High degradation half-lives can lead to 
failure from neoarterial dilatation, while reduced collagen turnover rates can lead to stenotic 
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remodeling. Since conditions such as hypertension can be modeled using our G&R tool, future 
work can combine this tool with optimization strategies to determine parameters that lead to 
normal remodeling under various pathological conditions. Furthermore, an important finding is 
that the interplay of graft degradation and ECM deposition are crucial factors that need to be 
controlled to achieve stable long-term G&R in ON remodeling. Biochemical evaluation show that 
ONs exhibit higher ECM deposition which, as our simulations suggest, coupled with slower 
polymer degradation half-life (faster graft degradation rate) can lead to stenosis. Thus, our results 
indicate that a balance of medium degradation half-life combined with lower ECM deposition rate 
is required for stable long-term remodeling.  
5.4.4  Conclusion 
In summary, we assessed the longitudinal remodeling process of TEVGs in young and aged 
hosts and observed that they remodel in two similar phases, but, at altered rates. We determined 
that both YN and ONs have altered remodeljng response in comparison with their respective native 
arteries. Nevertheless, YNs potentially demonstrate a relatively homogeneous response between 
samples to develop a stable neoartery at six months as evidenced by the reduction in inflammation 
and potentially stable proliferating VSMCs. In contrast, age seems to first and foremost confer 
heterogeneity in remodeling response of ONs. This leads to favorable remodeling in some, whereas 
altered and potentially unstable remodeling in others. We established that the remodeling response 
is highly non-monotonic in both YN and ON, not just in terms of cellular content, but also in terms 
of mechanical response. Future studies are needed to assess long-term remodeling to determine 
fate of these neoarteries.  We used this knowledge to tailor our G&R computational tool and 
applied this tool to assess salient mechanisms guiding arterial remodeling. We determined key 
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iTEVG and host parameters that need to regulated to have a stable long-term remodeling response. 
These studies have identified the next directions for future studies to reach our long-term goal of 
clinical translation of in host tissue engineering of vascular grafts to patients. 
Contributions  
Keewon Lee, a postdoctoral researcher in Dr. Wang’s group performed the histological, 
biochemical staining, and imaging in this chapter. Dr. Liwei Dong performed the surgical iTEVG 
implantation and explantation.  
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6.0 Pathological Growth and Remodeling: Calcification in Human Cerebral Aneurysms 
The work in this chapter was submitted in the following manuscript: 
Piyusha S. Gade, Riikka Tulamo, Keewon Lee, Fernando Mut, Eliisa Ollikainen, Chih-
Yuan Chuang, Bong Jae Chung, Mika Niemelä, Behnam Rezai Jahromi, Khaled Aziz, Alexander 
Yu, Fady T. Charbel, Sepideh Amin-Hanjani, Juhana Frösen, Juan Cebral, Anne M. Robertson. " 
Calcification in human intracranial aneurysms is highly prevalent and displays both 
atherosclerotic and non-atherosclerotic types." ATVB, Under Review. 
6.1 Introduction 
Patient specific treatment planning for unruptured intracranial aneurysms (IAs) remains a 
complex issue for both clinical and scientific reasons. Clinically, there is a need to balance the risk 
of intervention with the potential risk of rupture [168]–[171]. The main morphological and 
anatomical factors that are clinically implicated in higher risk of IA rupture are posterior 
circulation [172], high aspect ratio [173], surface irregularities like lobulations [174], and size 
(>7mm) [171], [174], [175]. Although these factors correlate with increased risk, they are not 
exhaustive or specific enough to impact clinical decision making for the vast majority of IAs. For 
example, while large IA size (>7mm) is often used as a metric of increased rupture risk, 38% of 
smaller IAs rupture[176] and there is no minimum size that alone guarantees structural integrity 
of the IA wall.   
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Aneurysms rupture when structural components of the wall, largely collagen fibers, are 
unable to withstand loading from transmural pressure. IA wall weakening is attributed to a variety 
of physical causes including enzymatic degradation of collagen fibers due to inflammation or wall 
remodeling, insufficient levels of collagen fiber deposition due to a dearth of intramural VSMCs, 
and localized stress concentrations from, for example, calcifications in the IA wall [160], [177]–
[179]. This diversity of causes can confound current efforts to identify statistical associations 
between rupture risk and rupture related factors such as sac geometry and patient characteristics. 
Hence, there is a crucial need to complement current efforts with studies that directly look for 
physical causes of IA wall failure and identify the possibly distinct pathologies responsible for 
these wall changes. 
It is well known that physical inclusions such as those formed from calcifications will alter 
the mechanical stress in a manner that is dependent on the inclusion size and material properties 
of the surrounding matrix [179]–[183]. The potential medical implications of these inclusions are 
seen, for example, in atherosclerotic lesions of extracranial arteries where micro-calcifications are 
associated with rupture of fibrous caps but macro-calcifications are associated with mechanical 
stability of the cap [183], [184].  
Vascular calcification is now known to arise from at least two different pathological 
processes which lead to different types of wall changes [185]. The most highly studied is a slow, 
inflammation driven, atherosclerotic type pathology of the intima with associated lipid pools [186] 
and the second is a non-atherosclerotic phosphate-dependent, rapid mineralization in the media 
[187]–[189]. Distinct therapies are needed for the prevention and possible reversal of these two 
types of calcification [190].   
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Despite these advances in understanding vascular calcification pathologies and recognition 
of their mechanical importance, the role of calcification in IA rupture has received limited 
attention, likely due to reports of a low prevalence between 1.7 – 29% [174], [181], [191]. 
However, these rates are based on clinical computed tomography (CT) imaging studies with a 
typical voxel resolution of 250-300μm that prevents the detection of micro-calcifications.  
Our aim in this work is to determine the prevalence, distribution and type (atherosclerotic, 
non-atherosclerotic) of calcification in IAs and assess differences in occurrence between ruptured 
and unruptured IAs. We are able to leverage our database of peri-operatively resected human 
aneurysm samples and use high resolution ex vivo imaging techniques that directly image 
calcification as small as 3µm.  As for extracerebral vessels, such knowledge can be leveraged for 
improved diagnosis and treatment methods once the role of calcification in IA pathology and 
mechanical strength are understood.  
6.2 Materials and Methods 
6.2.1  Aneurysm Tissue Harvesting  
Aneurysm samples (n = 65) were harvested from aneurysm sacs in consented patients 
undergoing surgical clipping for treating unruptured (n = 48) and ruptured (n = 17) aneurysms. 
This study was approved by an Ethics Committee, protocol number IRB REN18010236. Samples 
were collected from three study sites – Alleghany General Hospital (Pittsburgh, PA, USA), 
University of Illinois at Chicago  (Chicago, IL, USA), and Helsinki University Hospital  (Helsinki, 
Finland). Samples from Alleghany General Hospital and University of Illinois at Chicago were 
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transported in a dedicated cooled transport container to the University of Pittsburgh in a 0.9% 
(w/v) saline solution. Samples were then fixed using 4% paraformaldehyde or 3% glutaraldehyde. 
Samples from the Helsinki University Hospital were snap frozen in the operating room and 
transported to Pittsburgh after fixation in 10% formalin.  
6.2.2  Patient Clinical Data 
Patient clinical data was collected as previously described [160]. Briefly, patient age, 
gender, family IA history, smoking history, diagnosed hypertension, renal failure, diabetes and use 
of anti-thrombotic and statin medication were obtained from medical records. Patients were 
considered hypertensive if they were currently being treated for hypertension or if they were 
previously diagnosed with hypertension but declined treatment. Patients were categorized as non-
smokers if they had never smoked cigarettes or had not smoked within the last 5 years. Patients 
who currently smoked or who had quit within the last 5 years were categorized as smokers. Patients 
were categorized as having renal failure if they were on dialysis or were either recommended/had 
previously undergone kidney transplant. Clinical patient data for indication of hypertension, 
smoking and anti-thrombotic medication was not available for 5,1, and 1 patient respectively. IA 
size, aspect ratio and presence of bleb/lobulations were calculated from 3D vascular models 
constructed from 3D rotational angiography or computed tomography angiography images as 
previously described [192]. Size was calculated from these reconstructed images as the total 
volume of the IA and aspect ratio as the ratio of aneurysm height and neck width [193]. Geometric 
parameters could not be analyzed for 11 patients due to the absence of imaging data for vascular 
reconstruction. 
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6.2.3  Micro-CT Scanning 
Fixed aneurysm tissue samples (n = 65) were scanned using a high resolution (0.35μm) 
micro-CT scanner (Skyscan 1272, Bruker Micro-CT, Kontich, Belgium) at resolutions of at least 
3μm (range: 1 - 3μm) depending on sample size to ensure that micro-calcifications of a minimum 
size (range of 3 - 9μm) could be captured. For scanning, samples were mounted on wet gauze to 
minimize dehydration and placed in a 1.5ml clear microcentrifuge tube. This tube was vertically 
mounted as previously described [194] to ensure the sample remained stationary. Samples were 
scanned at 50kV and 200μA with a frame averaging of 8, a rotation step size of 0.3 degrees, 
scanned 180 degrees around the vertical axis. Sample scanning time was maintained at less than 
2.5 hours to prevent sample dehydration. A 3D image of the sample was reconstructed using 
NRecon (Bruker Micro-CT, Kontich, Belgium) with an axial step size equal to the scanned pixel 
size.    
6.2.4  Image Processing of Micro-CT data 
6.2.4.1 Aneurysm Tissue and Calcification Mesh Generation 
The surface mesh used for analyzing the locations of calcification within the wall was 
created using Simpleware ScanIP (Synopsys, Mountain View, USA) as previously described 
[158],[195]. Briefly, 3D reconstructed images from the micro-CT data were segmented into two 
distinct masks for the regions of calcification and non-calcified tissue. Tissue mask generation 
included segmentation, Gaussian smoothing, followed by morphological operations to remove 
surface noise, and connected components filtering. As previously described [195] and detailed in 
Supplementary Material, calcification was identified by elevated greyscale value relative to the 
 179 
tissue,  validated using Alizarin Red staining in histological sections. The calcification mask was 
generated as previously described [195] using a combination of thresholding (Otsu multilevel 
thresholding filter) for segmentation and Boolean operations for subtraction of the calcification 
mask from the tissue mask. An unstructured triangular surface mesh was then generated for each 
component. Calcification and tissue volume fraction were calculated using the general properties 
module in ScanIP. The calcification mask was split into connected components to analyze 
individual calcification diameter, volume and eccentricity. Two particles connected by only a 
single vertex were considered to be separate particles, whereas a connection with one or more 
faces was considered to be a single particle.  
6.2.5  Lipid Pool and Calcification Identification using Micro-CT Scanning in Intact 
Samples 
Lipid pools and calcification manifest as regions with distinct peak intensity levels in 
micro-CT scanning of intact specimens. In the micro-CT images, lipid pools were identified as 
regions of low intensity (<30) with distinct morphological patterns. Samples were scored for 
presence or absence of lipid pools using these two criteria. Calcified regions presented with high 
grayscale values (220-255) in normalized images where 0 represents black and 255 represents 
white. Calcification was then segmented using either manual thresholding or an automatic 
multilevel Otsu segmentation technique, followed by region growing that joins connected 
components using an intensity-based approach.   
In order to verify specificity, we compared grey levels of calcification and lipid pools with 
their respective histological sections using Alizarin Red and Oil Red O (Figure 58). False positives 
by hemorrhage or capillaries were ruled out by consideration of greyscale, morphology and size.  
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In particular, hemorrhage regions have a greyscale value similar to that of tissue which lies in the 
50 – 80 greyscale regime [196]. Capillaries, if filled with blood, also appear at a similar intensity 
to that of tissue, thereby distinct from lipid pools and calcification. Additionally, capillaries are 
morphologically different (circular vs elliptical/irregular shaped) from lipid pools and have smaller 







Figure 58: Verification of regions of calcification and lipid pools in control sample of a fresh cerebral artery 
identified under micro-CT 
 (A) Cross sections from high resolution micro-CT image of fresh cerebral artery imaged at 2μm resolution. 
White arrows point to micro-calcifications identified in micro-CT. (B) Alizarin Red staining confirming 
micro-calcifications (black arrows) as seen in micro-CT with high grayscale values (220-255) on a normalized 
scale. (C) Lipid pool (white dashed line) visible as low grayscale value in micro-CT image (< 30). (D) Oil Red 
O staining identifying neutral lipids (concentrated within black dashed line) in same sample. Nuclei were 
counterstained with hematoxylin. 
 
 181 
IA samples in our study were sourced from three sites - Alleghany General Hospital (AGH) 
(Pittsburgh, PA, USA), University of Illinois at Chicago (UIC) (Chicago, IL, USA), and Helsinki 
University Hospital (HUH) (Helsinki, Finland). Due to differences in site specific protocols 
(Finland versus U.S.) as well as differences in plans for further analysis (SEM versus classical 
histology), three different fixatives were used. Additional studies were performed to determine the 
role, if any, of each of the fixation methods on micro-CT results.  Segments of cerebral artery were 
scanned before and after fixation for each fixative.  
6.2.5.1 Wall Thickness Evaluation 
Local wall thickness was assessed using a custom-written code as previously described 
[158]. Briefly, distance vectors were calculated from the inner to the outer surface elements and 
from the outer to the inner surface elements. Using these vectors, new “medial points” were 
introduced half way along these distance vectors. The wall thickness at the medial points was then 
approximated as the sum of the length of the distance vectors to each surface. 
6.2.5.2 Calcification Location Analysis  
Calcification was identified as located in the inner, middle or outer  third of the wall using 
a previously developed approach [158].  Calcification location could not be analyzed for four 
samples for which the IA sample was collapsed, preventing identification of the inner and outer 
surfaces across the entire sample in these cases.   
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6.2.6  Visual Scoring of IA Surface Color  
Calcification surface mesh was overlaid with the non-calcified tissue and compared with 
ex-vivo dissection scope images of resected IA samples [158]. The surface color of calcified 
regions was scored as either being colorless, white or yellow. If a sample presented calcification 
in multiple color regions, it was scored individually in each of the categories.  
6.2.7  Histological and Multiphoton Analysis 
Samples were dehydrated in 30% sucrose solution at 4°C for 24 h. Tissue sections were 
embedded in optimal cutting temperature compound (Sakura Finetek, Torrance, CA, USA), frozen 
at -80°C overnight, and cryosectioned to 8µm thickness. This was followed by staining sections 
with H&E, Oil Red-O and Alizarin Red to stain for cell nuclei, lipids and calcification respectively. 
6.2.7.1 Neutral Lipid and Free Cholesterol Staining 
Tissue cryosections (8-µm thick) were fixed with 4% paraformaldehyde (PFA) for 1 h at 
4°C and rinsed twice with PBS. For neutral lipid staining, BODIPY 493/503 (D3922, 
Thermofisher Scientific, Waltham, MA) was dissolved in dimethyl sulfoxide (DMSO) (D4540, 
Sigma-Aldrich, St. Louis, MO) at a concentration of 1 mg/ml and diluted to 1:500 with PBS. 
Tissue sections were stained with 100 µl of the BODIPY working solution, incubated for 30 min 
at 37°C in the dark, and rinsed twice with PBS. For free cholesterol staining, filipin (F9765, Sigma-
Aldrich) was dissolved in DMSO at a concentration of 25 mg/ml and diluted to 1:500 with PBS. 
Tissue sections were stained with 100 µl of the filipin working solution, incubated for 2 h at room 
temperature in the dark, and rinsed twice with PBS. Stained slides were viewed using an inverted 
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microscope with two fluorescence filters: green (for BODIPY, excitation = 450-510 nm) and blue 
(for filipin, excitation = 340-380 nm). Tissue slides without the staining reagents were used as 
negative controls. Human cerebral aneurysm tissue that presented with lipid pools on micro-CT 
images was used for positive controls. 
 
6.2.7.2 Leukocyte and Macrophage Staining 
Both leukocytes and macrophages were examined using immunofluorescence staining. 
Tissue cryosections (8-µm thick) were fixed with 4% PFA for 15 min at room temperature (RT). 
Tissue sections on slides were blocked with 3% normal goat serum (NGS) (Sigma-Aldrich) and 
3% normal horse serum (Vector Laboratories) in buffer solution (3% bovine serum albumin in 
PBS) for 20 min at RT. incubated with primary antibodies in buffer solution for 30 min at RT, and 
rinsed with PBS, followed with the corresponding secondary antibodies in buffer solution at RT.  
For leukocyte staining, mouse anti-CD45 (clone 2B11 PD7/26, 1:100; Dako, Glostrup, 
Denmark) was used as a primary antibody, followed by Alexa Fluor 546 goat anti-mouse IgG 
(1:100, Invitrogen, Carlsbad, CA) as a secondary antibody.  For macrophage staining, mouse anti-
CD68 (clone EBM11, Dako) was used as a primary antibody, followed by Alexa Fluor 488 goat 
anti-mouse IgG (1:100, Invitrogen) as a secondary antibody. Nuclei were counterstained with 4',6-
diamidino-2-phenylindole (DAPI) (Life Technologies, Carlsbad, CA). Tissue slides without 
primary antibodies were used as negative controls. Human tonsil was used for positive controls. 
 
6.2.7.3 Calcification Staining in Histological Sections 
Micro-calcification was detected using a bisphosphonate-conjugated, near-infrared 
fluorescent imaging agent, OsteoSense 680 EX (PerkinElmer, Waltham, MA) as described 
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previously [195]. OsteoSense 680 EX was dissolved in 1.2 ml of PBS and applied to explanted 
samples for 2 h at room temperature. Samples were rinsed with PBS, fixed in 10% formalin for 1 
h at 4°C, and dehydrated in 30% sucrose solution at 4°C for 24 h. Tissue sections were embedded 
in optimal cutting temperature compound, frozen at -80°C for 2 h, and cryosectioned to 8-µm 
thickness. Tissue slides were rinsed twice with PBS, mounted with fluorescence mounting 
medium, and viewed using an inverted microscope with the Cy5 filter (excitation = 630-680 nm). 
Calcified cerebral vessels were used as positive controls. 
 
6.2.8  Calcification and Collagen Imaging in Intact Sample 
 
Simultaneous imaging of collagen and calcification was performed using two photon 
microscopy as previously described [195]. Briefly, the entire tissue sample was fixed in 4% PFA 
for 24h. This was followed by rinsing the sample with PBS. Sample was then incubated in 
OsteoSense 680EX (diluted 1:50) for 24h. This was followed by rinsing the sample with PBS and 
imaging with an Olympus two photon microscope (FV 1000, Tokyo, Japan) using the following 
settings: 1.12NA 259 MPE water immersion lens and 25X objective: 800nm excitation 
wavelength, dwell time of 8µs/pixel, a scan pixel count of 1024 X 1024 and laser intensity of 7%. 
Second harmonic signal from collagen was collected using a 350 – 450 nm filter and calcification 
signal using the fluorescent calcium tracer emission in the 665 – 735 nm channel. 
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6.2.9  Wall Classification for Presence of Calcification and Lipid Pools 
IA walls were classified according to the association of calcification with lipid pools in 
micro-CT. Type I walls contained calcification without any lipid pools. In Type II walls, both 
calcification and lipid pools were detected, though never co-localized. In Type III walls, 
calcification could be found co-localized with lipid pools. Calcifications within and around lipid 
pools were referred to as “atherosclerotic” (Type III) as is normally seen in peripheral 
atherosclerosis [197], whereas calcifications distinct from lipid pools or found in the complete 
absence of lipid pools were referred to as a “non-atherosclerotic” (Types I and II). Calcification 
particles were subcategorized based on their size. Micro-calcifications were defined by diameters 
<500µm, meso-calcification by diameters between 500 - 1000 µm and macro-calcifications by 
diameters >1000 µm.   
6.2.10  Statistical Analysis 
Statistical analysis was performed using SPSS (IBM SPSS Statistics 25, IBM Corp, North 
Castle, NY). Proportions were calculated for categorical variables and χ2 independence test or 
Fisher’s Exact test was used. For continuous variables, median and range or mean were calculated 
and analyzed using Mann-Whitney U test or independent samples t-test. For normally distributed 
data, multiple group comparisons were performed using one or two-way ANOVA followed by the 
Tukey’s post-hoc test. For data that violated the assumptions of parametric tests, multiple group 
comparison was performed using the Kruskal-Wallis test followed by the Mann-Whitney U test 
with a Bonferroni correction for post-hoc testing. The assumptions of normality and homogeneity 
of variance were tested using the Kolmogorov-Smirnov and Levene’s test respectively. 
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6.3 Results 
6.3.1  Human Cerebral Aneurysms Exhibit High Prevalence of Calcification  
High resolution micro-CT revealed the presence of calcification in 78% (51/65) of the IA 
samples. 60% of samples presented only calcification without associated lipid pools (Types I, II), 
Table 9. We did not find any significant differences in patient characteristics between calcified 
and non-calcified samples. None of the patients in our cohort had renal failure and only 9% had 
type II diabetes. Furthermore, 57% of the IAs were harvested from the MCA and there was no 
















Table 9: Patient characteristics and prevalence rates for calcification and lipid pools.  
 
 




Ruptured (n=17) p  
value 
Patient Clinical Characteristics 
Age (years) 57.50 (30 – 79) 58 (30 – 79) 54 (43 – 66) 0.089 
Female Sex (%) 50/65 (77) 36/48 (75) 14/17 (82) 0.741 
Family History for IAs (%) 15/65 (23) 13/48 (27) 2/17 (12) 0.478 
Smoker (%) 23/65 (35) 17/48 (35) 6/17 (35) 1.000 
Hypertensive (%) 28/65 (44) 21/48 (44) 7/17 (41) 1.000 
Anti-thrombotic medication 
(%) 
14/65 (22) 14/48 (29) 0/17 (0) 0.024* 
Statins (%) 16/65 (25) 15/48 (31) 1/17 (6) 0.086 
Type II Diabetes  6/65 (9) 5/48 (10)  1/17 (6) 1.000 
Size [mm3] 7.6 (4.6 – 15.6) 7.6 (4.6 – 14.5) 9.2 (4.8 – 15.6) 0.642 
Aspect Ratio 
Blebs/Lobulations 
1.06 (0.4 – 3.6) 
19/65 (29) 
1.05 (0.5 – 2.0) 
13/48 (27) 
1.18 (0.4 – 3.6) 
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Prevalence Rates of Calcification and Lipid Pools in IAs 
Calcification (%) 51/65 (78) 40/48 (83) 11/17 (65) 0.167 
Lipid pools (%) 39/65 (60) 29/48 (60) 10/17 (59) 0.783 
Both calcification and lipid 
pools (%) 
30/65 (46) 25/48 (52) 5/17 (29) 0.158 
Wall Type I, II (“Non- 
atherosclerotic calcification”) 
39/65 (60) 28/48 (58) 11/17 (65) 0.380 
Wall Type III (“Atherosclerotic 
calcification”) 
12/65 (18) 12/48 (25) 0/17 (0) 0.027* 
 
 
Median and range are given for continuous variables. *P<0.5 (χ2, Fisher’s Exact Test or Mann-Whitney U 
test). ¥ Other aneurysm locations in this study with a single case include ruptured aneurysms: BA tip, PICA; 
and unruptured aneurysms: ACA, PCOM-ICA, VA. Abbreviations used: MCA = Middle Cerebral Artery, 
ICA = Internal Carotid Artery, ACOM = Anterior Communicating Artery, PCOM = Posterior 
Communicating Artery, BA = Basilar Artery, PICA = Posterior Inferior Cerebellar Artery, ACA = Anterior 
Cerebral Artery, VA = Vertebral Artery. 
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6.3.2  Small, Dispersed and Large Aggregated Calcifications Exist throughout the Wall 
Thickness 
Calcification in the form of micro- and macro-calcifications were distributed in all three 
regions across the IA wall (Figure 59). Calcification in most samples occupied less than 0.1% of 
the sample volume (Figure 60A) and was approximately ellipsoidal in shape with an average 
aspect ratio of 0.39±0.21. 77.5% of calcified particles had a major diameter less than 30 μm. 
However, some calcified particles were as large as 3.87 mm (Figure 60B). For 70% of samples, 
no particular surface color was associated with calcification presence, even if calcification 
occupied a large volume fraction of the sample (Figure 59, row 1; Figure 60C, D). Calcification 
density, size (Figure 61) and area fraction in IA wall all increased with an increasing distance from 
the lumen, with largest values in the outermost third of the wall (Figure 60E). Additionally, thicker 
regions in the IA wall tended to have calcification in the outer third of the wall, whereas thinner 
regions tended to possess calcification in the inner and middle thirds of the wall (Figure 60F). 





Figure 59: Diversity of calcification morphology, location and tissue surface appearance as seen with high 
resolution micro-CT for four representative aneurysm samples (Rows 1-4).  
3D reconstructed and cross-section images of the micro-CT scans show calcification in yellow and non-
calcified tissue in grey. Cross section images are taken at locations indicated by a dashed white line in the 3D 
reconstruction image. L indicates lumen and insets show calcified region at higher magnification. Wall 
thickness contours are in mm. 


















Figure 60: Calcification volume fraction, size, visual manifestation and distribution. 
Calcification in human IAs (A) occupies less than 0.1% of sample wall volume, (B) exists mostly as small (< 
30μm) micro-calcifications which can exist in clusters and (C, D) does not associate with any specific tissue 
surface color even when it occupies a large volume.(E) Calcification area fraction increases with increasing 
distance from lumen (p = 0.016; n = 50). (F) Calcification in the outer third of the wall is found in regions of 
high relative wall thickness - the ratio of thickness in the calcified region relative to average wall thickness for 
that specimen (p = 0.0001,0.0001; n = 50) whereas calcification in the inner and middle layer occurs in region 
of average wall thickness. A relative wall thickness of 1 indicates the calcified wall region has a thickness 





Figure 61: Calcification size and density in wall layers 
(A) Calcification size and (B) density both increase with distance from the lumen with highest density and 




Qualitatively there was no visual difference in terms of presence, location or morphology 
of calcification and lipid pools in micro-CT images as a result of fixation (Figure 62A). 
Additionally, there was no differences in the relative attenuation levels of calcification and lipid 
pools due to fixation method, (Figure 62B) with calcification remaining in the 220-250 regime and 
lipid pools and tissue in the < 30 and 50 – 80 respectively. Furthermore, the calcification volume 
pre and post-fixation were evaluated (using same fixation as for the aneurysm samples, Material 
































































Table 10: Calcification volume pre and post fixation in three fixatives - 10% formalin, 3% glutaraldehyde 










Difference pre and 
post fixation 
Formalin 0.000583 0.000585 0.343 
Glutaraldehyde 0.0023 0.00236 2.608 






Figure 62: Comparison of cerebral vessels pre and post-fixation with micro-CT scanning. 
(A) 3D reconstruction of micro-CT scanned vessels, pre and post fixation in three different fixatives – 10% 
formalin, 3% glutaraldehyde and 4% paraformaldehyde. Calcification seen in yellow. (B) Cross section 





6.3.3  Calcification found in Atherosclerotic and Non-Atherosclerotic Forms 
Three IA wall types were identified (Figure 63); 39% (20/51) were Type I walls 
(calcification without any lipid pools; non-atherosclerotic calcification), 37% (19/51) were Type 
II walls (calcification that is never co-localized with lipid pools; non-atherosclerotic calcification) 
and 24% (12/51) were Type III walls (calcification co-localized with lipid pools; atherosclerotic 
calcification). When subcategorized by calcification particle size, samples with only micro-
calcification were the most prevalent accounting for 65% (33/51) of calcified samples. Most 
micro-calcifications were substantially smaller than the 500 μm upper bound for this category. In 
particular, 97% of micro-calcifications were less than 90 μm and 78% were less than 30 μm in 
size. These micro-calcifications could be found either in clusters or as isolated particles (Figure 
64C, D). All IA walls with meso- and macro-calcifications also included some (0.5 – 5%) dispersed 





Figure 63: Three main wall types found in aneurysm samples based on the relationship between calcification 
and lipid pools.  
Cross-section micro-CT images of representative calcified wall types present in IAs. Dotted regions indicate 
lipid pools. White and gold inset images show calcification and lipid pools, respectively, at high magnification. 




The existence of distinct non-lipid, non-inflammation associated calcification in the IA 
wall was confirmed in a region of Type II wall that had calcification without an associated lipid 
pool. The region was co-stained with lipid, free cholesterol and inflammatory markers. Both 
neutral lipids and free cholesterol were absent in the calcified region (Figure 64A), as were 
inflammatory cells (Figure 64B) such as macrophages and leukocytes. Positive controls are shown 





Figure 64: A region from a Type II wall presenting a non-atherosclerotic calcification region without an 
associated lipid pool.  
(A) Calcification (stained with OsteoSense) did not localize with neutral lipid (stained with BODIPY) or 
free cholesterol (stained with filipin) as typically seen in atherosclerotic plaques. (B) Inflammatory 
response was also absent as indicated by the absence of both CD45 stained pan leukocyte marker and 
CD68 stained macrophages at the calcified area.  Co-imaging of the relationship between collagen 
fibers and calcification particles under MPM showed (C) damaged regions of wall devoid of collagen 
fibers (red signal from second harmonic generation) were (D) filled with clusters of calcification 





Figure 65: Positive controls for immunofluorescent staining in a human cerebral aneurysm 
(A-B) and human tonsil (C-E) sample. Free cholesterol and neutral lipids are stained with (A) BODIPY and 
(B) Filipin respectively. Inflammatory cells are stained using (C) CD45, a pan leukocyte marker and, (D) 
CD68, macrophage marker. (E) shows the nuclei counterstained using DAPI . Negative controls for CD45 and 




6.3.4  Factors Associated with Ruptured Walls: Small Calcification Volume Fraction, 
Calcification Size and Non-Atherosclerotic Calcifications 
Ruptured IAs exhibited a lower calcification fraction than unruptured samples; a trend 
which existed across the three regions of the IA wall (Figure 66A). Furthermore, ruptured IAs did 
not contain macro-calcifications as opposed to unruptured IAs that possessed all sizes of 
calcification (Figure 66B).  
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Ruptured samples displayed only non-atherosclerotic calcification (calcification not 
associated with lipid pools- Types I, II) as opposed to unruptured samples which presented both 
atherosclerotic and non-atherosclerotic types (p=0.027). We did not find any significant 
differences in prevalence rates of either calcification or lipid pools between ruptured and 







Figure 66: Differences in calcificaiton fraction, wall types and calcification size with rupture status. 
(A) Ruptured walls have significantly lower calcification fraction than unruptured walls in human IAs, p = 
0.005, 0.006, 0.029 for inner, middle and outer thirds of the wall, respectively (n = 50). (B) Ruptured IAs are 
limited to either having no calcifications or “non-atherosclerotic” calcifications (Type I and Type II walls). No 
ruptured IAs display “atherosclerotic” calcifications (Type III walls) (p = 0.027*).  (C) with micro or meso-





This is the first analysis of the prevalence of micro through macro scale calcifications in 
the IA wall. We found very high prevalence rates of calcification in IA domes (78%), greater than 
previously reported in imaging [174], [191] and histological [181] studies. We believe this 
difference is due to the high resolution (1-3μm) ex vivo imaging modality used here, which enabled 
direct, non-destructive evaluation of calcification across the entire intact sample, including 
particles in the 3-30μm size range.  
This work is also the first to consider the possible existence of multiple mechanisms for 
calcification formation in the IA wall. Calcifications with and without associated lipid pools in 
extracranial arteries have already been shown to arise from distinct mechanisms. In particular, 
atherosclerotic intimal calcification of the extracranial arteries is found to be associated with later 
stages of an atherosclerotic process and is driven by lipid oxidation and inflammation. In contrast, 
the non-atherosclerotic medial calcification in extracranial arteries is not driven by a lipid 
oxidation induced inflammatory process but rather is attributed to aging as well as metabolite 
induced toxic changes that can arise from diseases such as renal insufficiency and diabetes mellitus 
[187], [188]. 
Motivated by these results for atherosclerotic and non-atherosclerotic type calcification in 
extracranial arteries, we introduced three wall types (I-III) to describe calcified IA walls and 
categorized these as containing “atherosclerotic” or “non-atherosclerotic” calcification. Type I 
walls (only calcification, no lipid pools) and Type II walls (calcification and lipid pools, not co-
localized) contained “non-atherosclerotic” calcification and accounted for 76% of all samples. 
Type III walls (include calcification that is located within or around lipid pools) are 
“atherosclerotic" and accounted for 23% of all samples. This Type III atherosclerotic pattern is 
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similar to later stage (type VII) atherosclerotic lesions in the classification of the American Heart 
Association (AHA) committee[197] where calcification is spatially associated with lipid pools and 
is formed through a lipid oxidation driven inflammatory process. Previous histological studies of 
the IA wall have shown that the VSMC phenotype[198] as well as lipoprotein accumulation and 
associated foam cell formation [199], [200] in the IA wall resemble changes accompanying 
peripheral atherosclerosis, further suggesting that some IA calcification shares common 
pathobiological mechanisms with calcification in atherosclerotic peripheral arteries.  
While inflammation driven, atherosclerotic like calcification has previously been studied 
in IAs[199], [200], the present work is the first to demonstrate calcification in IAs in the absence 
of lipids, suggesting a second mechanism of calcification formation is possible, potentially similar 
to non-atherosclerotic calcification in the medial layer of extracranial arteries.  In contrast to 
extracerebral vessels, the non-atherosclerotic calcification was distributed across with entire IA 
wall.  Cerebral arteries lack an external elastic lamina and the internal elastic lamina is additionally 
nearly universally missing in IAs. The absence of both these natural barriers in IAs could explain 
the more distributed nature of the non-atherosclerotic IA calcification compared with that in 
extracerebral vessels. 
To further assess the possible similarity of this non-atherosclerotic presentation in IAs with 
non-inflammatory calcification in extracranial arteries, a region from a Type II wall with 
calcification distinct from lipid pools was analyzed for lipid and inflammatory markers (Figure 
64A, B). The results confirmed that this calcification was not associated with lipids, cholesterol or 
inflammatory cells and was hence distinct from the typical atherosclerotic pathology outlined by 
the AHA. This non-inflammatory calcification in the IA wall was located near the IA lumen 
(Figure 64A, B).    
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In order to understand the potential mechanism of non-atherosclerotic calcification 
formation, we assessed the prevalence of renal failure and type II diabetes in our patient cohort 
since these conditions have been implicated in extracerebral non-atherosclerotic calcification 
formation [187], [188]. None of the patients in our cohort had kidney failure and only 9% had type 
II diabetes. Previous studies have also reported the existence of non-atherosclerotic calcification 
as a distinct form of calcification in the media of internal carotid arteries around the elastic lamina 
[201] and in peripheral artery disease[202]. Lanzer et al. [187] have conjectured that fragmented 
elastin can lead to such non-atherosclerotic calcification formation. Unpublished results from our 
group also show the presence of medial and adventitial calcification in control cerebral vessels. 
We therefore conjecture that at least some of the non-atherosclerotic calcification in the IA samples 
was formed due to the degradation of the elastic lamina in the cerebral artery prior to IA formation 
and would be exacerbated during IA formation. These findings suggest the need for future studies 
to understand the mechanism of non-atherosclerotic calcification formation. Building on the 
current work, an extensive evaluation of the prevalence, distribution and potential mechanisms of 
non-inflammatory calcification in IAs is the subject of ongoing investigation in our group. 
Another important and marked finding in our study is that ruptured IAs had a lower 
calcification fraction and lacked macro-calcifications as compared to unruptured IAs. The role of 
calcification in rupture is a subject of ongoing investigations. In the extracerebral vasculature, 
computational modeling studies show that larger calcifications in plaques can contribute to load 
bearing and hence play a protective role [183], [203]–[205]. Other studies have shown that plaque 
stress increases with increasing calcification, but only up to a certain limit, after which it plateaus 
or even reduces [206]. We surmise that larger plaques in IAs area can be protective against rupture, 
which would be consistent with the lack of larger plaques in ruptured IAs in our study.  It has been 
 202 
conjectured that micro-calcifications could also play a mechanical role in rupture by generating 
regions of elevated stress (stress concentrations) [183] -   leading, for example, to increased rupture 
risk in fibrous caps of extracranial arteries as well as in abdominal aortic aneurysms. Furthermore, 
the combined effect of collagen fibers, calcification and lipid pools on wall material properties 
ultimately dictates the mechanical behavior of soft tissues like the IA wall and this remains an 
ongoing area of investigation [179], [182]  
These potential differences in calcification pathologies and the expected mechanical role 
of calcification in wall vulnerability suggest a pressing need for further investigation of the multi-
faceted role of calcification in the IA wall. We anticipate that calcification will impact IA wall 
strength through a direct mechanical role as noted above, as well as an indirect pathological role 
related to aneurysm wall remodeling. For example, the cluster of micro-calcifications seen in the 
Type II wall (Figure 64C, D) exists within a pocket of distinctly damaged collagen fibers. A 
structurally deficient region of this kind could potentially reduce the local wall strength, increasing 
vulnerability to rupture. Hutcheson et al. have also shown that micro-calcifications associate with 
regions of reduced collagen fibers, and conjecture that collagen acts a scaffold for calcification 
aggregation[207]. These findings also suggest that the pathology and mechanics of collagen-
calcification interaction can determine IA wall strength. Further investigations of the role of 
calcification in  pathological changes of this kind can leverage the recently developed protocols 
for simultaneous  imaging of collagen fibers and calcification particles within intact samples [195]. 
These studies can be complemented by histological analysis of the IA wall to understand the 
indirect pathological role of calcification in IA wall remodeling.  
The present study also sheds light on recent efforts to infer information about aneurysm 
walls from intraoperative images. In particular, due to difficulty in obtaining IA samples for 
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analysis, intraoperative data on the aneurysm wall, such as color of the wall, are being collected 
as a possible surrogate markers of wall vulnerability [208], [209]. In this context, it is important to 
note there was no association between the presence of micro, meso or macro-calcifications and 
color of the aneurysm wall, reflecting a challenge in using intraoperative visual data to assess 
calcification in the IA wall.  
6.4.1  Limitations 
Prior studies of combined occurrence rates for lipid droplets and pools in the IA wall based 
on histological sections, reported prevalence rates of almost 100% [199], [200] . The high-
resolution micro-CT used in the present work is able to identify lipid pools across intact IA 
specimens, though is not suitable for resolving lipid droplets. Therefore, the prevalence rate of 
57% for lipid pools is not directly comparable to the results of the prior studies and may reflect the 
lower threshold for detecting lipids and lipoproteins compared with different histological staining 
methods. Other limitations of our study include small sample size and selection bias. Tissue was 
harvested from the aneurysm sac after aneurysm neck clipping only when it was feasible for the 
patients. Additionally, all aneurysm samples represent only one moment in time in their 
pathogeneses. Therefore, chronological order of wall changes and causal relationships between the 
changes remain unclear in this study setting. Nevertheless, we made every effort to include all 
relevant patient and sample information in order to better understand the population under study. 
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6.4.2  Conclusion 
In summary, we found calcification in intracranial aneurysms is substantially more 
prevalent than previously reported and manifests as both atherosclerotic and non-atherosclerotic 
types. Notably, ruptured IAs in this study had significantly lower calcification fraction in 
comparison with unruptured IAs, and only displayed non-atherosclerotic calcifications. Outside 
the brain, vascular calcification receives great focus as a potent player in mechanical stability of 
vessels and a target for pharmacological treatment [190]. Since no prior studies have assessed the 
prevalence, distribution or morphology of calcification in IAs with high resolution imaging 
modalities, there is an important gap in knowledge regarding even the presence of calcification in 
IA walls.  Our study bridges this gap and provides a motivation for future lines of investigations 
into IA pathology and the role of calcification in IA wall rupture that can impact risk assessment 
and IA treatment. Furthermore, this study provides an understanding of adverse remodeling in an 
extreme case of IAs. Appendix B also outlines a protocol used to image collagen fiber and 
calcification simultaneously. Taken together, these studies lay the framework for understanding 
the role of calcification in neoartery remodeling and designing mitigating strategies for its 
occurrence.  
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Appendix A Semi-Automated Salt Packing Device for Improved Repeatability of Graft 
Fabrication 
A.1 Introduction 
iTEVG microenvironmental parameters determine host cellular response, which in turn 
guide signaling pathways that determine long-term neoarterial fate. The iTEVG parameters not 
only dictate mechanical properties but also determine the initial foreign body response to the graft. 
In order to systematically investigate the role of host parameters (e.g. age, species etc.), there is a 
need to first ensure repeatable production of iTEVGs to eliminate variability in outcomes due to 
batch variability in graft production. 
As outlined in earlier chapters, graft fabrication consists of two key steps – i) creating the 
PGS core (packing salt into an annulus to create a the salt tubes – the negative for the PGS core, 
followed by adding PGS solution to the salt tubes, then leaching out the salt to recover the PGS 
core)  and ii) electrospinning the PCL sheath around the PGS core. The main element that 
introduces errors in fabrication is the salt packing stage. The error manifests itself either as gross 
geometric error in which the graft is not symmetric, or microscopic error, wherein the graft 
porosity is not repeatable or consistent across its length. Furthermore, the process of salt packing 
itself is highly inefficient and involves hand packing at the rate of roughly five tubes hour.  There 
are also losses associated with breakage of the packed salt tubes. 
In order to overcome these drawbacks, the goal of our work was to develop a machine that 
autonomously packs the salt tubes and decreases the packing time, while maintaining consistent 
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thickness and salt density (which determines graft porosity). This appendix will outline the details 
of the device developed to achieve these objectives.    
A.2 Design Requirements and Constraints 
A well-designed device must be capable of manufacturing 10 salt tubes/hour while meeting 
an 80% success rate. In order to be considered successful, a salt tube must meet the following 
requirements: 
1. The inner diameter should range from 0.75 - 0.80 mm.  
2. Wall thickness should range from 330 - 350µ𝑚𝑚 
3. Graft length should range from 15mm to 20mm.  
4. Total porosity of the tubes should be <= 25%. 
5. The 2D pore size distribution of the graft should range from 25-32 μm along the length of 
the graft.  
6. The salt tube must release from a 1.5 mm inner diameter polytetrafluoroethylene (PTFE) 
mold without cracking.   
7. The salt tubes should be axisymmetric. 
8. Packing time should be <5min/tube. 
9. The device should be modular. 
10. The device should have reduced human interaction. 
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A.3 Device Assembly Units 
The salt packing device was developed as an assembly of modular units. This modularity 
ensured ease of alignment and ease of future improvements to the device. The device can be 
described in 5 subassembly units - Tube Holder, Mandrel Assembly, Funnel Assembly, Plunger 
Assembly and the Support Structure. This section describes each of the subassemblies in detail. 
 
Tube Holder 
The tube holder is designed as the main housing chamber for PTFE tubes that are 
individually packed with salt and released from the machine for further processing. It consists of 
a 3D-printed cylindrical unit that houses 25 PTFE tubes (inner, outer diameter = 1.588mm, 3.175 
mm respectively)(Figure 67). Unlike the process of manual process, the holder prevents the PTFE 
tubes concentric with the mandrel to maintain axisymmetry. The tube holder also has a retaining 
plate is used to keep the tube flush with the bottom edge of the holder. After packing the tubes can 
be released using release mechanism for further processes like curing. Rotating the tube holder 
90° allows release of the tube through an indentation in the retaining plate from the machine for 
further processing. A push button switch activates a stepper motor that rotates the holder by 14.4° 





Figure 67: Tube holder assembly. 






The mandrel assembly consists of three parts; the inner mandrel, outer mandrel, and 
plunger holder (Figure 68). The inner mandrel is a 0.79 mm stainless steel 304 wire (McMaster-
Carr) that maintains the inner diameter of the salt tube. It is glued into an outer mandrel, which is 
made from stainless steel 304 and 302 hypodermic tubing (McMaster-Carr) and has an outer 
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diameter = 1.47mm and inner diameter = 0.81mm.  The purpose of the outer mandrel is to pack 
the salt as the assembly moves downward while the inner mandrel maintains the inner diameter of 
the tube.  These particular materials were chosen made to prevent buckling of the mandrel due to 







Figure 68: Mandrel assembly.  
The assembly is comprised of two mandrels that are press fit and held together in the holder that is attached 




The funnel assembly is used to guide a distributed flow of salt particles into the PTFE tubes 
in which the salt is then packed. The assembly consists of a custom designed, 3D printed funnel 
and a 20W Dayton Audio exciter (Dayton Audio, OH, USA) connected to a Lepai Tripath Class-
T Digital Audio Amplifier (Dayton Audio, OH, USA) (Figure 69). The entire speaker assembly is 
mounted on the funnel with two 6-32 screws. The screws allow for adjusting the distance between 
the speaker and funnel via tightening or loosening. The speaker enables creation of a repetitive 
series of impulses similar to that of a tapping motion shown to best produce salt flow during 
manual packing [111]. Salt flow is controlled by changing the frequency and amplitude on the 








Figure 69: Funnel assembly for salt packing device.  





The plunger assembly houses the mandrel assembly and enables automation of the packing 
routine. It enables application of force through a linear actuator guided mandrel assembly, centers 
of the mandrel assembly and stops the packing process when required. The assembly consists of a 
spring, set screw, bearings and a push button (Figure 70). The set screw-controlled spring is used 
to regulate the packing force applied through the application of a preload on the spring by 
tightening the set screw. The switch button is used to stop the packing routine through the push 
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button activation bolt. The activation bolt is triggered when a tube is entirely packed and the 







Figure 70: Plunger assembly. 
The plunger assembly is comprised of the mandrel assembly, linear bearings, a spring and push button for 
activation. The assembly enables translation of the mandrel assembly that pack salt crystals and stops when a 













The main frame features acts as the main supporting structure of the device. It consists 
three suction cup feet that keep the device anchored to a lab bench and serve as shock absorbers 
and a linear bearing rail. The main vertical support guides the linear actuator movement. It is 
reinforced with an aluminum rib to limit mandrel tip deflection to ≤ 0.355 mm. M3x0.5 mm socket 














The 3D and section view of the fully assembled device is shown in Figure 72 and Figure 
73. This device is controlled using Arduino hardware and Arduino’s Integrated Development 
Environment (IDE). An Arduino Uno microcontroller translates input signals and controls the 
motion of the actuator and stepper motor.  Figure 74 shows the circuit diagram for controlling the 























Item Number Part 
1 Actuator Mount 
2 Support Structure 
3 Linear Bearings (McMaster-Carr) 
4 Vibration Damper (McMaster-Carr) 
5 Funnel 
6 Linear Actuator (Progressive Automation, PA-14P-2-35) 
7 Modified Spacer 
8 Acrylic Base 
9 Suction Cup Feet (3X McMaster-Carr) 
10 Stepper Motor, (Sparkfun, 64 oz.in, 0.9 deg/step) 
11 Stepper Mounting Plate 
12 Shaft Coupler (5mm to 5/16 in, McMaster-Carr) 
13 Tube Holder 
14 Speaker Holder 
15 Speaker (Dayton Audio 20W exciter) 
16 Push Button Activation Bolt (McMaster-Carr) 
17 Push Button 
18 Plunger Holder 
19 Set Screw (McMaster) 
20 Spring (McMaster) 
















A.4 iTEVG Fabrication with Assembled Salt Packing Device 
Determining Packing force 
To achieve the appropriate salt density and thereby, porosity of the grafts, the salt tubes 
must be packed with the correct compressive force.  Packing the tubes too tightly prevents the salt 
from releasing from the PTFE tube while inadequate force keeps the salt from packing compactly 
and achieving the correct density. In previous studies, salt tubes were manually packed by “feeling 
the force”. In this section we aimed to determine the appropriate packing force required to achieve 
a final graft porosity ≥ 75%. 
The spring and set screw mechanism on the plunger assembly allow for adjusting the 
packing force.  As the set screw is tightened, it preloads the spring and increases the packing force 
while loosening it reduces the force.   
The baseline for packing force was determined with a manual test.  Tubes were filled with 
salt and packed on a scale to quantify downward force during packing. The tubes were then placed 
in a humidifier and released from the mold. Through a trial and error process, we determined that 
the optimal force required for packing tubes that did not crack or disintegrate upon release was 15 
N.  Using this data an appropriate spring with a spring constant 𝑘𝑘 = 20.22 𝑙𝑙𝑏𝑏𝑓𝑓/𝑖𝑖𝑎𝑎 was chosen.   
 
Packing Routine 
The packing routine begins by loading salt into the funnel and pressing a button on the 
breadboard. The exciter vibrates for 500ms, moving some salt into the PTFE tube before the 
actuator begins its downward motion. As the actuator moves downward (Figure 76a), the wide 
flange of the mandrel pushes the salt to the bottom of the PTFE tube (Figure 76b). After each 
compression cycle, the actuator moves the plunger assembly upward to allow more salt to funnel 
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into the hole.  In Figure 76c, note that the smaller diameter of mandrel remains in the guide hole 
throughout this process to assure symmetry. As the PTFE tube begins to fill up with packed salt, 
the packing force keeps increasing and the plunger assembly incrementally moves upward toward 
the push button activation bolt until eventually the plunger assembly hits the push button and stops 
the actuator movement.  This is the end of the packing process for one tube. After this, another 
button needs to be pressed in order to rotate the tube holder in order to pack the next PTFE tube. 
This process can be continued until the desired number of tubes are packed. These tubes can 
subsequently be released during any time after a tube has been packed by pushing against the PTFE 













Figure 76: Packing Routine 
(a) Actuator at the top of its stroke (top of salt tube), (b) actuator at the bottom of its stroke 
(bottom of salt tube), (c) salt refill stage. Note that the tip of the mandrel remains in the 





Figure 77: End of packing routine 





The packing routine ends when two conditions are met: 
1) The actuator only travels downward to a certain depth 
2) The push button is activated 
This state can be seen in the Figure below 
A.5 Conclusion 
In this chapter, we developed a semi-automatic salt-packing device that is capable of 
fabricating small diameter (800µm) salt molds at the rate of <5min/mold and >80% yield/batch. 
The device is capable of packing 25 tubes per session and is comprised of a modular assembly. 
Furthermore, we determined the ideal packing force required to repeatably achieve a graft porosity 
of 72% with pore size in the range of 25-32µm. These represent significant developments over the 
process of manually packing salt tubes which took a significantly longer time with lower yield and 
unrepeatable salt molds. A major limitation of this work is that these molds are not always 
axisymmetric. This is due to the high tolerances (20-50µm) required for fabricating these small 
diameter grafts.  This prototype design lays the foundation for the manufacture of the production 
device.  Parts which are currently 3D printed with lower tolerance for the prototype will be 
machined to tolerances needed to manufacture salt tubes with the required level of axisymmetry. 
 
Contributions 
The senior design team (Andrew Lawniczak, Elizabeth Craig, Nathaniel Kissen) fabricated 




Appendix B Simultaneous Imaging of Collagen, Elastin and Calcification in Intact Samples 
The work in this chapter was published in the following manuscript: 
Gade, Piyusha S., Anne M. Robertson, and Chih‐Yuan Chuang. "Multiphoton Imaging of 
Collagen, Elastin, and Calcification in Intact Soft‐Tissue Samples." Current protocols in 
cytometry 87, no. 1 (2019): e51. 
B.1 Introduction  
Soft biological tissues, such as arteries, heart, bladder, and skin, are layered composites 
containing collagen and elastin fibers. These load-bearing proteins represent the bulk of the ECM 
and play a primary role in determining the passive mechanical properties of soft tissues. It is widely 
acknowledged that cellular phenotype and function are influenced by the properties of this fibrillar 
architecture. This phenotype, in turn, influences rates of deposition and removal of collagen fibers 
[31], [210], [211]. Hence, understanding how pathological changes to the ECM alter the stiffness 
and failure properties of soft tissues is crucial for advancing the treatment of diseases such as 
cerebral aneurysms, aortic dissection, hypertension, and stroke [212]. A quantitative assessment 
of these fibers is also important for the design of tissue-engineered soft tissues, including blood 
vessels and other organs [31], [149] The organization of ECM proteins varies across the wall 
thickness and generally includes fibers oriented along orthogonal planes. Therefore, there is a great 
need for effective 3D noninvasive imaging of the fibrous structure of intact soft tissue samples, as 
2D histological studies cannot adequately capture this organization. 
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Multiphoton laser-scanning microscopy (MPM) is a powerful technique that can be 
leveraged for noninvasive 3D imaging of intact tissue volumes. MPM-induced intrinsic second-
harmonic generation (SHG) from ECM proteins such as fibrillar collagen combined with two-
photon emission (2PE) of elastin enable high-fidelity imaging without the need for exogenous 
staining. This approach offers an important advantage over other imaging modalities by enabling 
simultaneous imaging of the 3D microstructure of both collagen and elastin fibers at relatively 
large depths (typically hundreds of microns), including the layer-specific inter-relationship of 
these components. The imaging depth depends on the scattering and absorption coefficients of the 
tissue, the efficiency of the fluorophore, and the throughput of the optics. Background material on 
the principals of MPM imaging of biological tissues can be found in various sources [213]–[216]. 
Although SHG and autofluorescence imaging offers multiple advantages for collagen and 
elastin fibers, there is a need for complementary protocols for simultaneous imaging of additional 
wall components using stains and fluorescent probes. Ideally, these protocols would also be 
effective in fresh samples. Here, we provide such a protocol for simultaneous MPM imaging of 
calcification along with collagen and elastin fibers that is suitable for both fixed and fresh intact 
tissue samples. While calcification is a pathology of numerous soft tissue diseases, particular 
attention has been given to arterial calcification because of its importance as a major predictor of 
cardiovascular events [217]. Calcification can form in the intima of arteries through a slow, 
inflammation- driven, atherosclerotic-type process during plaque formation. A second mechanism 
for calcification is a non-atherosclerotic, phosphate-dependent mineralization in the media that is 
associated with aging as well as disease pathologies such as diabetes mellitus and chronic kidney 
disease [187], [202]. Given the involvement of calcification with the ECM, it is important to 
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understand the location of calcification within the wall as well its physical relationship with 
collagen and elastin fibers [74]. 
Since MPM imaging of intact sample volumes is time consuming, it is valuable to identify 
regions of interest (ROIs) to permit targeted scanning. In the first protocol in this article, we 
provide a methodology to achieve this objective using microcomputed tomography (micro-CT), 
which creates a 3D geometric model of the sample along with wall thickness and calcification 
maps. We demonstrate how these maps can be used to guide the MPM studies. Targeted 
approaches of this kind are particularly important for unfixed (fresh) tissue samples, which degrade 
over time. The second protocol provides the methodology for MPM imaging of collagen, elastin, 
and calcification within the ROIs of the intact specimen. Fiducial markers on the tissue specimen, 
visible under micro-CT, are then used to identify the ROIs in the sample under MPM. This protocol 
also provides methods to obtain quantitative data from MPM images, including fiber orientation 
and waviness, important metrics critical for understanding the mechanical properties of soft 
tissues. 
B.2 Basic Protocol 1: Use of microcomputed Tomography for A Priori Selection of Imaging 
Location 
To scan a square millimeter of tissue (four 500 µm2 regions) of 200 µm thickness by MPM 
requires on the order of 1 to 2 hr. It is therefore valuable to identify ROIs prior to MPM imaging, 
particularly for fresh sample analysis. In this first protocol, noninvasive 3D micro-CT scanning of 
the tissue specimen is performed to generate a 3D geometric model of the sample with a 
corresponding wall thickness map and 3D calcification map. Regions for focused MPM analysis 
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are then chosen using the 3D geometric model based on features such as focal areas of 
calcification. The preferred scan region is located on the fresh tissue sample through the use of 
fiducial markers (dye and beads) that are visible in the micro-CT model. This protocol is designed 







Figure 78: Preparation and assessment of calcification and geometry using micro-CT.  
(A) Dissection scope image of a PFA-fixed aneurysm. (B,C) Mounting setup for micro-CT scanning (B) and a 
3D reconstructed image of the micro-CT data (C) for an aneurysm sample with calcification (yellow) and 
tissue (gray). Note the beads on both the physical and reconstructed sample. These beads and dyes serve as 
physical markers for mapping MPM images to the 3D CT images and the physical samples. (D) Wall 
thickness map of aneurysm sample constructed from micro-CT data. This map can be used for selecting 
appropriate ROIs for MPM imaging 
 
Materials 
• Tissue sample to be imaged  
• Wet gauze  
• Tissue dyes: Davidson Marking System dyes (Bradley Products Inc.), preferably 
blue and/or red (see step 2) 
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• Dissection microscope (Olympus SZX10)  
• 200 to 300µm polystyrene beads (e.g., Polysciences Inc.)  
• Loctite 404 glue (McMaster-Carr) 
• 1.5-ml clear microcentrifuge tube (e.g., Thermo Fisher Scientific) 
• Mounting brass stub  
• Desktop microcomputed tomography (micro-CT) scanner (Skyscan 1272, Bruker 
highest magnification) Corporation, Belgium; resolution = 0.35 µm (16 megapixel 
X-ray detector)   
• Computer hardware and software for image acquisition, reconstruction (NRecon, 
Bruker Corporation, Belgium), and analysis (Simpleware ScanIP, Synopsys, 
Mountain View, CA, USA) 
 
Application of fiducial markers  
1. Dry the sample using Kimwipes until no excess fluid is visible on the tissue 
surface.  
2. Place the sample under the dissection scope and mark fine dots in a grid structure 
using the tissue dyes (Figure 78A). This grid structure is visible under MPM analysis and 
enables the mapping of MPM imaging locations to CT images (step 3). Turn off the 
dissection scope light and let the sample stand for 5 min to allow the dye to bond to the 
tissue surface. Turning off the light helps avoid any potential damage to the tissue. 
Although in principle, any color of Davidson dye could be chosen for tissue 
marking, the chemical makeup of each dye is different. Therefore, in addition to having 
different contrast with the tissue, the different colors of dye also have varying affinity with 
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the tissue. We found that the blue and red dyes provide the best results for vascular tissues. 
The yellow and orange dyes do not provide sufficient contrast with the tissue surface color, 
while the green and black dyes are highly miscible in water and can spread excessively on 
the tissue surface. 
3. Attach marking beads over the dye location using a small amount of Loctite 404 
glue (Figure 78A). 
Loctite 404 glue was chosen for attaching the beads as the application of this 
adhesive is easily controlled and little glue volume is needed. These features ensure there 
is negligible change to tissue material properties. The beads are visible under micro- CT; 
however, they can detach and separate from the tissue during the preparations for MPM 
scanning. Although the dye mark cannot be detected under micro-CT, it is more permanent. 
Therefore, this bead/dye combination guarantees that beads will be visible under micro-
CT and that dye marks (and possibly some beads) will be visible under the MPM, while 
avoiding excessive use of adhesive. This ensures the presence of sufficient markers to 
register points from the surface of the 3D micro-CT data set to MPM images. 
 
Tissue mounting in micro-CT scanner  
4. Place wet gauze or Kimwipes at the bottom of a 1.5ml clear microcentrifuge tube 
to prevent sample dehydration during scanning. Place the sample vertically on top of the 
gauze at the center of the tube (or on top of an added piece of Styrofoam, if needed to help 
position sample) and seal it tightly (Figure 78B). 
To ensure maximum field of view, place the sample in the center of tube, 
symmetrically located with respect to the vertical axis. Alternatively, if the sample is very 
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small, Glad R? cling wrap can be used to mount the sample on the stub [218]. This 
particular brand of wrap has been found to avoid substantial X-ray attenuation. 
5. Place the microcentrifuge tube vertically on the mounting brass stub and seal the 
tube to the stub using Parafilm sealing film (Figure 78B). 
6. Mount the stub onto the micro-CT scanner. 
 
Tissue scanning  
7. Scan the sample using the settings outlined here while maintaining a scan time 
of <2 hr for fixed samples and <1.5 hr for fresh samples to prevent sample dehydration. 
Note that the settings will vary slightly depending on the sample dimension. Samples image 
pixel size of 1 to 3 µm, frame averaging of 8 to 10, and rotation step size that have 
dimensions <1cm × 0.5 cm can be scanned at 50 kV, 200 µA, with an of 0.1° to 0.4°, 
scanned 180° around the vertical axis. Since this protocol pertains to biologic tissues, no 
filter is used for scanning. However, aluminum, copper, or a combination of the two can 
be used for samples with higher density.  
A flat-field correction is done prior to every scan to ensure optimal image contrast.   
Two hours is a conservative estimate for micro-CT imaging affixed tissue samples using 
this procedure. Thicker samples will dry out more slowly and can be scanned for a longer 
time if required. If the sample does dry out, the corresponding change in sample volume 
will generate misalignment artifacts that will be seen during post-processing. 
 
Creation of sample volume and selection of region of interest  
8. In order to ensure optimal image quality, correct the images for the most 
commonly occurring CT artifacts, such as beam hardening and ring artifacts. Then, select 
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an ROI and corresponding volume of interest for reconstructing raw CT images. The 
interested reader can reference the NRecon User Manual for further details on image 
reconstruction. 
9. Segment calcification from the reconstructed tissue data set using one of a variety 
of image processing software (e.g., MATLAB, ITK, VTK, Slicer 3D, etc.). In this protocol, 
we use Simpleware ScanIP for image analysis owing to the ease with which high-quality 
surface mesh from CT data can be generated with this software. Segment the calcified 
regions (regions of relatively high grayscale value) using a combination of thresholding, 
connected regions filtering, Boolean operations, and Gaussian smoothing to create a 
calcification mask. Create a second mask for the tissue with beads. To enable 3D 
visualization of the calcification within the tissue sample, overlay these masks (Figure 
78C). 
The interested reader is referred to the online Supporting Information for detailed 
methodology for segmentation and analysis of calcification and tissue. 
10. Select the ROI for MPM analysis using the overlaid image based on the 
scientific objective of the investigation. For example, in Figure 78C, an ROI is selected for 
a targeted MPM study (rectangle) due to the clustering of calcification in that region. 
11. MPM imaging can also be targeted on the basis of geometric features such as 
sample thickness or interfaces between thick and thin regions. These geometric features 
can be evaluated from the surface/volume mesh and thickness maps for the sample. In this 
protocol, we have used Geomagic (3D Systems) for this purpose, using an analysis function 
for wall thickness maps (Figure 78D). 
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B.3 Basic Protocol 2: Simultaneous Second-Harmonic Generation and Two-Photon 
Excitation Imaging of Collagen, Elastin, and Calcification 
In this protocol, we describe how to use MPM-induced SHG and 2PE imaging to detect 
collagen and elastin in soft tissue along with calcification, which is made visible using a far-
infrared tracer. Using this technique, it is possible to nondestructively investigate the three-
dimensional structural relationship between ECM and calcification. This protocol can be used to 
image either fresh or fixed tissue samples. We illustrate some key results using a fresh human 
cerebral artery and a fixed specimen from a human cerebral aneurysm. 
 
Materials 
• Osteosense 680 stock solution (see recipe) 
• 10X PBS 
• Tissue sample to be imaged 4% paraformaldehyde (PFA)  
• Custom-made sample chamber (Figure 79) assembled from two threaded metallic 
rings (e.g., IDEX Health and Science), a silicone gasket (e.g., Roettele Industries), 
and two 18-mm-diameter round microscope glass coverslips (e.g., Thermo Fisher 
Scientific) 
• Olympus FV 1000 Multiphoton Microscope Spectra-Physics DeepSee Mai Tai 
Ti:Sapphire laser (Newport Corp.) 1.12-NA 25X multiphoton excitation (MPE) 
water-immersion objective Backscatter epifluorescence detectors 350 to 450nm 
emission filters with 50 spectral bin (Chroma Technology)  
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• Computer hardware and software for 3D reconstruction of MPM images and fiber 
analysis: e.g., Imaris 9.2 (Bitplane) or CT-Fire, an open source software developed 
by researchers at the University of Wisconsin Madison [152]. 
 
Sample preparation with calcium stain  
1. Dilute the Osteosense 680 stock solution (a near-infrared bisphosphonate-based 
calcium tracer) 1:50 (v/v) with PBS. 
2. If staining a fresh sample, incubate the intact sample in the calcium tracer for 24 
h at 4°C in dark. 
3. If staining a fixed sample, fix the intact sample for 24 h in 4% PFA. Rinse the 
sample and incubate it with the calcium tracer for 24 h at 4°C in the dark. 
4. After incubation, rinse the sample thoroughly with 10X PBS.  






Figure 79: Ring assembly for MPM imaging.  
(A) Two threaded round metallic rings with coverslips and appropriately sized gaskets. (B) Sample placed 
onto one half of the assembly and immersed in 10× PBS. (C) Completed assembly after the two metallic rings 






6. It is important that the sample is securely held during MPM imaging to minimize 
artifacts from sample movement. As the soft tissue is often composed of layers, it can be 
advantageous to slightly flatten the tissue so that it can be imaged orthogonally to these 
layers. For these purposes, we use a simple custom-made chamber that can be placed on 
the MPM stage (Figure 79), consisting of two concentric metallic rings, with threads on 
the inner and outer surface, respectively, two round coverslips, and a gasket (Figure 79A), 
whose thickness determines the internal chamber height. To assemble the chamber, place 
a round glass coverslip within one ring and place the the second coverslip over the tissue 
with the metallic ring on top (Figure 79B and C). gasket on the coverslip, followed by the 
tissue sample. Fill with 10X PBS and place After ensuring that no air bubbles are present, 
tighten the coverslip-ring assembly. 
Once the chamber is assembled, notations can be marked on the outer coverslip to 
identify the imaging side (e.g., luminal) and, if desired, a grid can be drawn on the glass 
to clarify the orientation (Figure 80A). The spacing between the rings can be altered by 
selecting gaskets of different thicknesses. 
As an alternative, hanging-drop slides (Fisher Scientific) of appropriate depth can 
be used to secure the sample. These are available in varying depths from 1.4 to 3.2 mm. 
Place the sample in the slide, fill with PBS, and cover with disposable coverslips. However, 
the sample will generally be held more securely and flattened more effectively with the 
custom chamber.  
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Image acquisition  
7. Place custom chamber on the microscope stage and add distilled water on the top 
coverslip of the chamber so that the lens is immersed in water during imaging. 
8. Select the appropriate settings for MPM imaging. The following settings work 
well for imaging collagen, elastin, and calcification with a 1.12-NA, 25X MPE water- 
immersion lens: 800 nm excitation wavelength, dwell time of 8 µs/pixel, scan pixel count 
of 1024 × 1024, and laser intensity of 7%. 













Figure 80: Simultaneous MPM imaging of calcification and collagen.  
(A) Aneurysm sample mounted in custom-made device to hold tissue sample steady and flat during the 
course of MPM imaging. The xand ydirections have been marked manually on the coverslip. (B) 
PFA-fixed aneurysm sample marked with tissue dye and polystyrene beads. Areas of zoomed images 
in later panels are indicated. (C) Montage of area C showing projection of 3D stacked MPM images 
of collagen (red) and calcifi- cation (magenta). (D) Zoomed images of location D. From left, note the 
degraded collagen fibers in regions that are occupied by calcification. At right, 3D image showing 





9. Take sequential scans across the thickness (a z-stack series) at 2µm intervals. 
The locations of the first and last images of the z-stack series are chosen based on a fast 
prescan using a coarse setting. 
Samples can be scanned from both the luminal and abluminal sides and can 
typically be imaged to a depth of 200 to 300 µm without optical clearing, depending on the 
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signal intensity from the components of the ECM. For example, the elastin in the internal 
elastic lumina of cerebral arteries has strong autofluorescence that can prevent imaging 
through to the medial collagen fibers for unloaded samples. However, when the cerebral 
artery is mechanically stretched, the medial collagen can usually be imaged from the 
luminal side. 
10. Collect SHG signal from collagen using backscatter epifluorescence detectors 
and 350 to 450nm Chroma emission filters with a 50 spectral bin. Collect the intrinsic 
elastin 2PE signal using a 500 to 550nm filter and calcification signal using the fluorescent 
calcium tracer signal in the 665 to 735nm range for either fixed (Figure 80C and D) or 
fresh samples (Figure 81). 
The emission range for the calcium tracer provided by the manufacturer was used 
to select the optimal filter to use for MPM scanning. An excitation wavelength of 800 nm 
provided good signal quality for the calcium tracer, thereby allowing simultaneous 
imaging of collagen, elastin, and calcification. As a result, it is possible to see all three 
components in images and 3D reconstructions where the signals are combined, enabling 
analysis of the interactions between these three components. 
 
Three-dimensional image reconstruction  
11. Create 3D image volumes from the acquired z-stack series of images using software such 
as Imaris 9.2 (Bitplane) (Figure 80 and Figure 81). 
After this point, collagen, elastin, and calcification can be quantitatively analyzed in the 








Figure 81: Projections of 3D stacks from MPM imaging of a fresh native human cerebral vessel, imaged en 
face from luminal (top panel) and abluminal (bottom panel) sides.  
(A) Internal elastic lamina (IEL) (green) with visible fenestrations. (B,C) Calcification (magenta) visible on 
the lumen side along the IEL. (D–F) Thick, wavy adventitial collagen fibers (red; D) and calcification 




Quantitative analysis of collagen fiber orientation and waviness  
12. Calculate metrics of fiber orientation and waviness on each individual axial slice or by 
tracing collagen fibers using manual filament tracing (Figure 82A). In this protocol we 
used the commercial software Imaris 9.2 (Bitplane) to manually trace fibers and thereby 
ensure that the filament captures the curves of the fibers to obtain accurate measurements 
of fiber waviness [12]. Waviness and fiber orientation can be determined using built-in 
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functions within Imaris. The variation of these metrics across the wall thickness can be 
visualized using, for example, a heat map or rose plot (Figure 82B and C).  
Collagen fiber orientation and waviness are important structural features of soft tissues 
that influence their mechanical function. For example, fiber waviness enables a sample to 
undergo large deformations with very little load (high compliance), as occurs in arterial 
collagen fibers. Once the collagen fibers are straightened, they contribute to load bearing, 
leading to a stiffer response at higher strains [12]. By obtaining quantitative descriptions 
of these features, tissue structure can be compared, for example, between treated and 
untreated tissue or between diseased and healthy tissue. Furthermore, this information can 
be used to develop mathematical equations (constitutive models) with which to model the 
mechanical responses of these tissues [12].  
The conformation of the collagen and elastin fibers can be extracted from single planar 
images either through the manual tracing described here, or through automated methods 
that include 2D discrete Fourier transform analysis [219], and a combination of fast 
Fourier transform and wedge filtering [220]. We find the fiber-tracing approach preferable 
for evaluating the fiber straightness (inverse of waviness) and obtaining average fiber 








Figure 82: Manual fiber tracing to determine collagen fiber orientation and waviness using Imaris 9.2.  
(A) Volume projection of collagen fibers (images in Fig. 4D) with fiber tracings. Each image fiber orientation 
distribution. (C) Heatmap of fiber straightness as seen across the imaged wall is a 500 µm × 500 µm projected 
stack of 2-µm-thick sections. (B) Circular rose plot of collagen thickness of the sample. Top row represents 
luminal side and bottom row represents abluminal side of sample. (D) Areal density of calcification and 








Quantitative analysis of collagen and calcification areal density  
13. Calculate calcification and collagen areal density by analyzing the separate 
color channels in each image. Using a custom-written MATLAB script (MATLAB2017A) 
(see Supporting Information online), load images and separate color channels. Segment 
each of the constituents (collagen and calcification) using Otsu segmentation [221] in their 
respective channels. Calculate the area of segmented pixels in each slice and sum up the 
segmented area across the volume to calculate total areal density in the image volume 
(Figure 82D). 
B.4 Reagents and Solutions 
 Osteosense stock solution: gently shake or vortex to ascertain that the agent is fully in 
solution. Keep the stock Add 1.2 ml of 1× PBS to one vial of Osteosense 680 solution (Perkin 
Elmer) and solution wrapped in aluminum foil at 4°Cfor <2 months. 
B.5 Commentary 
Background Information Quantitative evaluation of the microstructure of biological tissue 
samples is essential for understanding tissue function, disease pathologies, disease progression, 
and the role of therapeutic agents. Classical histological techniques have been instrumental in 
elucidating the microstructural anatomy of various tissues, which has improved understanding of 
the related physiology and also contributed to the design of novel treatment strategies of image 
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alignment [222], montaging [223], and autofocusing have markedly increased the utility of serial 
sectioning for 3D visualization of tissue microstructure [20]. However, histological techniques are 
inherently destructive, must be conducted on fixed, processed samples, are associated with a 
number of artifacts, including tissue shrinkage, changes in morphology, tears, detachment of 
layers, and folds, and can be applied to only small volumes of tissue [224]. Therefore, there is a 
great motivation to develop protocols for directly imaging whole volume samples. 
MPM leverages the intrinsic SHG and 2PE signals from collagen and elastin, respectively, 
to provide high imaging depth, typically on the order of hundreds of microns. This is in contrast 
to confocal imaging, which has significantly smaller imaging depth (<100 µm) due to the lack of 
localization of imaging to a single spot, which increases out-of-plane emission. However, many 
tissues, such as the walls of many extracerebral vessels in humans and larger mammals, are thicker 
than 1 mm and therefore beyond the MPM imaging depth using the approaches described here. 
Both confocal and MPM imaging depth can be increased by optically clearing the tissue using 
solutions with refractive indices closer to those of the wall components, reducing light scattering 
[225]. Although this process cannot be used on fresh tissue samples, it can increase imaging depths 
in fixed samples by orders of magnitude. 
Imaging of intact, fresh specimens using MPM also opens up the possibility of analyzing 
changes in tissue structure during mechanical loading. For example, using custom-MPM 
compatible uniaxial and biaxial mechanical testing devices, our group has elucidated the role of 
collagen fiber waviness in determining the material properties for rabbit carotid artery [12] and rat 
urinary bladder wall [212], respectively. Thus, MPM is crucial not only for understanding the 
anatomical microstructure, but also for developing mathematical descriptions of the role of this 
microstructure in determining the mechanical function of the tissue. These models can be used to 
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quantitatively compare tissue in health and disease as well as to test hypothesis about the 
mechanical role of wall components. 
Intrinsic MPM-induced SHG and 2PE signals can be combined with fluorescent tracers 
that do not interfere with the emission range of collagen and elastin to simultaneously image other 
wall components such as cell nuclei, flavins, NAD(P)H, porphyrins and lipofuscins. A list of stains 
with their emission spectra is provided by Bestvater et al. [226] In this protocol we introduce the 
use of a calcium tracer, Osteosense 680 (Perkin Elmer, MA, USA) for use with MPM. This tracer 
was previously used with confocal microscopy by Hutcheson et al.[207] to study the role of 
microcalcification in atherosclerotic plaque rupture using collagen fiber SHG signal. Here, we 
adapted their protocol for MPM analysis of both fresh and fixed samples, enabling simultaneous 
imaging of calcification and intrinsically fluorescing ECM components (collagen, elastin) up to 
depths of hundreds of microns. In vivo two photon calcium imaging has been extensively used in 
the neuroscience community to detect neuronal activity at high depth and high resolution [227]–
[229]. In this protocol, the focus on complimentary calcium staining is motivated by its role in soft 
tissue pathologies. For example, ectopic calcification of vascular tissue is associated with 
cardiovascular risk fac- tors such as hypertension, inflammation and chronological aging [230], 
[231]. While it has long been understood that large calcification deposits will alter the mechanical 
and transport properties in arteries, the potential role of even small (micro) calcifications in altering 
tissue mechanics is being explored in the context of atherosclerotic plaque rupture [183], [207]. 
This unit provides the techniques necessary for achieving the resolutions required to image the 
calcification-ECM interaction and ultimately can be used to quantify the effect of calcification on 
ECM recruitment and mechanical function during loading. 
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Micro-CT, conventionally used for imaging hard calcified tissue inclusions, has also been 
used in imaging soft non-calcified tissue, especially in the presence of X-ray contrast agents. 
Metscher [232] provides a comprehensive overview of various contrast agents suitable for soft-
tissue X-ray imaging. While the micro-CT protocol described here was introduced for the purpose 
of selecting regions of interest within the tissue sample, it can also be used for a variety of 
applications that re- quire structural assessment. For example, our group has previously 
demonstrated the use of high-resolution micro-CT to analyze the role of fabrication technique on 
tissue engineered vascular grafts [154] as well as their in vivo and in vitro degradation rates [150]. 
The combination of nondestructive imaging modalities such as micro-CT and MPM offers unique 
opportunities for targeted assessment of the wall content in heterogeneous materials. The 
resolutions achieved by both of these techniques for imaging calcification are comparable to that 
of standard histology, but the nondestructive techniques avoid common artifacts associated with 
mechanical sectioning and staining of samples. The protocol introduced here uses micro-CT to 
first image the entire samples to guide the selection of ROIs for detailed study of ECM-
calcification inter- faces. Using the micro-CT model of the physical sample, the MPM 
microstructural data can also be mapped to computational data for blood flow and mechanical 
loading within the wall [158], [194]. Mapping of this kind is particularly important when there are 
heterogeneities in the tissue, including those due to disease and structural heterogeneities such as 
those at the bifurcations of arteries. 
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B.6 Critical Parameters 
 
Sample stability during imaging  
The sample must be held stationary during MPM imaging, either by using a custom 
chamber such as the device described here or by placing the sample in a slide with a well. 
Furthermore, clay (Renishaw Inc., part no. A- 1085-0016) can be used to ensure that the device 
itself is affixed to the micro positioning stage during imaging and that there is negligible device 
movement. 
 
Sample stability and centering in CT  
If the sample cannot be held vertically in the center of the mounting tube, place some 
Styrofoam (or other material of similar low density) around the sample to ensure that it does not 
move. Image quality can also be compromised by “movement” caused by the sample drying out; 
therefore, ensure that wet gauze is placed at the bottom of the tube prior to scanning. If the sample 
still begins to dry out, wet gauze can also be placed on top of the sample. 
 
Micro-CT scanning time  
As outlined in Basic Protocol 1, sample scanning time must be <1.5 h for fresh and <2 h 
for fixed tissue samples to prevent sample dehydration and image movement artifacts. This can be 






Table 12 lists problems that may arise with these procedures as well as their possible causes 
and solutions. 
Anticipated Results  
If the protocols outlined above are followed, simultaneous MPM images of collagen, 
elastin, and calcification can be acquired and mapped to the 3D in silico model of the physical 
sample that is created from the micro-CT data. These images can help in better understanding the 
ECM structure and its integrity from either qualitative and/or quantitative analysis. For example, 
in some cases damaged fibers will be revealed and recognized as representing a disease pathology 
(Fig. 3C and D). The data can then be used to quantify the local interaction and morphological 
changes to elastin and collagen due to the presence of calcification. The location of calcification 
within the wall can be quantified and metrics like the percentage of calcified area in the sample 
can be calculated [158]. Thus, the micro-CT model can not only serve as a mapping tool but also 
provide geometric information about the sample and a bulk assessment of calcification burden. In 
addition to guiding MPM studies of the tissue, the micro-CT data can be used to select regions 
within the large tissue samples for mechanical testing. For example, guided by the micro-CT data, 
specimens for mechanical testing can be cut from the larger sample so as to include clusters of 
micro-calcifications. The tissue specimen will then be well suited for evaluating the impact of 
these particles on tissue mechanical properties. Quantitative data on collagen fiber orientation and 
waviness enables the development of structurally motivated constitutive models that 




Time Considerations  
The time required for this protocol from the time the sample is acquired will vary based on 
whether the sample needs to be imaged fresh or fixed, its size, and the number of locations that 
need to be scanned by MPM. For fixed tissue, a fixation time of 24 h followed by 24 h of incubation 
with calcium tracer adds up to 48 h for sample preparation prior to any imaging. The preparation 
time for a fresh sample is 24 h. Both fixed and fresh samples can be scanned using micro-CT for 
<2 h depending on sample size. The MPM scanning time also is the same for fresh or fixed samples 
and will vary based on the depth and area of scanning: each 500 µm × 500 µm × 200 µm section 

















Table 12: Troubleshooting Guide for MPM Imaging of Collagen, Elastin, and Calcification 
 
 
Problem Possible Cause Solution 
Poor or no calcification signal Inadequate diffusion of 
calcium tracer due to high 
(>450µm) sample thickness. 
Increase incubation time with 
calcium tracer. 
Check if solution is still 
viable (is within 2 months of 
preparation date). 
Poor or no collagen, elastin 
signal and high background 
noise 




Inadequate dwell time  
 
Sample movement  
 
 
Inadequate immersion of lens 
in water 
Optimize laser intensity 
(typical range = 4 – 7%) 
Optimize wavelength (typical 
range = 800 – 870 nm) 
Optimize dwell time (typical 
range = 4 - 8µs/pixel) 
Ensure the sample is fixed to 
stage. Fasten the imaging 
device to stage using putty 










PSG developed the protocol for micro-CT and two-photon imaging of calcification and 
ECM components. PSG performed the micro-CT scanning, reconstruction, and analysis. CYC and 
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